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Summary 
M. haemolytica, H. somni and Pasteurella multocida are the main bacterial agents 
involved in the multifactorial Bovine Respiratory Disease complex (BRD), along with viral 
coinfections such as bovine respiratory syncytial virus (bRSV). This disease complex costs 
the agricultural industry vast sums of money annually due to morbidity, mortality and 
the costs of metaphylaxis, prophylaxis and treatment. Vaccines and antibiotics are 
available for certain strains of these species, however, the increasing incidence of 
antibiotic resistance is decreasing the effectiveness of many of these drugs. It is 
therefore vital to discover new antimicrobial targets, enabling the continued and ideally 
improved prevention and treatment of the diseases these pathogens cause. 
This project investigated homologues of a protein identified in Neisseria meningitidis, 
known as Gonolysin 1 (Gly1).  N. meningitidis Gly1 was previously implicated in haem-
iron uptake in vitro, a phenomenon that was also observed with the Neisseria 
gonorrhoeae homologue. Iron uptake is essential for bacterial survival and is an 
important virulence factor. A recognised mechanism to limit bacterial growth is iron 
sequestration; preventing the bacteria from accessing haem or iron sources is therefore 
a potential target for therapeutic intervention. 
Putative Gly1 homologues were discovered in other economically relevant bacterial 
species. With the aim of characterising these homologues in M. haemolytica, A. 
pleuropneumoniae and Salmonella enterica arizonae (IIIa), the genes predicted to 
encode the Gly1 proteins were cloned and overexpressed in E. coli cells.  
These proteins were studied using a range of experimental techniques to elucidate their 
biological function. To further characterise the protein structure, biophysical 
approaches such as circular dichroism, X-ray crystallography and bioinformatics were 
employed. A crystal structure of the M. haemolytica paralogue (MHpara) was deduced, 
along with the functions of a number of these novel proteins. While the homologues 
discovered in M. haemolytica and S. enterica arizonae (IIIa) showed interactions 
supporting the haem- binding hypothesis, the A. pleuropneumoniae homologue and 
MHpara did not. MHpara did, however, display some adhesion to respiratory tissue. To 
conclude, not all Gly1 homologues have the same function with some involved in 
nutrient uptake and some potentially involved in virulence.
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1 Introduction 
1.1 Key Bacterial Pathogens 
1.1.1 Pasteurellaceae 
The Pasteurellaceae family of gammaproteobacteria currently consists of 78 species, 
which are made up of 21 genera; Mannheimia, Haemophilus, Histophilus and 
Actinobacillus form the genera of interest in this family (Euzeby, 1997). They are all 
Gram-negative, rod shaped, non-motile facultative anaerobes. These species have been 
reclassified a number of times in recent decades due to the development of more 
sophisticated genetic identification techniques. Within the Pasteurellaceae family are 
species that are capable of existing as commensals and/ or pathogens in vertebrates. 
Haemophilus influenzae, for example, is an opportunistic human pathogen, often found 
as a commensal yet able to cause respiratory disease. The various species of 
Pasteurellaceae can be differentiated by their phenotypes such as haemolytic activity, 
indole production, β-NAD dependence and enzymatic activity as well as analysis of 16S 
sequences (Dousse et al., 2008).  
Other bacteria from this family inhabit similar niches in many other species, colonising 
the mucosal surfaces of the respiratory tract, oropharynx and reproductive tracts. For 
example, Mannheimia haemolytica exists as a commensal in ruminants, mainly found in 
the bovine and ovine nasopharynx. These bacteria are again able to make the switch 
from commensal to pathogen when the host is stressed or immunocompromised, 
leading to respiratory disease. Infection often occurs during transport of herds of 
animals- known as ‘feedlots’- between farms giving rise to the name ‘Shipping Fever’. 
This is due to the heightened stress caused by transportation and the close proximity of 
the animals being moved. In the case of cows this is known as Bovine Respiratory Disease 
(BRD).  
In addition to BRD, this bacterial family is responsible for infections in many mammals 
and other vertebrates from cows, to pigs, to chickens. The major pathogens isolated 
from diseased animals are Pasteurella multocida, Bibersteinia trehalosi, M. haemolytica, 
A. pleuropneumoniae, Haemophilus parasuis, and Avibacterium paragallinarium 
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respectively. Disease in these species is responsible for huge economic losses in the 
agricultural industry. Pneumonia is the most common symptom of disease arising from 
Pasteurellaceae infections, although further pathology does occur including mastitis in 
sheep and severe systemic infection.  
In addition to the respiratory tract, H. somni also resides in the reproductive mucosa 
and, like other bacterial species mentioned, can cause systemic disease in the bovine 
host with comorbidities including septicaemia, infertility and abortion, myocarditis and 
meningoencephalitis (Harris et al 1989). These systemic infections enhance the 
economic burden of the bacteria causing BRD to the agricultural industry. A. 
pleuropneumoniae is a commensal of the porcine host, where it again can be isolated 
from asymptomatic carriers, generally found inhabiting the tonsillar crypts and 
nasopharynx (Bisgaard, 1993). This too is able to cause disease; porcine 
pleuropneumonia can be highly contagious, with high mortality rates depending on the 
strain causing the outbreak (Bandara et al., 2003). Similar to other members of the 
pasteurellaceae family it causes severe necrotic lung lesions (Ajito et al., 1995). It can 
also lead to pericarditis and abortion in pigs, costing the US economy vast sums annually, 
reported to be in excess of $32 million in 1995 (Losinger, 2005).  
1.1.2 Salmonella 
Salmonella species are members of the Enterobacteriaceae family. There are two 
species- S. bongori and S. enterica, which are split into 12 subspecies and further 
subdivided into over 2000 serovars according to the NCBI database. They are Gram-
negative, rod shaped facultative anaerobes that can cause infections in a wide range of 
species. The pathology resulting from these bacterial infections depends upon both the 
serovar and the host. The non-typhoidal S. enteretidis causes gastroenteritis in humans, 
S. typhi can cause typhoid fever in many hosts depending on the bacterial sub-species 
and S. enterica arizonae (IIIa) resides as a commensal in its cold-blooded host. Both 
humans and a wide variety of animals are carriers or reservoirs for Salmonella, and the 
bacteria can be food-borne or spread by contact with an infected party. This ability to 
survive and multiply in numerous different host species enhances the potential for 
disease outbreaks. 
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The typhoidal S. enterica strains often begin as a gastric infection, being taken into the 
epithelium by pinocytosis after ingestion. The infections can then become systemic, 
invading by crossing the intestine using the host immune defence to its advantage to 
enter the blood stream. Salmonella infections represent a huge public health issue that 
is exacerbated by the rise in antibiotic resistance, limiting the treatment options 
available. In Asia, typhoid caused by S. typhi is considered endemic, partly due to lack of 
vaccination and overcrowding in certain locations. Salmonella outbreaks are therefore 
still a concern in the Western world. The CDC recently reported that non-typhoidal 
Salmonella infections are one of the leading causes of food borne hospitalisation in the 
USA (Scallan et al., 2011). 
S. enterica arizonae (IIIa) is rarely isolated in cases of human disease. It is, however, a 
common commensal of reptiles and amphibians, estimated to contribute to 8.3 % of the 
Salmonella species colonising wild reptiles (Briones et al., 2004). Contact with these 
species is the main cause of disease in humans caused by S. arizonae. Some cases of 
transmission to poultry have also been reported, highlighting the danger of enzootic 
transmission. Reptile acquired Salmonella infection in general accounts for 
approximately 6%  of human salmonellosis overall (Mermin et al., 2004). Infection 
mainly manifests as gastroenteritis, although cases of meningitis (Lakew et al., 2013) 
and osteomyelitis (Kolker et al., 2012) have also been reported.  
1.1.3 Neisseriaceae 
The family Neisseriaceae are Gram- negative, non-motile, diplococcoid, capsular 
bacteria. It contains 5 main genera; Acinetobacter, Kingella, Moraxella, Oligella and 
Neisseria. The genus Neisseria contains species of bacteria known to be the main causes 
of disease in humans from this bacterial family. Neisseria species are found within the 
human host with some inhabiting niches in other mammals such as dogs and monkeys. 
The majority of these species are commensals of the respiratory and reproductive 
mucosa, such as N. cinerea. Some, such as N. lactamica, while often isolated from the 
nasopharynx of asymptomatic carriers, are rarely associated with disease in 
immunocompromised hosts. The most important human pathogens of this genus are N. 
meningitidis and N. gonorrhoeae.  
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N. meningitidis is the major global cause of meningococcal meningitis and infection can 
lead to septicaemia and death. While 10% of the population are asymptomatic carriers 
of the bacteria, when disease occurs the mortality rate from meningococcal meningitis 
is between 10- 15% in the US. Of the survivors, 11- 19% will suffer serious long term 
effects (CDC, 2015). These devastating sequale include loss of vision, deafness and loss 
of limbs (Heckenberg et al., 2008). There are 12 serogroups of N. meningitidis which are 
differentiated according to their capsular polysaccharides. Five of these serogroups, A, 
B, C, W and Y, are commonly implicated in causing disease globally (Harrison et al., 
2009). Cases of meningococcal meningitis have decreased in many countries over recent 
years due to the availability of vaccines to serogroups A, C, W and Y. However, the 
efficacy of the available vaccines to different serotypes is variable, which led to the 
multivalent vaccine MenACWY-CRM. These are based on the polysaccharide components 
of the bacterial serotypes. Serotype B vaccines were unable to be developed using this 
technique due to the similarity of the polysaccharide to a component of human cells. A 
recent review summarised the development of the 4CMENB vaccine against N. 
meningitidis serotype B (Andrews and Pollard, 2014).  
N. gonorrhoeae is also an important human pathogen, causing the sexually transmitted 
infection gonorrhoea. Gonorrhoea infects both men and women. It is characterised by 
urethritis and cervicitis, leading to pelvic inflammatory disease, infertility and ectopic 
pregnancy if not resolved. The global burden of Neisseria gonorrhoeae infections is 
exacerbated by rising antimicrobial resistance. Globally, approximately 106 million of 
the curable sexually transmitted infections are due to N. gonorrhoeae each year which 
equates to around 20% (WHO, 2012). 
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1.2 Bovine Respiratory Disease 
1.2.1 Causes and Importance 
The Bovine Respiratory Disease (BRD) complex, as the name suggests, is a multifactorial 
disease. It is caused by the interplay between viral and bacterial agents and the host 
immune system. Mannheimia haemolytica and Pasteurella multocida are the most 
commonly isolated bacterial agents, with H. somni also less commonly isolated from 
diseased cattle. These bacteria also infect sheep and B. trehalosi is an additional factor 
found in isolated in ovine disease cases. Bovine respiratory syncytial virus (bRSV), bovine 
viral diarrhoea virus and bovine parainfluenza virus are all among common concomitant 
viral infections involved in the overall pathogenesis of the disease. M. haemolytica is 
also a well-documented cause of ovine mastitis, which has a detrimental effect on the 
sheep farming industry.  
BRD presents a huge challenge to the agricultural industry. The morbidity and mortality 
rates in the US alone cost the economy $1 billion annually (USDA, 2011), with costs of 
prevention and treatment also increasing year-on-year. New prevention or treatment 
measures are desperately required as antibiotic resistance increases. 
1.2.2 Host- Pathogen Interactions  
1.2.2.1 Mechanism of Colonisation and Infection  
M. haemolytica is the bacterial species most often isolated from diseased animals. It is 
also known to be a commensal of the bovine upper respiratory tract and nasopharynx, 
yet the mechanism of the switch from commensal to pathogen is not fully understood. 
A study into the bacteria commonly isolated in North America and Canada found that 
serotypes A1, A2 and A6 are prevalent. A1 and A6 are the serotypes generally isolated 
from diseased cattle (70 and 20%, respectively), with a lesser percentage of A2 (10 %). 
The study also showed that A2 was the predominant serotype isolated from healthy 
cattle (Klima et al., 2014a). Serotype A2 is found in other ruminants and is the primary 
serotype indicated as causing ovine respiratory disease. The current hypothesis is that 
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the A1 and A6 strains outgrow the A2 serotype as a result of additional factors such as 
co-infection, leading to disease. 
Bovine respiratory disease is characterised by initial symptoms of fever, nasal discharge, 
cough, lack of appetite and anorexia, which in itself affects the value of the cattle due 
to the quality and quantity of meat, before considering that approximately 5.9% of cattle 
with BRD die from the infection (Faber et al., 1999). A severe infection can lead to 
fibronecrotising pleuropneumonia.  The majority of factors enabling colonisation are 
also virulence factors, which work against the host defence systems to promote disease. 
These processes as a whole, or their individual protein components, therefore present 
potential targets for prophylaxis or treatment.  
1.2.2.2 Virulence Factors  
In the case of M. haemolytica, the bacteria- either already present as a commensal or 
transmitted from infected animals- grows rapidly in the host upper respiratory tract 
where it is located in the mucous layer. This mucous is secreted by either goblet cells or 
seromucous glands depending on the location within the respiratory tract. It contains 
antibacterial agents such as lysozyme, secreted antibodies and host antimicrobial 
peptides including β-defensins, which are innate defence mechanisms that attack the 
peptidoglycan walls of the invading bacterial cells (Ackerman et al., 2011). Another 
innate host defence mechanism is the mucociliary apparatus allowing clearance of 
pathogens captured in the mucous barrier. However, this is not always successful at 
clearing the infection, with bacteria eventually getting dislodged, inhaled, and settling 
in the lower respiratory tract or lung (Grey and Thomson, 1971). 
In healthy animals, the immune system is able to clear this infection- when the bacteria 
enter the lung, alveolar macrophages are activated by lipopolysaccharide (LPS) on the 
surface of M. haemolytica, causing the release of pro-inflammatory cytokines. These 
cytokines (e.g. IL-1, TNF-α and IL-8) signal to the host immune system and aid in the 
recruitment and priming of neutrophils (Hsuan et al., 1999). Neutrophil recruitment 
causes the release of further cytokines, reactive oxygen species and elastase which act 
to damage bacterial cell membranes. Expression of L- selectin on the neutrophil surface 
enables the cells to adhere to β2-integrins on the host respiratory epithelium allowing 
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the neutrophils to cross into the tissue to clear the infection. Phagocytosis by both 
neutrophils and tissue macrophages clears the bacteria and any cellular debris. Mast 
cells, lymphocytes and airway epithelial cells also play a vital part in responding to the 
infection.  
In stressed, immunocompromised animals that may have a viral co-infection, these 
defence mechanisms can fail and colonisation can lead to severe respiratory disease. 
Leukotoxin and LPS are the major virulence factors of M. haemolytica, H. somni and A. 
pleuropneumoniae playing key roles in disease severity. LPS can act as a protective 
barrier to the bacterial cell, preventing certain antimicrobial peptides from crossing the 
outer membrane and damaging or killing the bacterium. Descent of bacteria to the lower 
respiratory tract and lung leads to cellular infiltration of the alveoli by leukocytes causing 
a ‘pro-coagulation’ state. This results in fibrin polymerisation and necrosis of host tissues 
due to the cytokines and reactive oxygen species released (Car et al., 1991). Leukotoxin 
stimulates the release of leukotriene B4, histamine and prostaglandin E2, all of which 
contribute to the severe inflammatory damage in the infected lung (Adusu et al., 1994). 
At higher concentrations Lkt can also induce apoptosis in host defence cells, impairing 
the response to disease. A leukotoxin knock-out strain of Mannheimia haemolytica was 
created by Tatum et al which showed a dramatic decrease in host cellular damage in a 
bovine model of disease after infection with the knock-out strain (Tatum et al., 1998).  
Lafleur et al demonstrated an increased pathogenicity driven by LPS and Lkt together, 
as evidenced by an increase in cytolysis of alveolar macrophages due to Lkt in the 
presence of non-cytolytic levels of LPS, compared to Lkt alone (Lafleur et al., 2001). Prior 
exposure to Lkt or LPS increased the production of β-defensins which actually enhanced 
the cytotoxic activity (Leite et al., 2002). The leukotoxins of Mannheimia haemolytica 
have been shown to vary depending on the serotype, with slightly differing levels of 
toxicity to bovine and ovine neutrophils (Davies and Baillie, 2003). 
A. pleuropneumoniae infection in pigs causes necrotic lung lesions in a similar way, 
leading to the production of pro-inflammatory cytokines and the subsequent 
characteristic accumulation of neutrophils. Viral co-infection is a predisposing factor to 
BRD. BHV-1 has been shown to increase the pathogenicity of M. haemolytica by 
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increasing the amount of LFA-1 (a β2-integrin) produced by host cells, which is known 
to be involved in Lkt binding (Leite et al., 2002, Rivera-Rivas et al., 2009).  
Endotoxins produced by H. somni and A. pleuropneumoniae are also implicated in 
bacterial virulence. Lkt is a member of the RTX family of toxins, to which the major 
virulence factor proteins of A. pleuropneumoniae, Apx, also belong (Jansen et al., 1995). 
This family of toxins target both macrophages and neutrophils creating pores through 
the membranes which leads to cytolysis (Thumbikat et al., 2003) and, via release of 
reactive oxygen species (ROS), contributes to the damage of the pulmonary epithelium. 
H. somni also possesses the ability to damage bovine endothelial cells via lipo-
oligosaccharide (LOS) with a similar pore forming mechanism (Sylte et al., 2001). Rtx 
toxins are also known hemolysins, potentially providing a cellular mechanism for 
nutrient acquisition in low iron environments, although there is little evidence to 
support this.  
The bacterial polysaccharide capsule prevents phagocytosis by the host immune system, 
as demonstrated by a capsule negative strain of M. haemolytica that was both 
phagocytosed more readily than the wild type bacteria and more susceptible to 
complement-mediated killing (McKerral and Lo, 2002, Chae et al., 1990). The capsule 
can also interact with proteins in the pulmonary surfactant, increasing bacterial 
adhesion. M. haemolytica serotypes have been demonstrated to have differing capsular 
polysaccharide composition, which may be relevant to the virulence of each serotype 
(Adlam et al., 1984, Adlam et al., 1986, Puente-Polledo et al., 1998). Cellular adhesion is 
considered another important virulence factor, enabling the initial host colonisation and 
allowing, if the conditions are appropriate, invasion of the host.  
Outer membrane proteins (OMPs) are also involved in adhesion when not masked by 
the capsule, as seen in many bacterial species, such as OmpA in M. haemolytica 
(Hounsome et al., 2011) and OMPs of A. pleuropneumoniae (Van Overbeke et al., 2002). 
Of the mannheimia outer membrane proteins, OmpA and PlpE are known to be major 
targets of host antibodies. Outer membrane proteins have been demonstrated to be 
vital in bacterial host colonisation, especially iron regulated OMPs, and it is therefore 
understandable that they present a target for the host immune system. OmpA1 is found 
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in bacterial isolates from the bovine host whereas OmpA2 is found in strains of ovine 
origin (Hounsome et al., 2011), which demonstrates some species specificity. These and 
other OmpA proteins differ between serotypes in the hypervariable extracellular loop 
region (Hounsome et al., 2011). OM components of M. haemolytica are outlined in 
Figure 1.1. 
 
 
Figure 1.1 Outer Membrane Virulence Factors of M. haemolytica. 
LPS (green) with the O antigen (depicted in light green), pili on the cell surface (orange) 
and Lkt secreted from the cell via a Type I secretion system comprised of LktB and LktD 
in M. haemolytica (yellow). OmpA shown with characteristic 4 extracellular loops and a 
membrane bound beta barrel (brown). The capsule of M. haemolytica is shown on the 
extracellular face. Om - outer membrane, cm - cytoplasmic membrane. Adapted from 
Gill EE, Brinkman FS - Bioessays (2011), open access.  
 
Virulence factors of M. haemolytica differ between serotypes and host species.  Lkt is 
found throughout M. haemolytica serotypes, as is LPS. While Lkt is relatively well 
conserved, LPS of M. haemolytica differs between serotypes in both the core region and 
O antigen (Davies and Donachie, 1996). LPS of A. pleuropneumoniae is also involved in 
adhesion along with the fimbriae and a number of other OMPs (Van Overbeke et al., 
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2002). Some LOS in H. somni and other bacterial species have been found to mimic 
mammalian LOS in an attempt to impair immune surveillance (Mandrell et al., 1992). 
LPS has been shown to enhance the effect of the Apx toxins of A. pleuropneumoniae on 
phagocytes and further activate the host inflammatory response in a study comparing 
the wild type strain to a LPS mutant strain (Ramjeet et al., 2008). 
Alterations in the components of the lipo-oligosaccharide component, such as phase 
variation and sialylation, have been identified as virulence factors in H. somni, enabling 
the bacteria to evade the host immune system (Inzana et al., 1992). Other outer 
membrane proteins involved in virulence include receptors for host iron-containing 
proteins such as transferrin and lactoferrin. Many proteins involved in nutrient uptake 
such as haem and iron receptors are iron regulated, demonstrating the importance of 
iron uptake for bacterial survival and colonisation. An important factor in colonisation 
and pathogenesis is the presence of essential nutrients, and the ability of the bacteria 
to capitalise on what is available. The host employs methods to reduce the ‘free’ 
nutrients available to limit the possibility of colonisation and to protect itself from 
cellular damage in the case of iron and other reactive species. 
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1.3 Iron and Haem Acquisition  
Bacteria such as M. haemolytica reside within the upper respiratory tract of ruminants. 
The availability of iron within these mucosal surfaces is low compared to the blood, yet 
iron uptake is essential for bacterial survival and is therefore counted as an important 
virulence factor. Iron is used in numerous cellular processes from cellular respiration, to 
regulation of transcription, to DNA repair. Different bacteria obtain this iron from a 
variety of sources depending upon the ecological niche they inhabit. The host 
environment generally maintains a low level of free iron by sequestering it from 
circulation in high affinity complexes such as lactoferrin and transferrin. These proteins 
bind free iron both to prevent toxicity to the hosts own cells and to reduce nutrients 
available to invading organisms.  
Iron exists in equilibrium between ferrous (Fe2+) and ferric (Fe3+) forms, depending on 
the surrounding environment but is generally found in its insoluble ferric form within 
living things i.e. at a neutral pH (Fontecave and Pierre, 1993). Iron is a core component 
of haem, which itself is integral to life in the form of diverse hemoproteins such as 
haemoglobin and cytochrome C. Too high a concentration of iron or haem can lead to 
cellular toxicity due to the formation of reactive oxygen species (ROS) and free radicals 
in the Fenton Reaction (Fe2+ + H2O2 → Fe3+ + ·OH + OHˉ) causing DNA and protein 
damage. It is for this reason that haem levels are tightly controlled within the host. With 
the majority of iron being complexed in haem or hemoproteins in vertebrate systems, 
these are important targets for pathogens. Haem is often found in the ferrous form 
within cells, whereas hemin, the oxidisation product of haem, generally exists in 
extracellular niches and is therefore the form involved in the uptake process as part of 
hemoproteins.  
Bacteria have evolved many different ways of surviving in environments where nutrients 
are scarce, which include secretion of molecules that chelate iron with a high affinity 
and proteins to retrieve haem known as siderophores and hemophores, respectively as 
summarised in Figure 1.2. These scavenger systems retrieve nutrients for the bacterial 
cell, binding to specific outer membrane receptors for internalisation. Periplasmic 
binding proteins then transport the nutrient to the cytoplasmic membrane ATP binding 
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cassette (ABC) transporters, which shuttle it into the cytoplasm where it is used or 
stored. All of these systems are tightly regulated due to the reactive nature of haem.  
 
Figure 1.2 Haem and Iron Uptake Systems in Gram-negative Bacteria. 
Gram-negative bacteria produce specific outer membrane proteins (purple and blue) to 
capture iron/ haem protein complexes. The substrate binds to the OM receptor and the 
iron/ haem is internalised using the pmf delivered by the TonB complex (green). The 
periplasmic binding proteins (yellow) shuttle the internalised molecule across the 
periplasm to an ABC transporter (navy blue) where it is transported into the cytoplasm 
for use or storage. Adapted with permissions (Anzaldi and Skaar, 2010).  
 
1.3.1 Siderophores and Hemophores 
Siderophores and hemophores are secreted by certain bacterial species to scavenge iron 
and haem from the surrounding environment. They bind these molecules with 
moderately high affinity, for example HasA of Serratia marcescens binds hemin with a 
Kd of 5.3 x 10-10 M (Deniau et al., 2003), and delivers it to the bacterial cell. The nutrient 
uptake occurs by the binding of the secreted chelating agent to specific outer membrane 
proteins. Hemophores such as HmuY from Porphyromonas gingivalis have been shown 
to have a higher affinity for hemin than haem whilst retaining the ability to bind the 
reduced form (Smalley et al., 2011). The mechanism of initial haem removal from 
haemoglobin is hypothesised to be by passive diffusion based upon the higher affinity 
of hemophores for haem than haemoglobin for example (Letoffe et al., 1999). A novel 
proposed method of haem capture centres on the enzymatic oxidation of the ferrous 
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iron at the centre of the haem molecule. This decreases the affinity of haemoglobin for 
haem, allowing HmuY to scavenge the haem (Smalley et al., 2011).  
Siderophores of E. coli, for example, include ferric enterobactin, which binds to the 
receptor FepA, and ferrichrome, which binds to the OM protein FhuA. The mechanism 
of siderophore- OM receptor interaction has been described by Locher et al. 
Ferrichrome binds, iron-complexed region first, to an aromatic pocket located on the 
cell surface side of the β-barrel, which in its closed form is obstructed by a plug. The 
ferrichrome binding site comprises loops L3 and L11 of the β-barrel and part of this plug. 
Binding to the receptor leads to a conformational change whereby part of the plug 
region shifts towards the ligand, causing the backbone to be displaced and a subsequent 
N-terminal conformational alteration (Locher et al., 1998). This movement is 
hypothesised to be the signal to the TonB receptor to produce the energy required to 
bring the iron into the cell. N. gonorrhoeae is an example of a bacterial species that do 
not produce their own siderophores. The bacteria compensate for this by utilising those 
secreted by other cells, or ‘xenosiderophores’, internalising the iron from enterobactin 
via the fbpABC proteins in a TonB independent manner (Strange et al., 2011). 
The hemophore HasA, secreted by Serratia marcescens, was the first to have its 
structure solved and has therefore been widely investigated. It consists of an α/β protein 
fold, and the haem molecule is held between two loops within this; L1 and L2. 
Conformational alterations in this site are key in the binding and release of the haem 
molecule (Wolff et al., 2008). As mentioned, hemophores bind haem with very high 
affinity; the iron of the haem binds to HasA via hydrogen bonding to His-32 and Tyr-75 
(Caillet-Saguy et al., 2012), and delivers the haem to a specific OM receptor, HasR (Figure 
1.3). They are able to acquire both free and complexed haem. A hemophore found in 
pasteurellaceae species, HxuA, is able to acquire haem from hemopexin (Gioia et al., 
2006). The mechanism of haem acquisition by hemophores has been described as either 
competition with the hemoprotein to appropriate the haem or by causing 
conformational changes to liberate the haem from its carrier protein, thereby allowing 
the hemophore to capture the haem. 
27 
 
 
Figure 1.3 Hemophore Structures and Interactions with Haem.  
A. shows the HasA monomer crystallised with bound haem in red sandwiched between 
the loops (PDB code 1DK0), C. shows the haem coordinating amino acids- His-32 and 
Tyr-75 and B. shows the hemophore bound to HasR (PDB code 3CSN). Structures were 
both S. marcescens taken from RSCB-PDB Protein workshop and ray traced and rendered 
in Pymol. 
 
 
HasR, the HasA receptor, binds holo-HasA between loops L6 and L9, with the haem 
molecule facing the receptor. The haem is bound by two histidines within the receptor, 
His-189 and His-603 on the plug and barrel respectively (Izadi-Pruneyre et al., 2006). 
HasR has a slightly weaker affinity (Ka = 5 x 10-9 M) for haem than HasA (Ka = 5.3 x 10-10 
M). The transfer of haem between the two proteins is thought to be driven by protein-
protein interactions that rely on both the aforementioned histidines, and the 
conformational changes caused by the hemophore interacting with the receptor. The 
HasA: HasR binding was reported with an affinity of >10-9 M, and this is proposed to be 
the method of overcoming the minimal difference in affinity for haem between the two 
proteins (Izadi-Pruneyre et al., 2006). This differs from other haem and iron uptake 
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systems which utilise proton motive force (pmf) to internalise the nutrient as outlined 
in section 1.3.3. In this case the pmf is required only for haem internalisation (Izadi-
Pruneyre et al., 2006). Examples of this acquisition method have been demonstrated in 
P. aeruginosa, S. pyogenes and S. marcesens. Once the haem has been transferred to 
the receptor, the apo-HasA dissociates enabling the haem to be transported into the 
bacterial cell. The haem is then internalised using proton motive force generated by a 
proton gradient from the cytoplasm to the outer membrane of the cell. This electron 
transport chain leads to a positive outer membrane and a negative internal 
environment, resulting in alterations to OM proteins. 
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1.3.2 Bacterial Outer Membrane Receptors 
Haem is a lipophilic molecule and alone is unable to cross the negatively charged outer 
membrane, therefore transmembrane proteins are required to allow haem uptake into 
the cell. Known OM receptors involved in haem and haemoglobin uptake include, but 
are not limited to, HpuAB and HgbA found in neisserial species and pasteurellaceae 
species such as H. somni, and the previously mentioned haem/ hemophore receptor 
HasR from S. marcescens.  
HmbR is one outer membrane protein involved in haem uptake from haemoglobin found 
in neisserial species. A similar as yet uncharacterised potential homologue of HmbR has 
been discovered in M. haemolytica along with further putative homologues in a number 
of other Gram-negative bacteria. These outer membrane receptors are predicted to 
have a general basic structure of a beta barrel creating a pore through the membrane, 
which is blocked by an N-terminal plug. Based on structural modelling, the 
meningococcal HmbR is predicted to consist of 22 beta strands, 11 surface exposed 
loops, 10 periplasmic loops and an N-terminal plug (Evans et al., 2010). The haem is 
again bound to the protein by histidine and tyrosine residues and exists with ferric iron 
at its centre as a 5-coordinate high-spin molecule (Mokry et al., 2014). No crystal 
structure of this neisserial HmbR protein has been published to date, however the ShuA 
haem/ haemoglobin receptor (PDB code 3FHH) bears some similarities to that described 
by Evans et al (Evans et al., 2010). It is mostly composed of beta strands, and the 
structure depicts 22 of these; the classic number of beta strands forming the barrel 
structure of haemoglobin receptors. This basic structure was also observed in the Phyre2 
predicted tertiary structure of the M. haemolytica haemoglobin receptor when analysed 
with Pymol (Figure 1.4).  
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Figure 1.4 Predicted Structure of the M. haemolytica HmbR.  
Predicted structure of putative M. haemolytica HmbR (accession number EDN75148) 
generated with Phyre2 and rendered and ray traced in Pymol. The template protein used 
was the crystal structure of TbpA from Neisseria meningitidis serogroup b in complex 
with the c-lobe of human transferrin (3V89). A. shows the plug within the beta barrel 
structure, and B. shows the structure from the side with the N- terminal highlighted in 
blue at the lower right hand side of the plug within the barrel. The predicted structure 
had 93% coverage (668 amino acid residues) and 100 % confidence. 
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The neisserial HmbR is a TonB dependent receptor (see section 1.3.3) and is predicted 
to bind haem via surface loops 2 and 3, with loops 6 and 7 hypothesised to be involved 
in haem utilisation, possibly to bring haem into the periplasm (Evans et al., 2010). 
Haemoglobin receptors lacking the plug domain are unable to acquire haem from 
haemoglobin, suggesting that this component is involved in binding or transport (Fusco 
et al., 2013). Haemoglobin binding by HgbA of H. ducreyi has been shown by 
mutagenesis studies to occur partly via a series of residues in loop 5 along with histidines 
in the plug region, whereas the phenylalanine of the ‘FRAP’ motif on loop 7 was found 
to be vital in haem uptake (Fusco et al., 2013). Srikumar et al identified the protein HgbA 
in Actinobacillus pleuropneumoniae (APP). This appears to form a part of a whole 
functional haemoglobin receptor, as although a hgbA mutant was able to bind 
haemoglobin, the bacteria was unable to utilise it as a source of iron suggesting that it 
is a multicomponent receptor complex (Srikumar et al., 2004).  
Two-component receptors whose function is to bind lactoferrin or transferrin were 
initially discovered in bacteria, followed by the identification of a two-component 
haemoglobin receptor in N. meningitidis, HpuAB. These receptors generally consist of a 
surface exposed lipoprotein, which interacts with the iron-containing substrate, and a 
transmembrane protein enabling transport into the cell. The neisserial transferrin 
receptor ‘transferrin binding protein AB’ (TbpAB) proteins were not found to co-localise 
on the bacterial membrane, with TbpB forming a surface exposed lipoprotein that binds 
iron laden-transferrin and TbpA a membrane spanning protein that interacts with TonB 
(Powell et al., 1998). This TonB interaction allows the protein to transfer the energy 
required to internalise the substrate (see Section 1.3.3). While the majority of two 
component receptors require both proteins to be functional, TbpA of TbpAB can act 
alone as it is capable of binding transferrin and extracting the iron from within, however 
both components are required for optimal uptake (Stokes et al., 2005).  
Lactoferrin binding protein (Lbp) also works as a dual component receptor, as displayed 
in Figure 1.2, consisting of two OM proteins that are co-transcribed. The two proteins in 
N. meningitidis are again an outer membrane lactoferrin-binding lipoprotein LbpB and 
the transmembrane protein LbpA. LbpA uses energy provided by the TonB protein to 
internalise the iron in a similar manner to TbpAB. These proteins are well conserved and 
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the neisserial LbpB protein has a 55% amino acid sequence identity with TbpB (Lewis et 
al., 1998). 
1.3.3 Cellular Uptake Mechanisms 
The transport of proteins across the outer membrane of the bacterial cell requires both 
an OM receptor and energy to assist the uptake process, however, the OM is not 
equipped to provide said energy alone. The uptake is powered by a proton motive force 
(pmf), which exploits the ion gradient throughout the cell. HasR, as previously 
mentioned, uses the pmf to bring haem across the membrane (Izadi-Pruneyre et al., 
2006). The pmf is transmitted from the cytoplasm to the outer membrane via the TonB 
complex, which consists of three protein subunits; TonB, ExbB and ExbD (Figure 1.5). 
These proteins are known to form homo-multimers however the stoichiometry has not 
yet been deduced. ExbB and ExbD are transmembrane proteins located anchored in the 
cytoplasmic membrane. They facilitate the transfer of the pmf from the cytoplasm 
outwards, with ExbB transmitting it to ExbD and on to TonB. The N-terminal of TonB also 
sits in the cytoplasmic membrane. 
 
 
Figure 1.5 TonB-ExbB-ExbD Complex.  
 
Panel A. shows the uptake system at rest with the TonB protein (lilac) separate from the 
TonB Box of the outer membrane receptor, and the plug still in place. B. Upon the OM 
receptor binding a substrate, the pmf allows the TonB C-terminal to contact the TonB 
Box on the N-terminal of the OM receptor allowing uptake of the substrate. This is a 
representation of the proteins involved in this process and does not accurately display 
the ratios of each protein within the TonB complex and cytoplasmic membrane.  
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The pmf is also required for the cross linking of ExbB and TonB, and can only be 
transmitted to the OM protein if all three proteins within the complex are intact. An 
early theory of how TonB transmitted the required ‘energy’ was the ‘Shuttle Hypothesis’ 
which suggested that the TonB protein detached from the cytoplasmic membrane and 
shuttled across the periplasm to the OM receptor in an ‘energised’ state to transmit the 
energy. This theory was replaced after a study by (Gresock et al., 2011) showed the 
findings to be due to non-specific binding of the dye used in the experimental procedure 
to other proteins. The method of energy transmission is now believed to involve pmf 
transfer via the C-terminal of TonB, which contains a proline-rich region able to span the 
periplasmic space. This contacts both the ExbB-ExbD complex via the C-terminal of ExbB 
on the cytoplasmic membrane (which is also integral in the association of ExbD and 
TonB), and the TonB Box. The TonB Box is on the N-terminal region of the outer 
membrane receptor which contains a motif rich in asparagine and valine residues over 
6 or 7 amino acids.  TonB-TonB Box contact allows the pmf to transfer to the OM protein 
and enables a conformational change in the receptor- although the exact mechanism of 
pmf transmission by TonB is not yet fully understood (Jana et al., 2011).  
The pmf provides energy to both remove haem from the holo-protein and to reversibly 
dislodge the β-barrel plug facilitating the passage of haem through the pore into the cell 
(Flores Jimenez and Cafiso, 2012).  Conformational changes allow all three proteins in 
the TonB complex to be recycled after the pmf has been transmitted to the OM receptor. 
TonB proteins are not limited to their role in iron and haem uptake, but are involved in 
the acquisition of many other nutrients- it is no surprise in this case that other TonB 
homologues and paralogues have been discovered, such as the S. marcesens HasB, 
which while the overall function is conserved, do not necessarily have similar structures 
(de Amorim et al., 2013). 
1.3.4 Periplasmic Haem Binding Proteins  
A core component of nutrient uptake in Gram-negative bacteria is the periplasmic 
binding protein (PBP). These proteins are important in facilitating the dissociation of the 
haem or iron from high affinity scavenger proteins which require a conformational 
change to release their ligand. There are three classes of PBP determined by the number 
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of connecting regions between the two lobes characteristic of this protein family. Class 
I has three β connector regions, Class II two β, and Class III just one alpha helical 
connecting region. These connector regions are involved in the conformational changes 
that occur upon ligand binding.  
In H. influenzae, the removal of iron from the OM receptor-bound transferrin complex 
requires the combination of; 1) A possible conformational change to transferrin upon 
binding to the OM receptor TbpAB, allowing transferrin to release the iron and; 2) the 
PBP, in this case H. influenzae’s ferric binding protein A (FbpA), to capture this iron due 
to its higher affinity for iron than transferrin (Khan et al., 2007). The PBP then acts as a 
shuttle system to take the iron across the periplasmic space to the ABC transporter at 
the cytoplasmic inner membrane.  
The ferric enterobactin iron uptake system has been described and the siderophore not 
only binds to the OM receptor FepA with a reported affinity in the nanomolar range, but 
also to the PBP FepB with higher affinity- a Kd of 30 nM as opposed to 60 nM with FepA, 
which may be vital in the siderophore crossing the cell membrane (Sprencel et al., 2000). 
FepB, like ShuT and PhuT, is a class III PBP. A study by Chu et al investigated the 
conformational changes occurring upon ligand binding. Class I and II PBPs display a 
higher degree of movement in a ‘Venus fly trap’ like motion upon ligand binding, 
however Chu et al showed this movement was minimal in class III PBPs, and binding was 
centred around a movable loop region that placed the PBP in an advantageous position 
for binding to the ABC transporter FepCD (Chu et al., 2014).  
The class III haem binding PBP found in Shigella dysenteriae, ShuT, had its haem binding 
mechanism characterised by Eakanunkul et al, where it was seen to interact with hemin 
via a proximal Fe3+-O bond to Tyr-94 (Eakanunkul et al., 2005). The amino acid sequence 
of ShuT has high levels of identity to predicted haem binding PBPs from other 
pasteurellaceae species (see Figure 1.6).  
Other PBPs that have been identified in pasteurellaceae include SapA, a haem binding 
protein found in H. influenzae shown by Mason et al to be vital in haem uptake across 
the cytoplasmic membrane via the transporter protein complex SapBC (Mason et al., 
2011). HbpA is another haem binding lipoprotein predicted to reside in the periplasm of 
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H. influenzae, again involved in the uptake and transport of haem from hemoproteins 
such as hemopexin and haemoglobin. Its importance is highlighted in a study performed 
by Morton et al where a HbpA mutant was not able to grow as well as the wild type 
counterparts on haem only medium (Morton et al., 2009). The study also concluded that 
H. influenzae had additional haem PBP’s, as the mutant was able to grow on haem based 
medium albeit at a reduced rate.  
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Figure 1.6 Periplasmic Binding Proteins in Pasteurellaceae.  
The alignment shows the H. infuenzae SapA (HI) AAQ12665.1 amino acid sequence with 
potential homologues identified in A. pleuropneumoniae (APP) EFL80116.1 and M. 
haemolytica (MH) WP_042803671.1. The levels of identity between these individual 
amino acid sequences are between 46.72% and 60.82%. * denotes identical residues in 
all sequences whereas . denotes identical residues in the majority of sequences. Signal 
peptide cleavage site indicated by red arrow. 
 
1.3.5 ABC Transporters 
ABC transporters are proteins situated on the cytoplasmic membrane of the Gram-
negative bacterial cell. They are essential for the active transport of nutrients such as 
iron or haem into the cytoplasm. The PBP delivers the substrate to the ABC transporter 
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which in turn provides a channel for said substrate to pass through the inner membrane 
into the cytoplasm. ABC transporters are generally composed of four subunits; two 
transmembrane domains and two ATP binding cytoplasmic domains (see Figure 1.7). In 
the case of Yersinia pestis, the PBP HmuT recognises HmuU1 and 2 of the ABC 
transporter on the cytoplasmic membrane and transfers the haem to a channel between 
the monomers. ATP drives the PBP shuttling across the periplasm and enables the 
conformational change, opening the channel between helix 5 in each transmembrane 
domain (TMD) of the ABC transporter (Woo et al., 2012). The substrate can then cross 
into the cytoplasm. 
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Figure 1.7 ABC Transporter HmuUV in Yersinia pestis.  
This haem ABC transporter complex structure (PDB code 4G1U) displays the 
characteristic two transmembrane domain- two ATP binding protein domain structure. 
A channel opens between HmuU1 and HmuU2 allowing haem to pass through the 
cytoplasmic membrane. The ABC transporter domains are on the cytoplasmic side of the 
inner membrane and provide the energy needed to import the haem. Structure taken 
from RCSB-PBD and rendered in Pymol. 
 
The Sap system in H. influenzae is believed to behave in a similar manner to that of Y. 
pestis. The PBP SapA shuttles the haem across the periplasm, delivering it to the 
transmembrane proteins SapBC. This undergoes a conformational change using the 
energy derived from hydrolysis of ATP on SapDF, the final components of the ABC 
transporter complex (Morton et al., 2009). With the BtuCD transporter, the hydrolysis 
of ATP allows the TMD region to open, accepting the ligand and causing the subsequent 
release of ADP, which allows the TMD proteins to flip inwards, enabling the ligand to 
then pass into the cytoplasm (Hollenstein et al., 2007).  Both of these uptake systems 
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rely on type II transporters. While not identical in mechanism of uptake, the Sap and 
Hmu systems are related to the Vitamin B-12 transporter BtuCD, highlighting the diverse 
functions of the family of proteins.  
1.3.6 Iron and Haem Homeostasis 
Whilst nutrient uptake, and in particular iron acquisition, is vital for cellular survival, iron 
and haem can also be highly toxic to the bacterial cell. It is for this reason that both the 
iron and haem levels within the cell and the production of proteins involved in the 
nutrient uptake systems are tightly controlled. Many bacteria such as N. meningitidis 
are capable of synthesising their own haem in a process using multiple enzyme catalysts 
(see Figure 1.8). This requires exogenous iron to make haem from protoporphyrin IX 
(PPIX). Not all bacteria have the enzymes required for haem biosynthesis, for example 
H. influenzae lacks the first 6 enzymes in the pathway (Figure 1.8). While the cell can 
acquire iron for its metabolic needs, it relies on exogenous sources of haem for use in 
cytochromes and other hemoproteins necessary for cellular functions. White et al 
showed that H. influenzae could survive for a short while on haem stores when grown 
in a haem-limited medium, but growth slowed and only adding exogenous haem back 
to the enabled cellular replication to resume (White and Granick, 1963).  
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Figure 1.8 Haem Biosynthesis in N. meningitidis.  
An example of bacterial haem biosynthesis with the completed haem being 
incorporated into cytochrome C. This pathway is well conserved in many bacteria, 
animals and plants. ALA - Aminolevulinic acid. Adapted with permission from (Anzaldi 
and Skaar, 2010).  
 
To avoid cellular toxicity, haem and iron is either utilised in metabolic functions as it is 
internalised or, if there is an excess, it is sequestered in storage forms within the cell. 
Iron can be stored in bacterial proteins such as ferritins to avoid the build-up of toxic 
ROS thereby reducing the potential for DNA and protein damage. When haem is the iron 
source, the enzyme haem oxygenase (HO) liberates the iron atom by breaking down the 
protoporphyrin ring leaving CO and biliverdin as by products. A study by Letoffe et al 
identified the proteins YfeX and EfeB as haem-iron liberating agents in E. coli (Letoffe et 
al., 2009). These proteins were subsequently found to be conserved in a wide range of 
41 
 
bacteria, and function to remove the iron from haem by a novel mechanism 
‘deferrochelation’.  
Bacterial haem and iron sensing mechanisms are crucial to adaptation and survival to 
allow the cell to regulate protein production depending on available resources. The Fec 
system regulates iron uptake in E. coli. The Fec signalling system starts with ferric citrate 
binding to the OM protein FecA. The periplasmic N- terminal of this interacts with the 
C-terminal of FecR, an inner membrane protein. FecR then interacts with FecI, which is 
an extracytoplasmic sigma factor, so called as it is responding indirectly to extracellular 
stimuli. FecI then acts on the genes associated with the FecABCDE uptake system 
causing transcription to occur (Enz et al., 2003).  
Bacterial iron levels are tightly regulated by variations in gene expression dependant on 
the cellular environment. Whitby et al demonstrated the importance of iron and haem 
regulation in H. influenzae with microarray results showing that approximately 10% of 
the entire genome is dedicated to acquisition and control of homeostasis of this 
particular nutrient (Whitby et al., 2006). Iron restriction has been shown to promote the 
expression of iron acquisition genes such as the ExbBD genes in N. gonorrhoeae (Jackson 
et al., 2010), haemoglobin receptors in APP and general iron transport proteins and 
permeases in M. haemolytica (Klitgaard et al., 2010). Down-regulated genes in M. 
haemolytica were those involved in metalloprotein formation (Roehrig et al., 2007). 
The regulation of iron-related gene transcription is widely controlled by the Ferric 
Uptake Regulator (Fur). The best known function of the protein Fur is as a co-repressor 
with metals such as iron, cobalt or manganese. The protein dimerises with the help of 
the metal ion, causing a conformational change. This enables binding of the dimer to a 
region overlapping the promotor of the target gene known as a ‘Fur Box’. The Fur dimer 
prevents RNA polymerase binding to the promotor and thereby inhibits transcription. 
When intracellular levels of iron fall, the Fur dimer dissociates and leaves the promoter, 
and transcription can then occur (see Figure 1.9) (Stojiljkovic and Hantke, 1995). Fur has 
also been reported to positively regulate transcription when in its monomer form, 
although the mechanisms are not completely understood. A hypothesis for the 
mechanism of positive regulation suggests that dimer binding may prevent the 
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association of other repressors to the DNA, allowing transcription of certain genes 
(Delany et al., 2004, Yu and Genco, 2012).  
 
Figure 1.9 Repression of Transcription by the Fur Dimer.  
A. In a high iron environment, iron enables dimerization between Fur monomers B. The 
dimer binds the Fur Box (sequence shown Fur Box of E. coli) preventing transcription C. 
Cellular iron levels fall, the iron dissociates and transcription can resume. RNAP denotes 
RNA polymerase.   
 
In specific environmental niches, nutrients may be limited. It is therefore important for 
the bacterial cells to conserve energy whilst maintaining the ability to acquire sufficient 
resources to survive. In concentrating the resources available to the vital functions for 
cellular survival and the appropriate nutrient acquisition, the bacterial cells are giving 
themselves the best chance of survival in a harsh environment. Fur and other systems 
of transcription regulation, such as Zur and ArsR, are crucial in the control of these 
functions, which are also known as bacterial virulence factors.  
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1.4 Prophylaxis and Treatment  
BRD, porcine pleuropneumonia and ovine mastitis all contribute to the disease burden 
on feedlot animals in the agricultural industry worldwide. BRD causes huge financial 
problems to the agricultural industry due to the costs of the loss of cattle to BRD, the 
weight loss during illness due to loss of appetite and the time taken to recover. 
Morbidity due to infection has been estimated at 20.6% (Faber et al., 1999).  Economic 
costs of this disease are caused by a mortality rate estimated at 6%, decrease in value 
of infected animals and treatment costs. The decrease in animal value includes a 
reported $57 lower net profit due to less weight gain in infected animals and lower 
quality meat (Faber et al., 1999). Treatment costs again have been estimated at $12 per 
head of cattle in one study performed in the U.S.A, with 81% of this being the costs of 
the drugs administered. It is telling of the impact of BRD on feedlots that 87% of all 
treatments administered to cows are aimed at BRD complex (Faber et al., 1999). One of 
the major etiological causes is M. haemolytica, and this pathogen is also a commonly 
isolated bacteria from sheep suffering from mastitis, which can impact on nursing lambs 
of infected sheep, causing a further burden to the industry. 
Vaccination of cattle prior to introduction into feedlots had proved to be of inconsistent 
efficacy (Larson and Step, 2012). As a result of this, farmers have turned to 
antimicrobials, namely antibiotics, as the primary measure to prevent serious losses to 
their cattle stocks. Due to liberal non-strain specific use of these antimicrobial agents, 
the rise of antimicrobial resistance is becoming a real problem.  
1.4.1 Prevention 
Metaphylaxis is used to protect high risk cattle upon entry to the feedlot prior to the 
development of immunity resulting from vaccination. In the USA, over 73% of cattle 
received metaphylactic antibiotics upon entry to feedlots in 2011 ((USDA), 2013). 
Common antibiotics registered for this use include tilmicosin, florfenicol, tulathromycin 
and ceftiofur. These have to be controlled and prescribed by experienced veterinarians 
to reduce the chances of the development of antibiotic resistance. Metaphylaxis has 
been estimated to reduce disease incidence by up to 50% and overall mortality by up to 
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25% although meta-analysis highlighted that results for these investigations are 
inconsistent due to large differences in variables (Van Donkersgoed, 1992). While this is 
impressive, it has been widely suggested that improvements in vaccination protocols 
could render this unnecessary, thereby decreasing the chance of selecting resistant 
bacteria. 
It can take between 1-3 weeks for calves to develop an immune response post- 
vaccination, and further booster doses may be required depending upon the vaccine 
used. There are a wide range of vaccines available against the common viral and 
bacterial causes of BRD, which can be used in a variety of combinations. Preconditioning 
of the cattle has been shown to aid in the decrease in disease incidence, however this is 
not always possible (Taylor et al., 2010). 
Cattle vaccinated with killed vaccines had higher morbidity rates than those 
administered modified live vaccines and 52% of calves vaccinated in one study relapsed 
after vaccination (Faber et al., 1999). A meta-study conducted by Larson et al on over 
20 years of data found that vaccines against M. haemolytica did not significantly 
decrease mortality in North American feedlots, although an overall decrease was 
observed in many of the trials studied (Larson and Step, 2012). The same was found for 
H. somni, although the number of trials assessed was much lower. Overall the trials 
assessing the efficacy of vaccines used to reduce BRD caused by bacteria were 
inconsistent, and had many limitations (Larson and Step, 2012). Current vaccines used 
against the Gram-negative bacterial causes of BRD include killed vaccines, such as 
Pulmoguard (Prolabs), and combined vaccines such as the newly released in 2014 
Titanium 5 + PH-M (Elanco) which covers both viral and bacterial causes. Independent 
reviews of the latter have not been reported, yet reports from the company show that 
it does reduce the mortality resulting from M. haemolytica infections when compared 
to an unvaccinated control group (Milliken, 2013).  
Phase variation is one recognised mechanism of bacterial survival, whereby changes in 
expressed proteins can aid host defence avoidance. An example of this is the expression 
of variations of the PorA protein on the outer membranes of N. meningitidis, enabling 
the bacteria to avoid antibody detection (Tauseef et al., 2013). Phase variation can also 
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present a problem when considering drug targets; a high level of phase variation in a 
target protein for example would decrease the efficacy of the drug designed to work via 
that particular protein. A protein that is necessary for some aspect of cellular survival 
and proliferation is more likely to be expressed, and can therefore present a more 
attractive target. 
1.4.2 Treatments  
Effective treatment of BRD requires knowledge of the specific causes to tailor the 
therapy appropriately, and to minimise the selection of resistant bacteria. Classes of 
antibiotics used include macrolides (e.g. Tilmicosin), chloramphenicols (e.g. Nuflor), 
tetracyclines, cephalosporins (e.g. Naxcel) and fluoroquinolones (e.g. Baytril). The 
mechanisms of action are to disrupt or entirely inhibit cell wall synthesis in the case of 
cephalopsporins, which inhibit the peptidoglycan crosslinking by penicillin binding 
proteins. Protein synthesis is targeted by macrolides and tetracyclins, which prevent the 
formation of peptide bonds via inhibiting the 50S subunit interactions and the binding 
of aminoacyl tRNA to the ribosomal subunits, respectively. Fluoroquinolones inhibit 
nucleic acid synthesis by targeting DNA topoisomerases. Despite efforts to reduce the 
rise of resistant bacterial strains, reports over recent years have indicated that the 
number of antibiotics that still provide protection are dwindling. 
1.4.3 Antibiotic Resistance 
Antibiotics currently used to both prevent and treat bacterial infections involved in BRD 
have been widely used in agriculture for many years. While attempts have been made 
more recently to control the indiscriminate usage, there are still instances of 
inappropriate and over use. Resistance can occur by favourable mutations to targets 
such as the topoisomerases, preventing antibiotic binding. Limiting the availability of the 
antibiotic by decreasing membrane permeability or an increase in efflux pumps can also 
lead to failure. Other mechanisms include the inactivation of antibiotics, such as 
chloramphenicol, by acetyl transferases. The gene for β-lactamase also confers 
resistance to penicillin and others in this class of antibiotics by targeting the β-lactam 
ring leading to inactivation. 
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Klima et al found that of the Mannheimia isolates from diseased animals investigated, 
37% (Klima et al., 2014a) and 72% (Klima et al., 2014b) in two different studies had some 
variety of antibiotic resistance, with up to 18% of these showing resistance to 
tetracycline (Klima et al., 2014a, Klima et al., 2014b). All of the isolates displaying 
antibiotic resistance in both studies were serotype A1, with the exception of one 
serotype: A2. In a further study, they investigated the importance of integrative 
conjugative elements (ICE) in conferring resistance upon bacteria, finding that 88% of 
isolates from the samples from the USA contained multidrug resistant ICE (Klima et al., 
2014b). ICE regions are known mobile genetic elements able to transfer between 
competent bacteria, which presents a further survival mechanism. A dangerous by-
product of this was highlighted in the ability of these regions to transfer between P. 
multocida and E. coli (Klima et al., 2014b). This could potentially lead to the spread of 
resistance not just intra-species but also in bacteria colonising similar ecological niches. 
Plasmid mediated resistance has also been observed in M. haemolytica, with genes 
conferring resistance to both florfenicol and chloramphenicol found in a particular 
isolate  (Katsuda et al., 2012). Resistance is not limited to M. haemolytica, with reports 
of disease isolates of A. pleuropneumoniae harbouring resistance genes to tetracycline. 
Lower levels of resistance to florfenicol, tilmicosin and ampicillin were also noted in this 
species (Kucerova et al., 2011). 
1.4.4 New Targets 
As illustrated by the high cost of treatments for BRD, new targets that can affect 
numerous causative agents of this multifactorial disease complex could significantly 
lower this economic burden.  Additional significant costs include the prophylaxis and 
treatment of herd of cattle. To target bacteria in a manner to reduce the likelihood of 
resistance arising, key components in cell survival are an obvious choice.  
A promising vaccine trial used the A. pleuropneumoniae Apx toxins against them, 
utilising a fragment of ApxII as part of a vaccine. Nasal immunization was shown to 
induce protective immunity against infection by multiple serotypes of A. 
pleuropneumoniae in a murine model (Seo et al., 2013). Using this toxin as a target may 
function by both neutralising the damaging effect of the toxin alone and preventing the 
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bacteria from colonising the respiratory and reproductive mucosa by maintaining low 
numbers of bacteria (Chiang et al., 2009, Seo et al., 2013). 
As previously discussed, OM proteins can be involved in adhesion and are also known to 
be immunogenic. The addition of one of these, PlpE, to vaccines for M. haemolytica was 
found to enhance vaccine efficacy and broaden the specificity to A6 as well as A1 (Confer 
et al., 2006). There is a need for greater cross-serotype protection amongst M. 
haemolytica vaccines, as the majority target A1. There is a reported increase in the 
prevalence of other serotypes causing infection, therefore a conserved protein 
throughout serotypes would be an ideal target.  
1.5 The Gly1 Protein Family 
1.5.1 Neisserial Gly1 Proteins 
The protein gonolysin1 (Gly1) was originally discovered by Arvidson et al in Neisseria 
gonorrhoeae while screening the genome for putative bacterial toxins (Arvidson et al., 
1999). The gly1 gene was found by screening clones created in an E. coli library 
containing DNA of N. gonorrhoeae and investigating the coding DNA in colonies that 
displayed some haemolytic activity. Strains of N. gonorrhoeae exhibited increased 
toxicity to human fallopian tube cultures when Gly1ORF1 protein was mutated, and 
found to reduce the toxicity when wt Gly1ORF1 was added back into the growth 
medium, although this finding has not been confirmed with subsequent experiments. 
Gly1ORF1 was discovered at a locus along with a second open reading frame (ORF), with 
no obvious promoter sequence in between the two genes. The proteins, Gly1ORF1 and 
Gly1ORF2 were therefore thought to be co-transcribed (Figure 1.10). Gly1ORF1 was the 
protein of interest in this study. This protein had no known function, and screening in 
the NCBI database initially revealed no matches, with more recent searches finding only 
‘hypothetical’ proteins with similar sequences. Arvidson et al found that this protein was 
mainly located in outer membrane blebs of the Neisseria along with some associated 
with the OM itself. The Gly1 protein was not detected in the soluble lysate proteins of 
N. gonorrhoeae, yet was observed in small quantities in outer membrane blebs- 1010 
cells were required to detect the protein via immunoblot. Although the Arvidson group 
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hypothesised it to be related to inhibition of cellular toxicity in the fallopian tubes, 
further work has not confirmed this. Studies by the Arvidson group also showed that the 
Gly1 proteins were not essential factors in neisserial adhesion or invasion into host 
tissues in vitro (Arvidson et al., 1999).  
 
 
Figure 1.10 Gly1 Locus in Neisserial Species 
The gly1ORF1 and gly1ORF2 genes are located adjacent to each other in the genome. 
No promoter binding region was discovered between the two genes however a 
predicted ribosomal binding site (RBS) was discovered. Gly1ORF2 had some similarity to 
E. coli HemD. Other haem biosynthesis genes were found downstream of the Gly1 locus. 
 
The second protein of the locus, Gly1ORF2 was also entered into the NCBI BLAST 
database search, and the results here showed that it shared a degree of similarity to E. 
coli’s HemD, a protein involved in haem biosynthesis (see Figure 1.8). More recent 
searches of the NCBI database have further suggested that this is the neisserial HemD, 
with updated annotations of the genomes showing a very high degree of conservation 
of this gene and its locus between neisserial species and strains. Other flanking genes of 
Gly1 also appeared to be involved in haem biosynthesis (see Figure 1.10 and 3.5 in 
Chapter 3) which lead to the hypothesis that Gly1 is involved some way in haem uptake 
or metabolism.  
The Neisseria gonorrhoeae Gly1ORF1 protein sequence was entered into the NCBI BLAST 
database to search for potential family members in other bacterial species. The results 
of this search are ever increasing as more and more genomes are added to the database. 
The Gly1 protein was found to be highly conserved throughout neisserial species 
including Neisseria meningitidis and Neisseria lactamica to name a few. These bacteria 
are found in human hosts, often as commensals in the respiratory tract in the case of N. 
lactamica and N. meningitidis, however disease can occur when N. meningitidis moves 
to the lower respiratory tract or enters the bloodstream.  
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Sathyamurthy conducted experiments with the wild type and a ΔGly1 mutant strain of 
N. meningitidis strain MC58, the mutant created with the insertion of an erythromycin 
cassette within the gly1 gene.  These experiments showed that while the wild type 
bacteria were able to grow in medium containing either iron, haem or haemoglobin, the 
ΔGly1 knock out strain was unable to grow in medium containing haem or haemoglobin 
alone. When purified Gly1 protein was reintroduced to the medium, growth was 
restored in a dose dependent manner. The ΔGly1 mutant was able to grow on medium 
containing inorganic iron (Sathyamurthy, 2011). 
Further work with the N. meningitidis Gly1 protein also showed interactions with the 
neisserial HmbR (Weirzbicka, 2014) suggesting that Gly1 has a central role in iron uptake 
from haem sources. Interactions with erythrocytes were also demonstrated, with Gly1 
causing deformation of the red blood cells (Sathyamurthy, 2011) thought to be via 
transient protein interactions (Weirzbicka, 2014). Characterisation of this interaction 
was suggested to be via the erythrocyte membrane protein EBP 4.2, initially shown by 
Yeast-2-hybrid experiments (Meadows, 2005). Sathyamurthy et al demonstrated 
interactions using fluorescently labelled neisserial Gly1 incubated with a mouse cell line 
expressing the membrane protein (Sathyamurthy, 2011). These interaction results could 
not be replicated using purified EBP 4.2 in Gly1 binding experiments performed using 
the BLItz (ForteBio), which was suspected to be a result of incorrect folding or protein 
instability (Weirzbicka, 2014). 
In addition to this potential role in nutrient uptake, serum bactericidal assays were 
performed which showed bactericidal activity of serum antibodies raised against the N. 
meningitidis Gly1 protein (Sathyamurthy, 2011, Weirzbicka, 2014). These data 
supported the idea that anti-Gly1 antibodies could be used as a potential vaccine 
candidate, although further experiments would be required in an animal model of 
neisserial infection to verify this.  
Studies of antibacterial agents focussing on iron acquisition in the form of haem uptake 
include targeting HasA of P. aeruginosa. This investigation showed that HasA was able 
to bind synthetic metals rather than haem, and in doing so on a haem only medium P. 
aeruginosa was unable to grow (Shirataki et al., 2014). Not all vaccine candidates have 
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shown cross-serotype protection, for example using HgbA of H. ducreyi along with an 
adjuvant only conferred protection against those isolates expressing one class of 
receptor (Fusco et al., 2010). Highly conserved target proteins throughout serotypes 
would enable a cross-serotype vaccine, and potentially even cross-species. 
1.5.2 Potential Homologues- The Gly1 Protein Family  
Potential homologues were discovered in Actinobacillus pleuropneumoniae, Histophilus 
somni (formerly Haemophilus somnus) and Mannheimia haemolytica (formerly 
Pasteurella haemolytica), among others. Of particular interest is the recent addition of 
a putative homologue in P. multocida, another bacteria commonly isolated in BRD along 
with M. haemolytica and H. somni. Of these species, M. haemolytica boasts 12 different 
serotypes, P. multocida 5 and A. pleuropneumoniae 15. H. somni is not classed into 
serotypes that are widely used, and just two strains have their complete genome 
sequences available as of August 2015.   
Further NCBI BLAST searches revealed potential protein homologues of the Gly1 protein 
within a number of Gram-negative bacteria, ranging from highly similar neisserial 
species such as N. lactamica as previously mentioned to S. enterica IIIa and E. tarda - 
reptile and fish pathogens, respectively. 
1.5.3 Project Aims at the Outset 
Due to the economic importance of the diseases caused by these animal pathogens, the 
members of this possible new ‘gonolysin1- like’ protein family may be of interest as they 
are present in all available sequenced neisserial genomes at time of writing. This, 
coupled with prior research showing neisserial Gly1 proteins conveying complement-
mediated bactericidal activity, could present Gly1 proteins as potential novel targets for 
vaccines or therapy.  
The initial aims of the project were to investigate potential Gly1 family proteins found 
within a number of animal pathogens. The proteins in question were of unknown 
function and structure, with only the ORFs highlighted within the genomes in the NCBI 
database as an indication that they existed. Therefore the proteins from M. haemolytica, 
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A. pleuropneumoniae and S. enterica arizonae (IIIa) were chosen to undergo 
characterisation experiments to discover whether their structures and/ or functions 
were similar to that of the neisserial Gly1 proteins previously investigated. The initial 
hypothesis was that the Gly1 protein family is involved in haem- iron acquisition in gram-
negative bacteria based on the neisserial Gly1 studies conducted in the Sayers group. 
Specifically, we set out to: 
 Identify putative sequence homologues in different bacterial species 
 Discover the prevalence of Gly1 homologues in M. haemolytica isolates  
 Screen these isolates to analyse sequence conservation within Mannheimia 
species 
 Express and purify Gly1 homologues and investigate the structural similarities 
of these proteins 
 Determine haem binding ability of these proteins of interest.  
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2. Materials and Methods 
2.1 Cloning 
2.1.1 Preparation of Chemically Competent Cells 
Axenic cultures of E. coli M72, BL21 (DE3), BL21 (DE3) RIPL or XLI Blue cells (all lab strains, 
see Appendix for genotypes) were grown on LB agar plates overnight at 30°C (see 
section 2.2.4). One colony was used to inoculate 10 ml of LB medium, which was 
incubated overnight at 30°C. The 10 ml culture was added to 100 ml LB and incubated 
at 30°C until an A600 of 0.4 was reached. The cell suspension was centrifuged at 335 x g 
for 10 minutes at 4°C. The cell pellet was re-suspended in 25 ml 100 mM MgCl2. The 
suspension was again centrifuged at 335 x g for 10 minutes, 4°C, and the cell pellet 
gently re-suspended in 5 ml of 100 mM ice cold CaCl2. A further 45 ml of 100 mM ice 
cold CaCl2 was added and this solution was incubated on ice for 1 hour. The cells were 
again centrifuged at 335 x g for 10 minutes at 4°C. This pellet was re-suspended in 6 ml 
100 mM ice cold CaCl2 plus 15% glycerol and immediately frozen in aliquots at -80°C.  
2.1.2 Transformation of Chemically Competent Cells 
Competent cells that had been grown in 0.1% glucose enriched LB medium were 
defrosted on ice and 50 µl added to pre-chilled micro-centrifuge tubes. The control 
tubes contained 1. competent cells only, and 2. an empty vector relevant to the 
transformation.  To each subsequent aliquot, 2.5 µl of diluted plasmid was added. 
Samples were incubated on ice for 1 hour followed by a 1 minute heat shock at 42°C. 
The cells were immediately returned to ice for 5 minutes. A 50 µl aliquot of each sample 
was plated onto an LB agar plate containing ampicillin and 0.1% glucose, and incubated 
at 30°C overnight.  
2.1.3 Mini Prep of Plasmid DNA 
Cells containing the plasmid (XLIB for pET-21-a and pUC19 storage followed by BL21 
(DE3)) for subsequent protein overexpression, and M72 for pJONEX4 and pJONEX4 C-
his) were grown in LB medium plus ampicillin overnight at 30°C. For XLIB and BL21 (DE3) 
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cells, LB was enriched with 0.1% glucose. Of this, 6 ml was centrifuged, the supernatant 
was discarded and the cell pellet used for a DNA mini-prep (Omega Bio-Tek USA, Plasmid 
Mini-Prep Kit). For midi-preps (Qiagen Ltd, UK), 100 ml overnight cultures were grown, 
of which 50 ml was used.  
2.1.4 Double Digest of Gene and Plasmid 
Restriction sites compatible with the multiple cloning site in pJONEX4 (EcoRI and 
HindIII), for pJONEX4 C-his (EcoRI and BamHI), for pUC19 (EcoRI and BamHI) and for 
pET21-a (NdeI and HindIII) were incorporated into the gene of interest using custom 
designed primers (see table 2.1) and were designed to allow over expression from either 
the lambda, lac or T7 promoter depending on the vector of choice (see Table 2.1). For 
the double digest, an initial single digest was carried out using approximately 40 ng of 
vector from the mini-prep with 10 units of each restriction enzyme plus 2 µl 10 x buffer 
and dH2O to a final volume of 20 µl. An undigested control was included containing only 
10 ng vector plus dH2O to a final volume of 5 µl. Samples were incubated for 1 hour at 
37°C. Of each single digest, 15 µl was transferred into a single tube to give a final volume 
of 30 µl. A further 10 units of each restriction enzyme was added to this and all samples 
were incubated for 1 hour at 37°C. A 1% agarose gel containing ethidium bromide (final 
concentration of 1 µg/ml) was prepared and 5 µl of each sample, mixed with 1 µl 6 x 
loading dye, and either a 100 bp or a 1 kb DNA ladder (both NEB), was run at 4 V cm-1 
for approximately 45 minutes. A large well containing 25 µl (approximately 250 ng) of 
the double digest mixture was also included for gel extraction. The wells containing 
approximately 50 ng DNA were UV imaged and marks made to enable extraction of the 
larger band of DNA without UV exposure. Gel Extraction was performed using a Qiagen 
Gel Extraction kit. The APP Gly1 gene was synthesised by Eurofins MWG Operon in the 
pEX-A-new plasmid to enable restriction digest with EcoRI and HindIII, allowing for direct 
cloning into the pJONEX4 vector. 
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Target gene Forward sequence Reverse sequence 
MHA_1205 5’-
TTTCGAATTCTAGAGGAAACAAAAAT
GCGTAAATTATTAGTAATT-3’ (EcoRI) 
5’-
TGTTGGATCCCTAAAGTATTCATC
AAATGAACATC-3’ (BamHI) 
MHA_0579 5’-
AAAAGAATTCAAAGGAAACTAACAT
ATGAAAAAAATGGC-3’  (EcoRI) 
5’-
TTAAGGATCCCGGCTGCAAATCC
AGATTTTCTCATCA-3’ (BamHI) 
MHpara 5’-
AAAGGAAAACATATGAAAAAATTGA
TGATATTCGC-3’ (NdeI) 
5’-
TCTTAAGCTTTTACTATTTTTGAG
GTGTGCAACCTTT-3’ (HindIII) 
PhuT 5’-
AATACATATGAGAACCTTACTTTTTTC
TTT-3’ (NdeI) 
5’-
TATAAAGCTTATTTTAAACAAGG
TTGAATAGT-3’ (HindIII) 
HmbR 5’- 
TAAAGGATCCAGAGGACTAAAATAT
GCAAATAAAGCAAA-3’ (BamHI) 
5’-
AAAAGAATTCATTTACAAAAAAT
GGGCCAAAATTA-3’ (EcoRI) 
 
Table 2. 1. Primers Used for Cloning. Restriction enzymes in brackets and recognition 
sites underlined, start codon highlighted in yellow. 
 
 
2.1.5 Ligation of Gene into Vector 
Ligation of the Gly1 insert into the plasmid was performed using an approximate 1:3 
molar ratio of vector: insert. Samples were incubated in ligation buffer and 5 units of T4 
DNA Ligase (both Fermentas) and made up to 10 µl with dH2O. The reaction was left on 
ice overnight. A 1% agarose gel was run to check ligation. The complete plasmid was 
then transformed back into the appropriate competent cell type (see section 2.1.2). 
After transformation, 50 µl of cells were plated (see section 2.2.4). These included a 
negative control of cells containing no vector, a control for self-ligation with vector and 
ligase alone, and insert and ligase alone. The experimental cells contained different 
ratios of the ligation of vector and insert and a positive control of the undigested vector. 
The plates were grown at 30°C. Colonies were grown up in 6 ml LB cultures (see section 
2.2.5) and the DNA extracted using the Omega plasmid mini-prep kit as before. The DNA 
was sent for sequencing using either M13 primers applicable for both of the pJONEX4 
vectors or T7 primers for the pUC19 and pET-21a vectors to assess the quality of the 
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cloning. Sequencing was performed by the University of Sheffield Core Genomics 
Facility, and sequences were analysed using FinchTV 1.4.0 (Geospiza, Inc.; Seattle, WA, 
USA; http://www.geospiza.com). 
The M. haemolytica Gly1 paralogue was cloned from a 50 ng stock of genomic DNA (a 
gift from Intervet Innovation GmbH, Schwabenheim, Germany). The periplasmic haem 
binding protein PhuT and the haemoglobin receptor (HmbR) were also cloned from this 
genomic DNA.  
2.2 Protein Overexpression and Purification 
2.2.1 Cell Culture- Buffers and Reagents 
Lennox Broth (LB) medium consisted of 1% tryptone w/v, 0.5% yeast extract (Oxoid) w/v, 
0.5% NaCl (Acros Organics) w/v plus 1.5% Bacto™ Agar (BD) w/v for agar plates. The 4YT 
(yeast- tryptone) medium consisted of 3.2% tryptone, 2% yeast extract and 0.5% NaCl. 
The ampicillin and carbenicillin (Melford) were both diluted to a final concentration of 
100 µg/ml in cell culture media. Cell lines used were E. coli K- 12 M72, E. coli BL21 DE3 
and E. coli XLI Blue (all lab strains). Cell wash buffer consisted of 25 mM Tris·HCl pH 8, 2 
mM EDTA pH 8 and 100 mM NaCl. 
2.2.2 Heat Induced Expression System of pJONEX4 
M. haemolytica Gly1 MHA_1205 and MHA_0579 were cloned into the plasmid pJONEX4-
C-His (Sayers and Eckstein, 1991). To enable specific selection, the plasmid contained a 
gene coding for beta lactamase, which confers ampicillin resistance. A λPL promoter 
controlled transcription of Gly1 via a heat inducible system. The plasmid was 
transformed into M72 cells to enable over expression via a heat inducible cI857 
repressor on a defective prophage. 
2.2.3 IPTG Induced Expression System of pET21-a(+) 
An alternate system for protein over expression used IPTG induction of the vector pET-
21a(+) (Novagen). Also containing the beta lactamase gene conferring ampicillin 
resistance, cell lines containing this vector (BL21 DE3 for over-expression and XLI Blue 
for storage at -80°C) were grown in the same medium as pJONEX4 containing M72 cells, 
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but at a lower temperature of 25°C to avoid problems with solubility. Induction was 
instigated by the addition of between 0.5 mM and 1 mM IPTG to a cell culture of A600 
0.4. The BL21 DE3 cells were grown to this density in the presence of 0.1% glucose to 
prevent any leaky expression of T7 RNAP from the lac promoter.  
2.2.4 LB Agar Plates 
LB medium was made (see section 2.2.1) and 1.5% w/v agar added. The solution was 
autoclaved, cooled, and had appropriate antibiotics added as required prior to pouring. 
For XL1 Blue cell culture glucose was also added to a final concentration of 0.1% v/v prior 
to pouring. To plate the bacteria, a colony-sized volume of stock cells containing the 
plasmid (stored at -80°C, 20% glycerol) was streaked on an LB agar plate using a sterile 
loop and flame. The plate was incubated at 30°C overnight for pJONEX4 containing cells 
and 37°C for pET-21a(+), pUC19 and pEX-a-new vectors to get individual colonies. From 
liquid cell cultures, 50 l was plated, spread and left to dry prior to inverting and 
incubating at a temperature appropriate for the plasmid. 
2.2.5 Small to Medium Scale Cell Culture 
Ampicillin was added to 3- 10 ml LB medium to final concentration of 100 µg/ml.  A 
single colony was used to inoculate the medium and left overnight at 30°C or 37°C, 
shaking at 200 rpm. From the overnight culture, 1 ml was added to 100 ml LB with 
ampicillin (final concentration of 100 µg/ml) and allowed to either grow to the 
appropriate A600 for small scale expression, or to grow overnight for use as a feeder for 
large scale culture. 
2.2.6 Large Scale Cell Culture 
A 5 l fermenter was used to provide improved aeration of the cells in the hope of 
achieving a higher yield of protein. To 5 l of 4YT in the fermenter, 400 ml of overnight 
culture was added along with carbenicillin (see section 2.2.1) and 0.75 ml antifoam 
(Sigma). The fermenter was aerated (two volumes per minute) and stirred at 300 rpm 
constantly at a temperature of 25°C until it reached an A600 of 2. A 1 ml un-induced 
sample was taken, centrifuged and the supernatant and pellet separated then frozen. 
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For cells containing pJONEX4 vectors, the temperature was then increased to 42°C for a 
3 hour induction. After induction, the temperature was reduced to 26°C, and 
fermentation continued for 13 hours. For cells containing pET21-a(+) and pUC19, IPTG 
was added as described in section 2.2.3, with the temperature remaining at 25 °C. Post 
induction, a 1 ml sample was again taken, centrifuged and supernatant and pellet 
separated then frozen. The remaining culture was centrifuged at 9000 x g, 20 minutes 
and the supernatant stored at 4°C. The cell pellet was re-suspended in 200 ml cell wash 
buffer. The suspension was centrifuged at 15000 x g for 30 minutes at 4°C, supernatant 
discarded and pellet re-suspended in 200 ml of cell wash buffer minus EDTA. This was 
centrifuged and the supernatant discarded, and pellets frozen at -80°C. 
2.3 Protein analysis via SDS-PAGE 
2.3.1 SDS-PAGE- Buffers and Reagents 
A 13% SDS-PAGE gel was used throughout to enhance resolution of lower MW bands 
e.g. Gly1. The resolving gel contained 13% (w/v) acrylamide, 25 mM Tris-Bicine pH 8, 
0.1% SDS, 0.5 mg/ml APS and 0.016% (v/v) TEMED. The stacking gel contained 4% (w/v) 
acrylamide, 100 mM Tris·HCl pH 6.8, 0.08% SDS, 0.4 mg/ml APS and 0.2% TEMED. 
Sample loading dye consisted of 0.2% SDS, 40% glycerol, 75 mM Tris pH 8, a few crystals 
of bromophenol blue (Sigma), 5 mM EDTA (BDH) pH 8, with fresh dithiothreitol (DTT) 
(Melford) crystals added prior to use. The cell lysis buffer consisted of 25 mM Tris·HCl 
pH 8 and 1 mM EDTA pH 8. 
2.3.2 Sample Preparation SDS-PAGE Gel  
The cell pellet from the 1 ml samples was re-suspended in lysis buffer normalised using 
the A600 value at which induction was initiated i.e. (A600 x 100)/2, unless the culture was 
small-scale and no A600 reading was taken, in which case 100 µl of lysis buffer was 
uniformly used. To the cell suspension, SDS solution was added to a final concentration 
of 1%; the sample was mixed by vortex and then boiled for 3 minutes at 100°C. A 1:1 
ratio of loading dye (see section 2.3.1) was added to the sample and the solution was 
boiled again for 3 minutes at 100°C. A 10 µl sample was loaded on an SDS-PAGE gel. Cell 
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supernatants were mixed 1:1 with loading dye, boiled once at 100°C for 3 minutes and 
loaded onto the SDS-PAGE gel.  
2.3.3 Acetone Protein Precipitation 
Protein in the supernatant samples was precipitated out using the Thermo Scientific 
Acetone Precipitation Protocol. A 1:4 ratio of sample: acetone (pre-chilled to -20°C), was 
mixed using a vortex and incubated for 1 hour at -20°C. The sample was micro-
centrifuged at 13,000 x g for 10 minutes, the acetone discarded, and the pellet left to 
air-dry for 35 minutes. The pellet was re-suspended in 10 µl deionised water (dH20) and 
10 µl loading dye. The sample was then heated for 3 minutes at 100°C and run on an 
SDS-PAGE gel.  
2.4 Protein Purification- Buffers and Reagents 
2.4.1 Nickel Chelate Column Buffers 
Nickel column wash buffer consisted of 25 mM Tris·HCl, 500 mM NaCl and 5% glycerol 
v/v pH 8. This buffer was also used for dialysis of samples prior to running on the nickel 
column. Nickel column loading buffer consisted of 25 mM Tris·HCl pH 8, 500 mM NaCl, 
5% glycerol v/v and 20 mM imidazole. Nickel column cleaning buffer consisted of 3 M 
guanidine-HCl (GuHCl) (Acros Organics), 5 mM EDTA and 50 mM Tris·HCl pH 8. 
2.4.2 Ion Exchange Buffers 
For Q columns, low salt Q buffer consisted of 25 mM Tris·HCl, 1 mM EDTA, 5% glycerol 
v/v and 50 mM NaCl pH 8. Samples were dialysed into low salt Q buffer prior to running 
through the Q column.  High salt Q buffer consisted of 25 mM Tris·HCl, 1 mM EDTA, 5% 
glycerol v/v and 1 M NaCl pH 8. Buffers for the SP column consisted of 20 mM KH2PO4, 
20 mM K2HPO4, 5% glycerol, 2 mM EDTA and 50 mM or 1 M NaCl for the low and high 
salt elutions, respectively.  
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2.5 Protein Purification 
2.5.1 Bacterial Cell Pellet Lysis 
The frozen cell pellet was re-suspended in lysis buffer in a volume of 5 ml per gram of 
pellet at room temperature. Cell lysis buffer consisted of 200 mM NaCl and 25 mM 
Tris·HCl pH 8. Once fully re-suspended, lysozyme (Sigma) was added to achieve a final 
concentration of 200 µg/ml. PMSF (Sigma) was added to a final concentration of 23 
µg/ml. As the cell suspension became viscous, sodium deoxycholate (Acros Organic) was 
added to a final concentration of 1 mg/ml. The cell suspension was then sonicated 
(Jencons Vibra Cell) in 30 second bursts at 20% amplitude until thinned, left on ice for 
20 minutes, and sonicated again in 30 second bursts to ensure full disruption of the cell 
membranes. The lysed cell suspension was centrifuged at 20000 x g for 20 minutes at 
4°C, and the supernatant transferred to a clean container. To this, ammonium sulphate 
(Sigma) was added to achieve a final concentration of 3 M and left on a roller for 
minimum 1 hour at 4°C for protein precipitation. The suspension was centrifuged at 
40000 x g for 20 minutes at 4°C and the supernatant discarded. The pellet was re-
suspended in dialysis buffer and prepared for dialysis.  
2.5.2 PhuT Solubilisation 
The M. Haemolytica periplasmic haem binding protein, PhuT, was over expressed using 
the pET21a vector after transformation into BL21 (DE3) E. coli cells. A small quantity of 
the over expressed protein leaked out into the culture medium and was concentrated 
down for purification. The protein in the pellet fraction however, was found to be 
insoluble after cell lysis. To resolubilise the protein, KP buffer was added to re suspend 
the post-sonication pellet, and GuHCl was added in powder form to a final concentration 
of 7 M. The sample was left mixing for a minimum of 1 hour at 4°C. DTT to 1 mM was 
added to prevent any oxidative damage to the cysteines. The sample was centrifuged at 
40000 x g for 20 minutes and the supernatant was then separated from the non-soluble 
pellet fraction. The supernatant was then slowly dialysed into Q buffer pH 8 in 
preparation for ion exchange chromatography. This allowed re-solubilisation of 
approximately half of the insoluble protein.  
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2.5.3 Nickel Chelate Column Chromatography 
To purify the polyhistidine-tagged Gly1 proteins from the cell-free extract a 10 ml 
column containing 50% HIS-Buster Nickel Affinity Gel (Amocol) slurry was used. The 
column was equilibrated with 25 ml sodium acetate followed by 25 ml of wash buffer. A 
50 µl sample of the cell-free extract was retained and stored at 4°C. The remaining cell 
free extract was diluted 1:2 with loading buffer and loaded onto the column using gravity 
flow. The flow through was collected in fractions, and the column washed with 25 ml 
load buffer. The protein was then eluted using 10 ml washes of 50 mM, 100 mM and 
200 mM imidazole and collected in two 5 ml fractions. A final elution with 20 ml 500 mM 
imidazole was collected in two 10 ml fractions. The column was washed once more with 
wash buffer, cleaned with cleaning buffer (see section 2.4.1), and each flow through 
collected. All washes were stored at 4°C. The column was stored in 20% ethanol. To 
recharge the nickel beads, 100 mM NiCl2 was loaded onto the column twice. The 
samples were analysed on an SDS-PAGE gel. 
2.5.4 Ion Exchange Chromatography 
To further purify the protein of interest, anion and/or cation exchange chromatography 
was performed with either a Q column or an SP column respectively (GE Healthcare). 
The 1 ml or 5 ml Q column was equilibrated by washing with 10 column volumes (c.v.) 
low salt Q buffer, 10 c.v. high salt Q buffer, and 10 c.v. low salt Q buffer again. Following 
buffer exchange dialysis (see section 2.6), the eluted protein from the nickel column was 
loaded onto the Q column at 0.5 ml/min and the flow through collected. A 50 µl sample 
of the load was retained and stored at 4°C. The column was washed with 10 ml low salt 
Q buffer at a rate of 0.5 ml/min. The proteins were then eluted using a 20 ml NaCl 
gradient ranging from 50 mM to 1 M, followed by 5 ml of high salt Q buffer and fractions 
of 1 ml were collected. The column was then washed with 10 ml 3 M GuHCl followed by 
10 ml dH2O and stored in 20% ethanol at 4°C. The above method was performed for SP 
columns using the low and high salt SP buffers referred to in section 2.4.2. 
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2.6 Protein Analysis 
2.6.1 Dialysis 
Dialysis tubing (Spectra/Por 1 Dialysis Tubing, 6-8 kDa MWCO, Spectrumlabs) was boiled 
in 2 mM EDTA and 100 mM NaHCO3, followed by 100 mM NaHCO3 alone, then washed 
thoroughly with dH20. The solution to be dialysed was added to the tubing and secured. 
The dialysis bags were incubated in a minimum of a 40 fold dilution of the required 
buffer at 4°C for 4 hours, the buffer changed, and the dialysis continued overnight in a 
further minimum of a 40 fold dilution to allow equilibrium to be reached. 
2.6.2 Protein Quantification 
To measure protein concentration, a Bradford Assay was performed. The Protein Assay 
Reagent (Biorad) was diluted 2:7 in dH2O. Standards of 10, 8, 6, 4 and 2 µg of BSA (Sigma) 
in a 100 µl volume plus 900 µl diluted Protein Assay Reagent were measured at A595 in 
triplicate. The protein sample was diluted into a final volume of 100 µl in dH2O to fall 
within the limits of the standards. The A595 was measured in triplicate and the protein 
concentration deduced graphically from comparison with the known standards. 
Alternatively, the Pierce BCA assay kit was used following the user guidelines.  
2.6.3 Concentration of Protein Samples 
To increase the concentration of protein, the solution was centrifuged at 657 x g for 20 
minutes at 4°C in a 5000 MWCO Viva Spin tube (Sartorius Stedim Biotech) until the 
required volume was achieved. Alternatively, acetone precipitation was used (Ras, 
2009) for concentration of protein found in the sample supernatant. Briefly, a 1:4 
dilution of the protein sample in ice cold acetone was mixed by vortex and stored at -
20°C for 1 hour. The sample was then centrifuged at 13,000 x g for 10 minutes, the 
supernatant removed and the pellet left to air dry at room temperature. For SDS-PAGE 
analysis, the pellet was then resuspended in 10 µl dH2O before adding 10 µl SDS-PAGE 
loading dye, boiling for 3 minutes and running on a SDS-PAGE gel.  
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2.6.4 Circular Dichroism Spectroscopy 
The circular dichroism (CD) spectra were collected using the Jasco J-10 
Spectropolarimeter. The settings used are outlined in Table 2. 2. Proteins were 
measured between approximately 0.09 mg/ml and 0.2 mg/ml. All proteins were diluted 
in 1 x PBS buffer, with a baseline taken of the same 1 x PBS buffer. The ellipticity was 
calculated by subtracting the baseline from the protein values, with the spectra analysed 
using the following equation used to calculate molar residue ellipticity: 
 
[θ] MRW = θ x 100 x Mr 
                    C x D x NA 
Condition Setting 
Sensitivity 100mdeg 
Start 300 nm 
End 190 nm 
Data pitch 1 nm 
Scanning mode Continuous 
Scanning speed 20 nm/min 
Response 8 sec 
Band width 1 nm 
Slit width 1 nm 
Accumulations 5 
Table 2. 2 Circular Dichroism Settings 
_______________________________________________________________________ 
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2.6.5 Polyhistidine Tag Cleavage 
Enterokinase (polyhistidine tagged) (Biorbyt Ltd, UK) was diluted to 0.1 and 0.04 units 
per microliter in storage buffer (200 mM NaCl, 20 mM Tris·HCl, 2mM CaCl2). Target 
proteins were dialysed into 1 x PBS prior to use and 20 µg was used per 50 µl reaction. 
Each reaction was composed of 5 µl 10 x reaction buffer (20 mM CaCl2, 500 mM NaCl2, 
200 mM Tris·HCl pH8), 20 µg target protein, 5 µl diluted enterokinase and dH2O to make 
up the 50 µl volume. Reactions were left for 24 hours at 25°C, then analysed on SDS-
PAGE gels for cleavage. Once cleavage was confirmed, a small scale nickel pull-down was 
performed to remove both the cleaved polyhistidine tag and the enterokinase. Briefly, 
50 µl of nickel beads were washed and centrifuged as with the nickel column (see section 
2.5.3). The reaction was added to the beads, incubated at room temperature for one 
hour then centrifuged at 5000 x g in a desk top centrifuge for 5 minutes. The supernatant 
was carefully removed and a sample analysed on an SDS-PAGE gel alongside the protein 
before enterokinase cleavage.  
2.6.6 Antibody Production and Purification 
Purified APP protein resuspended in 1 x PBS to a concentration of 200 µM was injected 
into 14 week old BALB/C mice, 100 µl per injection at d0, d14 and d28 over a period of 
8 weeks. Tail bleeds were performed at 3 weeks and 6 weeks and a terminal bleed was 
taken at 8 weeks after confirming the presence of the antibody in the serum. 
MHA_0579 C- His and MHpara antibodies were created by Generon using 1 mg/ml pure 
protein in a 60 day immunisation and bleed protocol to ensure a response was elicited. 
Antibodies were subsequently purified using affinity chromatography columns specific 
for each antibody (ThermoFisher AminoLink Coupling resin). Briefly, corresponding 
proteins were immobilised onto equilibrated columns, washed with Binding Buffer and 
the antisera added. The columns were then washed again with Binding Buffer to remove 
non-specific antibodies and other proteins and the protein specific antibodies were then 
eluted using Elution buffer. Antibody presence was confirmed using western blotting.  
2.7 Bioinformatic Analysis 
The database used in this project for discovery of genomic information and protein 
sequences was the NCBI BLAST site  (Altschul et al., 1997) 
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http://blast.ncbi.nlm.nih.gov/Blast.cgi. To search for potential homologues of the initial 
neisserial proteins, their amino acid sequences were used to screen genomes uploaded 
in the database using an initial BLASTp search and a maximum of seven iterations. 
Potential protein homologues were chosen from these searches that had an ‘FSC’, ‘FMC’ 
or ‘YSC’ region near the N terminal, a C terminal cysteine and a predicted N terminal 
signal peptide sequence of between 19 and 24 amino acids in length. Signal peptide 
prediction was performed using SignalP (Choo et al., 2009) 
http://www.cbs.dtu.dk/services/SignalP/. The SABLE server (Adamczak et al., 2005) 
http://sable.cchmc.org/ was used to predict the secondary structure and Phyre2 (Kelley 
et al., 2015) to predict unsolved tertiary structures of the M. haemolytica Gly1 
homologues. PsortB V3.0 was used to predict the cellular location of proteins (Yu et al., 
2010).  
2.8 X-ray Crystallography 
Proteins were purified as mentioned in section 2.4, concentrated to a minimum of 10 
mg/ml, and buffer exchanged into 10 mM TE buffer in the case of the M. haemolytica 
Gly1 paralogue, and MHA_0579 C-His was crystallised in PACT D6, which is 0.1 M MMT 
(DL-malic acid: MES: Tris base) buffer pH 9 and 25% (w/v) PEG 1500 respectively. The X-
ray crystallography on the M. haemolytica proteins was performed by Jason Wilson, 
Dept. of Molecular Biology & Biotechnology, The University of Sheffield. Screening and 
optimisation was carried out on each protein. Additional screening of the MHA_0579 C-
His protein was attempted in the presence of hemin. The hemin soak was performed by 
adding small amounts of solid hemin to the drop with an acupuncture needle. 
Crystallography on SARI C-His was initially also attempted by Rick Salmon also of MBB 
at TUOS. 
2.9 Hemin Interactions 
2.9.1 Hemin Agarose Binding Assay 
Hemin immobilised on agarose beads was used to assess if bacterial proteins of interest 
interacted with hemin. Stock concentrations of proteins were diluted to approximately 
2 µg/ 20 µl in 1 x PBS plus 20 µg/ 20 µl BSA. The bovine hemin agarose beads (Sigma 
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Aldrich) were washed 3 times with 0.5 ml 1 x PBS 500 mM NaCl, centrifuged and the 
pellet re-suspended in 1 x PBS to achieve 50% bead slurry. To 20 µl aliquots of hemin 
beads, 10 µl of each protein stock solution or a further negative control of 10 µl 1 x PBS 
BSA only was added. The samples were mixed on a vortex and left rolling at room 
temperature for 1 hour. The samples were centrifuged at 5000 x g for 2 minutes and the 
supernatant and hemin bead pellet separated. The beads were washed three times with 
0.5 ml 1 x PBS 500 mM NaCl and centrifuged. All samples were re-suspended in 10 µl 
loading dye, boiled for 3 minutes at 100°C and loaded onto an SDS-PAGE gel (2.3). 
Densiometry analysis was performed using ImageJ (Rasband, 1997-2012) software, and 
the Students t-test was performed to generate statistical data. If proteins interacted 
with the hemin they would be found in the ‘pellet’ fraction associated with the hemin 
beads.  
Proteins used included the Gly1 proteins of interest, recombinant human growth 
hormone (polyhistidine-tagged, a kind gift from Dr. Pradhananga, TUOS), human flap 
endonuclease (FEN) and PhuT proteins. N. meningitidis Gly1 was used as a positive 
control, as haem binding had previously been shown with this protein in the Sayers lab 
(Sathyamurthy, 2011). Lysozyme was used as a negative control.  
2.9.2 Haemoglobin Agarose Binding Assay 
Haemoglobin (immobilised on agarose beads) was employed using the same method as 
the hemin agarose bead binding assay in section 2.9.1. In addition to this, glutaraldehyde 
was used to make any binding permanent between the Gly1 and haemoglobin to 
capture the binding in the event of a reversible reaction.  
2.9.3 Hemin Absorbance Assay 
Hemin (Sigma) was dissolved in 100 mM NaOH, and diluted with 1 mM Tris·HCl pH 8 to 
produce 0.1 mM hemin stock solution at pH 7.5. The hemin was diluted to a working 
concentration of 25 µM, with Gly1 protein concentrations varying. Samples consisted of 
250 µl Gly1 or other protein plus 250 µl hemin, along with a hemin-PBS control, and 
protein only. The samples were made up to 1 ml with 500 µl 1 x PBS. The absorbance 
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spectra were scanned from 260 nm- 500 nm wavelength, using PBS only as the baseline. 
Each spectrum is representative of a minimum of three repeats.  
2.9.4 Hemin Peroxidase Activity 
A 96 well microtitre plate with a maxisorb surface was coated with 0, 2, 4, 6, and 8 µg of 
protein made up to 100 µl with 1 x PBS buffer, and incubated at 37 °C for 2 hours. The 
plate was then washed with 200 µl 1 x PBS three times. 20 µg of hemin/ 100 µl 1 x PBS 
was added to each of the experimental wells, with 1 x PBS only or hemin to wells with 
no initial protein coating added to the control wells. The plate was incubated for 1 hour 
at 37 °C, and washed a further three times with 200 µl 1 x PBS. TMB (Sigma) was added 
at 50 µl per well and the reaction stopped after 45 minutes to allow sufficient colour 
change to occur. The reaction was stopped with 50 µl 1 M HCl and absorbance was 
measured on a plate reader at 450 nm.  
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2.10 PCR Screening 
Isolates 234, 235, 292, 296, 311, 351, 362, 411, 414 and 428 were kindly donated by Dr 
Miranda Kirchner at the AHVLA in Surrey, England. These were received on Dorset’s Egg 
Slope medium and re-streaked onto Columbia blood agar (CBA) plates made with 
defibrinated horse blood. In addition, a further 19 bacterial isolates were generously 
gifted on CBA plates by Professor Andrew Rycroft at the Royal Veterinary College, 
Potters Bar (see Table 2.3). The plates were incubated overnight at 37 °C and 5% CO2. 
Single colonies were resuspended in 20 µl TE buffer and boiled at 95 °C for 5 minutes. 
The samples were then centrifuged for 1 minute at 13,000 x g on a desktop centrifuge 
and the supernatant transferred to a fresh Eppendorf tube. This supernatant was stored 
at -20 °C until required for PCR reactions. Isolates were stored in cryo-protective tubes 
at -80 °C.
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Strain  Date (If known) 
M. haemolytica A10 (T10) 5/75 
M. haemolytica A12  5/75 
M. haemolytica p28  22/08/80 
M. haemolytica A1  5/75 
M. haemolytica A7  5/75 
M. haemolytica A9  5/75 
M. haemolytica CO2392  
M. haemolytica CO0600  
M. haemolytica CO4178  
M. haemolytica CO3983  
M. haemolytica CO3916  
M. haemolytica Gilly  2007/2008 
M. haemolytica CO0353  
M. haemolytica MH4 A8  5/75 
M. haemolytica MH8 A5  5/75 
M. haemolytica MH9 A2  5/75 
M. haemolytica A6  76/1 
M. haemolytica CO2008  
M. haemolytica CO1250  
234 Ovine, 05/2012 
235 Bovine, 05/2012 
292 Ovine, 09/2012 
296 Ovine, 09/2012 
311 Ovine, 09/2012 
351 Ovine, 05/2012 
362 Bovine, 10/2012 
411 Ovine, 11/2012 
414 Ovine, 11/2012 
428 Ovine, 12/2012 
Table 2.3 Isolates Investigated.  
The first 19 received from the RVC courtesy of Prof Rycroft, the latter 10 from the AHVLA 
courtesy of Dr Kirchner. The above isolate names have been shortened to that in bold 
for the purpose of this thesis. Serotypes were available for 9 of the 19 isolates acquired. 
 
For the PCR, Q5 Hot Start Polymerase (NEB) was used throughout. Initial screening 
reactions were carried out in 25 µl reaction volumes, and subsequent reactions for DNA 
sequencing were in 50 µl volumes. Typical 25 µl reactions consisted of 5 µl NEB Q5 
reaction buffer, 200 µM dNTP’s, 10 pmol forward primer, 10 pmol reverse primer, 
approximately 10 ng DNA and 1 unit of Q5 Hot Start Polymerase, made up to 25 µl with 
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dH2O. Reaction conditions were as follows: Initial denaturation at 95 °C for 5 minutes (1 
cycle), followed by 25 cycles of denaturation at 95°C for 1 minute,  annealing at variable 
temperatures for 1 minute, elongation at 72°C for 1 minute. The final elongation was 
carried out at 72 °C for 2 minutes. Samples were stored at 4 °C until separated on an 
agarose gel. 
The variable annealing temperature was optimised to each particular primer set as 
stated in the primer summary table. The PCR reaction was then analysed using a 1% 
agarose gel. Any positive reactions were PCR purified using the Qiagen PCR purification 
kit and sent to the core facility for sequencing. Sequences were again analysed using 
FinchTV 1.4.0 (Geospiza, Inc.; Seattle, WA, USA; http://www.geospiza.com). Sequences 
were aligned with the expected gene sequence based on the primers used with the 
Boxshade server. Any sequences that were showing poor identity, or were partial gene 
sequences for isolate identification purposes were screened using the NCBI BLAST 
database to discover the identity of the sequence and or isolate. ORF finder 
(http://www.ncbi.nlm.nih.gov/gorf/gorf.html) was used to analyse the impact of any 
substitutions or deletions throughout the sequences. 
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Name Target 
gene 
Forward Reverse Tm 
°C  
Set A MHA_0579 5’-
CAACGCACCAAAAGGAAAC
T-3’ 
5’-
ATGGTGGGTTAATGCTTTG
C-3’ 
53 
Set D  
MHA_1205  
or 
COI_1584 
5’-
GGCCCTAGTGCCATACAGG-
3’ 
5’-
CTGTCAGAAATCGCCAGG
TT-3’ 
54 
Set J 5’-
CTGTCAGAAATCGCCAGGTT
-3’ 
5’-
GATTTACCTACCGAGCATT
GT-3’ 
54 
Set L 5’-
TTTACCTACCGATCTTTGT-3’ 
5’-
CAAACTGGTGATATGAAT
GCTTT-3’ 
50 
Set M 5’-
CGCCAAGTTGATAATAATG-
3’ 
5’-
CGAGCTTTGTATTTTTTAA
C-3’ 
48 
Set H MHpara 5’-
ACTCACTTTCTAAACAATAG
C-3’ 
5’-
CGCTTGTTTCTGGATAGTA
-3’ 
50 
PhuT PhuT 5’-
GTTAACACTATATCATTTTA
ATTGAA-3’ 
5’-
AAATGGGTACAAATCACT
AAG-3’ 
50 
16S  5’-
GCTAACTCCGTGCCAGCAG-
3’ 
5’- 
CGTGGACTACCAGGGTAT
CTAATC-3’ 
59 
23S  5’- 
GACGGAAAGACCCCGTGAA
CCT-3’ 
5’- 
GGCAAGTTTCGTGCTTAG
AT-3’ 
53 
 
Table 2. 4. Primers Used for Screening.  
Primers used in cloning HmbR were also incorporated into the genomic screening 
process. Annealing temperature used is stated (Tm). 
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3 Structural Properties of Gly1 homologues 
3.1 Introduction 
The neisserial Gly1 proteins comprise a novel tertiary structure dubbed the ‘beta-diablo 
fold’, which consists of eight anti-parallel beta strands forming a barrel-like structure. 
The Gly1 homologues from N. gonorrhoeae and N. meningitidis have been crystallised 
showing identical structures. The proteins crystallised as dimers with their larger alpha 
helical residues facing towards each other, and it was thought that haem binding of the 
N. meningitidis Gly1 occurs in a 2:1 protein to haem ratio (Sathyamurthy, 2011).  
A number of species within the Pasteurellaceae family of bacteria contain genes that 
give rise to so called ‘hypothetical’ proteins of interest- potential Gly1 homologues with 
varying levels of amino acid sequence identity with the original highly conserved 
neisserial Gly1 proteins. In order to assess whether these proteins are indeed 
homologues despite the divergence, sequence analysis and structural studies were 
performed using a combination of online predictive software and laboratory based 
methods.  
The term ‘homologue’ in its broadest sense describes genes or protein functions of 
common ancestry. Paralogues are genes that may be found in the same genome as the 
original homologue, but differ from the original gene or protein in sequence and/ or 
function. Protein families can be highly conserved, such as histones or mammalian flap 
endonucleases, or can share as little as 10- 15% sequence identity, as seen between 
chicken egg and T4 lysozymes for example, whilst retaining a common function. While a 
high percentage sequence identity can be a good clue to homology, low sequence 
identity does not rule it out, and conversely, some proteins with 30- 40% identity may 
not necessarily be related.  
The sequence alignment in Figure 3.1 highlights a collection of ‘hypothetical’ proteins 
similar to the neisserial Gly1 protein found in a wide range of bacterial species. The 
lower the percentage identity between the amino acid sequences, the harder it is to 
confirm homology without analysis of structure and function. 
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Candidates for Gly1 homologues found through NCBI BLAST searches have been 
observed in numerous Gram-negative bacterial genome sequences with varying degrees 
of amino acid sequence identity (see Figure 3.1). More and more potential homologues 
are appearing as the online databases grow, with the figure below showing just a 
fraction of those discovered to date. Due to the vast number of species containing a 
possible gly1 gene homologue, for the purposes of this investigation the main focus is 
on those from M. haemolytica, with a parallel investigation into those found in A. 
pleuropneumoniae and S. enterica arizonae IIIa.  
 
Figure 3.1. Multiple Sequence Alignments of Gly1 Homologues from Different Species. 
 
Alignment depicting similarities between identified Gly1 proteins. Accession numbers 
are as follows A. pleuropneumoniae (APP) WP_005607867.1, H. influenzae 
WP_005653509.1, two M. haemolytica proteins, H. somni YP_719978.1, N. gonorrhoeae 
ACF29206.1, N. meningitidis NP_273818.1, N. lactamica WP_003710927.1, E. coli 
EIL56827.1, S. enterica YP_001573309.1, Edwardsiella ictaluri YP_002932900.1, P. 
multocida (PM) WP_046339897.1 Key regions are the FSC, YEYS (including variants) and 
the C terminal cysteine (highlighted). 
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3.2 Results 
3.2.1 Homologues and Flanking Genes 
In the first instance, identification of genomes available for bacteria of interest 
containing putative gly1 genes was imperative. At the time of writing the number of 
genomic sequences of M. haemolytica available on the NCBI database was 19. These 
differ in their origins; the majority were isolated from bovine hosts, with two from ovine, 
and one each from porcine and cervine hosts. They are either of unknown serotype or 
one of the three major worldwide serotypes i.e. those most commonly isolated (see 
Table ).  
The potential Gly1 homologues discovered using the initial neisserial Gly1 protein 
sequence span species from Actinobacillus pleuropneumoniae, a pig pathogen, to 
Salmonella enterica IIIa, which lives in reptile and amphibian hosts, to E. tarda, a fish 
pathogen. Higher sequence identity suggests increased likelihood of similar protein 
function. The neisserial Gly1 proteins share very high sequence similarity, with different 
neisserial species exhibiting above 98% identity throughout. This level of identity and 
even the presence of the gene decreases for other species, for example database 
screening found only one strain of S. enterica with a good candidate to be a Gly1 
homologue present - S. enterica arizonae IIIa which is a less common strain. Additionally 
A. pleuropneumoniae (APP) Gly1 is found only in one strain but 3 assemblies out of 22 
available genome assemblies within the database- serovar 6, strain FEMØ (RefSeq I.D 
GCF_000178555.1). There are 21 genome assemblies of M. haemolytica available to 
screen on NCBI database and hundreds of S. enterica genomes, however, just one isolate 
of S. enterica arizonae (IIIa) (RefSeq I.D GCF_000018625.1). 
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Strain Serotype Origin Pathogenicity 
MhBrain2012 A1 Bovine (Brain) Disease 
MhSwine2000 A1 Porcine (Lung) Pneumonia 
M42548 ? Bovine ? 
D193 A1 Bovine (lung) Pneumonia 
PHL213 A1 Bovine (lung) Pneumonia 
Serotype A2 str. 
Bovine 
A2 Bovine Pneumonia 
Serotype A2 str. 
Ovine 
A2 Ovine Pneumonia 
D171 A2 Bovine Pneumonia 
D35 A2 Bovine Pneumonia 
Serotype A1/A6 str. 
PKL10 
A1/A6 cross 
reactive 
Deer (Spleen) Pneumonia 
USDA-ARS-
USMARC-185 
A6 Bovine (nasal swab) ? 
Serotype 6 str. H23 A6 Bovine 
(nasopharynx) 
BRD 
D38 A6 Bovine (lung) Pneumonia 
D174 A6 Bovine (lung) Pneumonia 
USMARC_2286 ? Putative 
commensal 
Bovine 
(nasopharynx) 
Asymptomatic 
D153 A1 Bovine Pneumonia 
USDA-ARS-
USMARC-183 
A1 Bovine ? 
USDA-ARS-MARC-
184 
A2 Bovine Commensal? 
MH10517 ? Ovine (lung) ?  
Table 3.1 Genomic Sequences of M. haemolytica on NCBI Database.  
The genomic sequences listed above were obtained from the NCBI database. They are 
all full genome sequences, with the assembly level varying from complete genome, to 
scaffold, to contig. Accession numbers are as follows: MhBrain2012 GCF_000443225.1, 
MhSwine2000 GCF_000443185.1, M42548 GCF_000376645.1, D193 GCF_000443205.1, 
PHL213 GCF_000153645.1, Serotype A2 str. Bovine GCF_000176275.1, Serotype A2 str. 
Ovine GCF_000176255.1, D171 GCF_000427275.1, D35 GCF_000443085.1, Serotype 
A1/A6 str PKL10 Genbank accession only available GCA_000584935.1., USDA-ARS-
USMARC-185 GCF_000349785.1, Serotype 6 str H23 GCF_000341635.1, D38 
GCF_000443105.1, D174 GCF_000422095.1, USMARC_2286 GCF_000439735.1, D153 
GCF_000422145.1, USDA-ARS-USMARC-183 GCF_000349765.1, USDA-ARS-MARC-184 
GCA_000819525.1, MH10517 GCF_000931975.1. All data taken from the NCBI 
database.  
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Gly1 homologues in M. haemolytica share between 34% and 99% identity with each 
other, and overall just around 20% identity with the original neisserial Gly1 (see Table 
3.3). The M. haemolytica Gly1 paralogue (MHpara) shares only 13% identity with the 
homologues of the same species, however, the MHpara protein (or slight variations of 
this) has been found in all Mannheimia genomic sequences on the NCBI database at the 
time of writing. APP Gly1 is most similar to that found in the human pathogen H. 
influenzae, but shares around 30% identity with the M. haemolytica Gly1 proteins. The 
Salmonella Gly1 protein, SARI, is again most similar to a M. haemolytica Gly1, however, 
the level of identity is lower at between 16- 25%.   
Due to the large number of identical proteins found in M. haemolytica isolates on the 
database, the name of one has been used to represent the others present to avoid 
confusion. The representative protein name is highlighted in bold at the top of each 
column in Table 3.2. Interestingly, although there are three identical APP Gly1 proteins 
listed in the PSI-BLAST search, two exist in the same isolate, one in contig4, one in 
contig29. Genome analysis showed identical flanking regions and these therefore were 
identified as overlapping contiguous sequences. The third is named as a reference 
protein for ‘Actinobacillus species’ which is apparently a multispecies protein. This could 
mean that only one A. pleuropneumoniae strain carries this protein or that the genome 
has been incorrectly analysed. 
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Table 3.2. Protein Labelling. This table shows the reference protein used to represent itself and other identical proteins found throughout this thesis (bold). Protein 
name, accession number and strain are listed where known. MHpara is the name used for the so called adhesin throughout this thesis. The second adhesin lane has 
an I66F polymorphism compared to those in the first column.  The final adhesin has a frame shift. HW40_12515 has two amino acid substitutions Q118K and D115S 
when compared to MHA_0579.
APP (hypothetical) 
WP_005607867.1 
Actinobacillus 
species 
MHA_1205 
EDN74135.1 
M. haemolytica 
PHL213 
COI_1584 
EEY09775.1 
M. haemolytica 
serotype A2 str. 
OVINE 
mh0603 
ABG89179.1 
M. haemolytica 
Serotype A1 
L280_13705 
EPZ27028.1 
M. haemolytica 
MhBrain2012 
MHA_0579 
EDN73549.1 
M. haemolytica 
PHL213 
SARI (SARI_04389) 
YP_001573309.1 
S. enterica 
arizonae  str. 
RSK2980 
Putative adhesin  
(MHpara) 
AGK03253 
M42548 
(F) 
 Adhesin 
KIX31695 
MH10517 (F) 
 D650_16360 
YP_007666413.1 
USDA-ARS-USMARC-
183 
Hypothetical 
WP_006251605.1 
  D650_18560 
YP_007666633.1 
USDA-ARS-
USMARC-183 
 Adhesin 
EPZ03517 
D38 (F) 
 
 MHH_c22400 
YP_007884037.1 
M42548 
D648_11200 
YP_007668632.1 
USDA-ARS-
USMARC-185 
  D648_9020 
YP_007668414.1 
USDA-ARS-
USMARC-185 
 Adhesin  
AGQ38308 
D171 (F) 
Adhesin 
EPY99953.1 
M. haemolytica 
D35 (I) 
 J451_13885 
YP_008224091.1 
D174 
L278_09385 
EPY99626.1 
D35 
  MHH_c15060 
YP_007883313.1 
M42548 
 Adhesin 
AGQ40883 
D174 (F) 
Adhesin  
WP_032848124.1 
(I) 
 F382_13645 
YP_008235527.1 
D153 
   J451_12635 
YP_008223844.1 
D153 
 Adhesin  
AGQ25325 
D153 (F) 
Adhesin 
WP_006252140.1  
(I) 
 N220_08230 
YP_008339090.1 
USMARC_2286 
   N220_04720 
YP_008338402.1 
USMARC_2286 
 Adhesin  
AGR75796 
USMARC_2286 (F) 
Adhesin 
AGI31915  
USDA-ARS-
USMARC-183 (I) 
 F388_01724 
EME04507.1 
serotype 6 str. H23 
   F388_00421 
EME04732.1 
serotype 6 str. H23 
 Possible adhesin  
EDN75149.1 
PHL213 (F) 
Adhesin 
AGI35981   
USDA-ARS-
USMARC-185 (I) 
 L279_08800 
EPZ02514.1 
D38 
   L279_12960 
EPZ01215.1 
D38 
 F388_12512 
EME02394.1 
serotype 6 str. H23 
(F) 
Putative adhesin 
EEY09063.1 
serotype A2 str. 
OVINE (I) 
 L277_12690 
EPZ24426.1  
D193 
   L277_13080 
EPZ24311.1 
D193 
 Adhesin  
EPZ30550.1 
D193  
(F) 
Putative adhesin 
EEY12244.1 
serotype A2 str. 
BOVINE (I) 
 L281_12465 
EPZ26685.1  
MhSwine2000 
   L281_12860 
EPZ26326.1 
MhSwine2000 
 Adhesin  
EPZ26914.1 
MhSwine2000(F) 
 
 L280_13960 
EPZ26969.1  
MhBrain2012 
   L280_13305 
EPZ27491.1 
MhBrain2012 
HW40_12515 
KIX27265.1 
MH10517 * 
Adhesin  
EPZ29268.1 
MhBrain2012 (F) 
Adhesin 
AJE08768 USDA-A 
RS-USMARC-184A 
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Table 3.3. Identities Between Gly1 Homologues.  
The above table highlights the similarities in amino acid sequence between the Mannheimia Gly1 homologues and those in a selection of 
other bacterial species. Accession numbers as previously stated for reference proteins. NM = N. meningitidis (EFV62744.1), NG = N. 
gonorrhoeae (EFF39185.1), HS = Histophilus somni (WP_011609916.1), NL = Neisseria lactamica (WP_003710927.1) and HI = H. influenza 
(WP_005653509.1). PM = Pasteurella multocida, SARI = S. enterica arizonae. Boxes highlighted in red show percentage identity between 
the two proteins of ≥ 80%. Those highlighted in green show percentage identity of ≥ 30% and ≤ 79.9%. Those in blue share ≥ 20% and ≤ 
29.9%. Further homologues in bacterial species exist in addition to those mentioned here.  
 _____________________________________________________________________________________________________________________________________________________ 
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NM NG NL HS AP
P
HI SA
RI
PM
MHpara 12.97% 12.97% 13.75% 14.50% 12.97% 16.54% 16.41% 16.03% 12.21% 12.98% 11.57 16.79% 11.38
MHA_1205 35.90% 99.30% 85.60% 99.30% 17.04% 17.52% 14.29% 25.35% 33.58% 39.26 23.91% 15.45
MHA_0579 35.90% 34.00% 36.60% 24.06% 23.13% 16.43% 23.78% 29.93% 34.33 16.90% 15.57
MH0603 85.60% 98.60% 16.79% 19.12% 13.57% 25.35% 33.58% 39.26 23.91% 15.45
L280_13705 86.40% 20.93% 21.54% 14.39% 23.48% 31.06% 36.43 25.00% 14.05
COI_1584 17.04% 15.71% 14.29% 26.06% 33.58% 40.74 23.91% 19.38
NM 97.84% 81.29% 21.21% 21.05% 21.37 17.52% 26.19
NG 80.71% 20.15% 19.40% 21.21 18.12% 26.98
NL 12.86% 13.14% 21.97 15.94% 27.78
HS 27.01% 24.63 20.86% 22.4
APP 49.63 14.60% 13.6
HI 15.04 15.7
SARI 13.14
PM
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The criteria used to identify the potentially homologous proteins was based on key 
featured believed to be involved in the tertiary structure of the neisserial Gly1 proteins. 
It consisted of 1) an amino acid sequence length of between 130- 145, 2) an N terminal 
signal peptide of between 19- 24 amino acids in length as predicted by the programme 
signalP (Petersen et al., 2011), 3) a cysteine close to the C terminal and an FSC region 
around amino acids 25 to 29, depending on the homologue, and 4) a significant beta 
strand content. An additional fairly well conserved region noted in the majority of 
homologues is the YEYS at approximately position 50- 55. This method was fairly 
inclusive, with a number of potential homologues having either an YSC or FMC region 
substituting the FSC motif.  
Figure 3.2 shows the N. gonorrhoeae Gly1 protein structure with the key residues used 
in identification (highlighted), where they form parts of the antiparallel beta strands and 
a C terminal turn. The N. meningitidis Gly1 dimer structure, when analysed, was found 
to have a cavity in between the two monomer units. This contains a positive inner region 
due to the presence of lysine and arginine residues and a negative outer area containing 
asparagine and glutamate residues. This was identified as a putative haem binding 
region. Mutations in this region were not found to affect the ability of the Gly1 protein 
to interact with haem, showing binding must occur at a different site (Sathyamurthy, 
2011). The mutated residues did not include those utilised to identify these putative 
Gly1 homologues. Conserved regions such as those mentioned above are likely to be of 
functional/ structural importance across homologues. 
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Figure 3.2. N. gonorrhoeae Gly1 Structure Showing Key Residues Used in Identification 
of Homologues (as solved by Arvidson et al 2003.) 
 
Panels A and B show the locations of the FSC (Blue), YEYS (Red) and C- terminal cysteine 
(Purple) regions used in identification of further homologues in two orthogonal views. 
Panel C shows the amino acid structures as sticks of these regions within the dimer 
formation that neisserial Gly1 is believed to exist in. Rendered in PyMol from a pdb file 
supplied by Dennis Arvidson, Michigan State University. 
 
 
The Gly1 proteins found in M. haemolytica are highly conserved, as shown in Figure 3.3, 
with just MHA_0579 and the MHpara protein standing out due to the lower level of 
sequence identity. The presence of an N terminal signal peptide was predicted in all 
homologues and the ‘longer’ paralogue.  
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Figure 3.3. M. haemolytica Multiple Sequence Alignment.  
 
Alignment showing the regions of similarity between M. haemolytica Gly1 homologues 
discovered to date. Predicted signal peptidase cleavage sites shown with blue arrows. 
Conserved residues mentioned above highlighted in red boxes. 
 
The M. haemolytica paralogue (MHpara) was identified using a PSI-BLAST search of a 
neisserial Gly1 protein after several iterations. It does not have the same level of 
sequence similarities or key residues of the initial Gly1 homologues, however, the 
location in the genome is of interest. Three different paralogues have been found to 
date (see Figure 3.4) and all are situated in an area of the M. haemolytica genome 
surrounded by genes involved in haem uptake. This is in contrast to the neisserial Gly1 
proteins which are adjacent to genes involved in haem biosynthesis. The Mannheimia, 
Actinobacillus, Histophilus and Salmonella homologues are flanked by a number of 
different genes, many of which are of unknown function (Figures 3.5 and 3.6). 
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Figure 3.4. Alignments of M. haemolytica Gly1 Paralogues.  
The predicted signal peptide is underlined in red in the top two sequences. All proteins 
are labelled as ‘adhesin’ on the database, therefore an example of the M. haemolytica 
isolate in which they were found has been used to differentiate. Sequence 174 is 
representative of those suspected to be incorrectly annotated on the database, with 
identical signal peptides to D35 and M42548 found on closer inspection of the genomes. 
Sequence 184 has a shorter N terminal region due to the deletion of two DNA bases. 
 
Figure 3.4 shows an alignment of the MHpara proteins. The top two sequences in this 
figure were annotated on the database as having an additional eleven amino acids at 
the N terminal position comprising the majority of the signal peptide compared to the 
lower two. Those starting ‘MIVSN’ were not predicted to have an N terminal signal 
peptide when analysed with signalP. Closer inspection, however, revealed the MHpara 
gene sequence of the shorter protein to be identical to the longer protein upstream of 
the proposed methionine start codon, suggesting the methionine nominated in the 
database was incorrect. An area rich in A’s and G’s around 6 bases upstream of the 
longer proteins’ start codon indicated a possible ribosomal binding site (AAAGGAAA) 
(Shine and Dalgarno, 1974). This therefore suggests that the different protein lengths 
are a result of the annotation software used to predict translated proteins within 
genomes on the database, rather than there being different proteins. The correct 
sequences were identical to those with the signal peptide in Figure 3.4. The only 
difference discovered between the two longer proteins is at amino acid position 78, 
where either a phenylalanine or isoleucine is present.  
The third homologue of the MHpara protein, which had an alternate N terminal region 
that was not predicted to be a signal peptide, was found in isolate 184 and is discussed 
in more detail in Chapter 6. The PSI-BLAST search also revealed that proteins similar to 
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the proposed paralogue were found in other species, such as M. varigena 
(WP_025247386.1), P. bettyae (WP_005760720.1) and B. trehalosi (WP_015431624.1).  
The protein PSI-BLAST search identifies proteins similar to the reference protein, in this 
case N. meningitidis Gly1, revealed that the potential Gly1 proteins were all of unknown 
function, annotated as ‘hypothetical proteins’. Previous studies with the N. gonorrhoeae 
Gly1ORF1 protein showed that it was not essential for bacterial survival, and 
hypothesised that it was involved in regulation of host cellular toxicity caused by the 
bacteria (Arvidson et al., 1999). Weak haemolytic activity was also observed in wild type 
cells over-expressing this protein, which was conferred to E. coli cells by transformation 
of Gly1ORF1 in an overexpression system in this investigation. No conclusions were 
drawn from this study regarding the function of Gly1 other than that further studies 
need to be conducted. In the absence of published information regarding the possible 
function of this protein family, we examined the flanking genes of the neisserial Gly1 
locus. As described in the operon hypothesis by Monod (Jacob and Monod, 1961), the 
genomic locus can occasionally provide clues as to the function of the protein 
transcribed from genes such as the lac operon, and more recently in the flagella locus in 
A. caviae which contains five genes involved in flagellar formation (Gryllos et al., 2001).  
The flanking genes of the neisserial gly1 gene in N. meningitidis and N. gonorrhoeae 
(Figure 3.5) are identical and code for proteins that are involved in haem biosynthesis, 
for example the gene supposed to be HemD- gly1OFR2- has a high degree of similarity 
at protein level to that found in E. coli sharing 22.5 % sequence identity. Analysis of the 
flanking genes of the other possible gly1 genes revealed MHpara to be situated 
downstream of a putative Mannheimia haemolytica haemoglobin receptor (HmbR), 
along with other genes predicted to have an involvement in haem uptake (Figure 3.5).  
The flanking genes of the remaining genes of interest were also investigated (Figure 3.6), 
however, the majority of these coded for ‘hypothetical’ proteins, even when a BLAST 
search was performed with their respective sequences. Searches upstream of the 
MHpara gene uncovered genes for periplasmic transporter systems, including a possible 
PotC which is known to be involved in the periplasmic transport of putrescine and 
spermidine in E. coli.  
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The gene coding for a putative General control of amino-acid synthesis 5-like (Gcn5-like) 
acetyltransferase flanking the COI_1584 gene could have a role in transferring acetyl 
groups between acetyl coenzyme A and other proteins. The integrative conjugative 
element protein, or ICEP, labelled in the flanking genes of COI_1584 and MHA_0579 is a 
predicted mobile genetic element, and therefore does not provide any further indication 
of the possible function of the Gly1 proteins. This could suggest a similar mobile element 
to the gly1 genes.
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Figure 3.5. Flanking Genes of Interest.  
Neisserial flanking genes upstream of the gly1ORF1 gene are HemD (uroporphyrinogen III synthase, the enzyme responsible for 
uroporphyrinogen III synthesis), HemX (a suspected uroporphyrin-III C-methyltransferase), HemY (coproporphyrinogen oxidase which catalyses 
the formation of protoporphyrinogen III), and HemE (protoporphyrinogen oxidase, converts protoporphyrinogen III to protoporphyrin IX). Those 
downstream were genes coding for proteins of currently unknown function. The MHpara gene was flanked upstream by genes coding for 
proteins involved in haem uptake, and downstream by those involved in transportation. HmbR- haemoglobin outer membrane receptor, PhuT- 
periplasmic haem binding protein. Accession numbers as stated in Figure 3.2.  
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Figure 3.6 Flanking Genes of Gly1 Homologues.  
Flanking genes of certain Gly1 homologues were mostly genes coding for ‘hypothetical proteins’. One recurring gene is that for suspected 
membrane proteins of unknown function.  The S. enterica Gly1 flanking genes are all labelled as coding for hypothetical proteins (not shown). 
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3.2.2 Cloning, Expression and Purification 
To enable in vitro investigation into the structure and function of the potential Gly1 
homologues identified in the aforementioned database searches, the genes coding for 
proteins of interest were either cloned directly from M. haemolytica genomic DNA 
(Figure 3.7) or obtained by gene synthesis (EurofinsMWG), and transformed into E. coli 
cells for over expression. Protocols for overexpression and purification were optimised 
for each protein (Figures 3.8- 3.10). 
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Figure 3.7. Cloning of M. haemolytica gly1 Paralogue.  
A. PCR on the M. haemolytica gly1 paralogue gene cloned from genomic DNA (+P), 
reaction mixture without primers (-P) and the lambda positive control. B. A double 
digest of pET21-a and the gly1 paralogue with NdeI and HindIII ‘N’ and ‘H’ depict single 
digests, and ‘NH’ the double digest. ‘U’ denotes undigested plasmid. Restriction was 
followed by ligation and transformation into XLIB E. coli cells and PCR to confirm the 
genes presence, results of which are shown in panel C, all separated by agarose gel 
electrophoresis. Partial pET21-a plasmid map with restriction sites denoted in the lower 
panel. Edited in SnapGene. 
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Figure 3.8. Purification of MHA_1205 C-His Gly1.  
The polyhistidine tagged MHA_1205 Gly1 homologue was overexpressed in E. coli M72 
cells. The first panel shows SDS-PAGE analysis of pre-induction cell pellet, U1, and 
supernatant U2, compared with the post-induction cell pellet, I1, and supernatant I2, 
with the band of overexpressed seen at approximately 17 kDa. The 1:10 dilution of lanes 
I1 and I2 clarifies the protein over-expression. The lysate was passed through a nickel 
chelate column (Ni), removing the majority of contaminants in the flow through (FT) and 
wash. A final anion exchange ‘Q’ column removed the residual contaminating band. 
MHA_0579-c-his was also purified using this protocol.  
 
Neither the M. haemolytica proteins nor the APP protein were found to be secreted by 
E. coli into the cell supernatant, as shown in the SDS-PAGE gels above. The majority of 
MHA_1205 C-His was expressed in an insoluble form, so the purification was performed 
on the soluble fraction only. Due to the unknown function it would have been difficult 
to assess whether the protein had refolded correctly after solubilisation treatment. 
Some previous overexpression procedures showed MHA_1205 C-His to be secreted 
however this was not observed under these conditions. Batch to batch variation was 
observed upon purification of this protein. The elution of MHA_1205 C-His in increasing 
amounts in the early fractions as well as in the column wash could be explained by 
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insufficient resuspension of the first three elutions prior to loading on an SDS-PAGE gel 
for separation (Figure 3.8). MHA_0579 C-His and MHpara expression produced a good 
yield of approximately 2- 3 mg of soluble protein per gram of cells (Figure 3.9). 
N terminal sequencing of the purified APP Gly1 protein began with the residues ‘E-N-I-
S-I-F’, and the MHpara protein with residues ‘A-G-E-Q-S-D-A’, showing that these 
proteins had been processed as predicted by SignalP (performed by Dr. Arthur Moir, 
Department of Molecular Biology and Biotechnology, TUOS).   
 
Figure 3.9. Purification of M. haemolytica Gly1 Paralogue.  
 
The Gly1 paralogue, overexpressed in E. coli BL21 DE3 cells, was purified using anion 
exchange and gel filtration and analysed by SDS-PAGE. U1 shows the pre-induction cell 
pellet and U2 the supernatant. I1 shows the post-induction cell pellet and I2 the post-
induction supernatant. The overexpressed protein is seen as a band of approximately 16 
kDa. A cation exchange ‘SP’ column pH 7 followed by gel filtration and a final cation 
exchange ‘SP’ column pH 6 completed the purification.  
 
PhuT was both secreted from the E. coli cells (Figure 3.10, Panel B) in a soluble form and 
found in the cellular pellet in insoluble form. The secreted protein was concentrated by 
diafiltration using VivaSpin columns (see Methods, section 2.6.3) and purified using a Q 
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column pH 8 followed by an SP column pH 6 (Figure 3.10). The insoluble protein was 
purified in the same manner following solubilisation, however, much of the total 
quantity of protein expressed remained insoluble.  
 
 
 
Figure 3.10. Purification of PhuT. 
 
The periplasmic haem binding protein identified in M. haemolytica was cloned from M. 
haemolytica genomic DNA and inserted into the pET21-a vector- agarose gel 
electrophoresis of PCR products and vector fragments used for cloning PhuT (panel A). 
SDS-PAGE separation of the over-expression of PhuT induced by IPTG produced an 
insoluble protein Lane IP (induced pellet) as monitored by SDS-PAGE separation, and a 
soluble secreted protein from the cell-free supernatant Lane IS (Panel B) which were 
purified using ion exchange chromatography (Panels C and D). UP and US again 
uninduced pellet and supernatant, respectively. 
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3.2.3 Secondary Structure Analysis of Gly1 Homologues 
Proteins may have similar function if the overall structure allows, regardless of whether 
the polypeptides share a low percentage of sequence identity, as residues with similar 
properties can often be interchanged. It is therefore difficult to analyse the potential 
homologues without information regarding the protein structure. Secondary structures 
can be used to identify potential homologues that have weak sequence identity, and 
protein tertiary structure may enable identification of binding pockets that may be more 
reliant on charge than amino acid sequence. Structural folds can bring together residues 
that are important in ligand binding but distant in terms of the primary structure.  
The secondary structure of the neisserial proteins was discovered to contain eight 
antiparallel beta strands separated by a small section of alpha helix. To compare these 
neisserial Gly1 proteins to the potential new Gly1 homologues, the secondary structures 
of the proteins of interest were initially assessed using online prediction software, SABLE 
(Adamczak et al., 2005), followed by analysis by circular dichroism (CD) on the proteins 
available. In the structure and activity assays, MHA_1205 C-His was used to represent 
the most similar M. haemolytica Gly1 homologues with just one or two amino acids 
differing between the sequences.  
Analysis with the SABLE server estimated MHA_0579 and the other M. haemolytica 
homologues to have 9 - 11 beta strands contributing to approximately 34% of each 
structure, a high proportion of coils/ turns/ disordered regions making up 50% and a 
small amount of helical structure between 13 and 16% of the protein (Figure 3.11). 
Other species Gly1 homologues were also predicted to be mainly beta in composition 
(Figure 3.12). The paralogue, however, was predicted to have 8 regions of beta strands 
which was supported by the subsequent determination of tertiary structure (Figure 3.15 
and 3.16). PhuT was predicted to be formed of 47% alpha helices, as suspected from its 
predicted function based on other periplasmic haem binding proteins.  
The Phyre2 server secondary structure prediction largely agreed with that created by 
SABLE, other than a predicted beta strand at around position 110 rather than the SABLE 
predicted alpha helix in mh0603, MHA_1205 and COI_1584. The SABLE server predicted 
both alpha helical and beta strands at the IKKAV region, which differed between 
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proteins, whereas Phyre2 suggested all alpha at these points. Additionally an alpha 
helical region was predicted by Phyre2 at the C terminal of MHA_0579 where SABLE 
predicted beta strands. Phyre2 predicted that the 5th and 6th beta strands in SARI were 
just one continuous beta strand and an additional short beta strand was predicted of 
‘ESR’, at around position 100.  Secondary structure analysis was performed with the 
predicted signal peptides present at the N terminal region, and the first beta strands 
predicted in MHA_1205, mh0603 and COI_1584 reside upstream of the predicted 
cleavage site.
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Figure 3.11. Secondary Structure Prediction of M. haemolytica Proteins of Interest Using SABLE Red zigzags show predicted helical structures, 
green arrows show predicted beta structures. The red graph on the lower line indicates confidence in secondary structure prediction- high bars 
equates to high confidence.  
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Figure 3.12. Secondary Structure Prediction of Other Gram-negative Bacterial Proteins of Interest Using SABLE  
 
Red zigzags show predicted helical structures, green arrows show predicted beta structures. The red graph on the lower line indicates confidence 
in secondary structure prediction- higher bars equate to higher confidence. NM depicts the ‘original’ N. meningitidis Gly1 protein complete with 
eight beta strands. HS is the H. somni predicted Gly1 and PM is P. multocida.  
_______________________________________________________________________________________________________________________ 
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Once the proteins of interest had been expressed, circular dichroism was used to further 
analyse the protein secondary structure (see figure 3.13) to allow comparison with the 
neisserial Gly1 protein. Based on the commonly observed CD spectra of proteins, those 
with mainly antiparallel beta secondary structure generally have a negative peak at 216 
nm and a positive peak at 195 nm (Greenfield, 2006). MHA_1205 C-His, MHA_0579 C-
His and APP all had spectra resembling those of proteins consisting of a high percentage 
of beta strands. This is supported by the lowest point of the spectra, which was observed 
at 216 nm for MHA_1205 C-His and at 218 nm for MHA_0579 C-His. With APP, the 
negative peak occurred at 219 nm. All three had positive peaks at between 193 and 199 
nm. These positive peaks were measured at atmospheric pressure so must be analysed 
with caution, as at wavelengths below 200 nm air can absorb UV.  
PhuT had a spectrum indicating a mainly alpha-helical secondary structure, which 
supports the predicted secondary structure seen with SABLE analysis. Alpha helical 
proteins generally have a double negative peak at 222 nm and 208 nm with a positive 
peak at 192 nm (Greenfield, 2006). In this instance the negative peaks were observed at 
217 nm and 208 nm, and the positive peak at 195 nm.  
The spectrum of MHpara looked to be mainly beta but had a slight second negative dip 
suggesting that another structure was possibly affecting the shape. The protein gave a 
positive peak at 233 nm, a negative peak at 211 nm and a further positive peak at 195 
nm. SARI C-His, also predicted to have a mainly beta secondary structure, gave a similar 
double negative peak spectrum resembling that of helical reference proteins. The 
negative peaks were observed at 216 nm and 201 nm and a positive peak at 194 nm. 
To further analyse the data generated, DichroWeb (Whitmore and Wallace, 2008) was 
used, with the reference set SMP180 (Abdul-Gader et al., 2011), as this provides a broad 
coverage of proteins, and analysis programme CONTIN (van Stokkum et al., 1990). The 
results for MHA_0579 C-His, MHA_1205 C-His, SARI C-His and MHpara agreed with the 
SABLE predicted percentages of alpha and beta forming the secondary structures. The 
PhuT spectral analysis on average suggested that the protein was 19% alpha, 27% beta 
and 54% coils/ turns/ disordered protein. This did not agree with the predicted 
secondary structures generated by the SABLE and Phyre2 servers. 
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Figure 3.13. Secondary Structure Analysis Using CD Spectra.  
The CD spectra of Gly1 homologues showed curves characteristic of antiparallel beta strands (MHA_1205 C-His, MHA_0579 C-His and APP) or 
containing some alpha helical structures (MHpara and SARI C-His). PhuT also had a spectrum suggesting alpha helical structures. N=3.  
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3.2.4 Protein Tertiary Structure 
To investigate further structural similarities between suspected Gly1 homologues, X-ray 
crystallography was performed on purified protein samples. Solved structures could also 
provide clues to putative ligand binding pockets. Although crystals of MHA_1205 C-His 
and SARI C-His were produced using the hanging drop technique, they did not diffract 
well enough to allow structural analysis. MHA_0579 C-His crystals grown in PACT D3, 
which is 0.1 M MMT buffer pH 9 and 25% (w/v) PEG 1500 diffracted to 2.1 Å but the 
structure has not been solved to date. Additional attempts to solve this were made by 
soaking the crystal in hemin, however, further optimisation is required to produce 
results. Figure 3.14 shows the protein crystals.  
 
 
Figure 3.14. Crystals of Gly1 Homologues.  
 
Structures of the crystallised proteins seen above have not yet been solved. A. SARI C-
His in 0.2 M potassium phosphate and 20% PEG3350. 10 weeks incubation at 17°C (by 
Richard Salmon, TUOS) B. MHA_0579 C-His PACT D3 (0.1 M MMT buffer pH 6 and 25% 
(w/v) PEG 1500) C. and D. MHA_0579 C-His in PACT D3 (0.1 M MMT buffer pH 6 and 
25% (w/v) PEG 1500) after hemin soaking respectively (B, C and D by Jason Wilson, 
TUOS). A, B and C at 68x magnification. Red scale bar in D is 100 µM. 
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The M. haemolytica Gly1 paralogue was crystallised in JCSG+ A5 which contains 0.2 M 
magnesium formate and 20% PEG3350 to 1.37 Å (see Figure 3.16). No structure was 
solved for the other Gly1 homologues. The MHpara protein was crystallised in dimer 
formation as shown in the structure solved by Jason Wilson (Figure 3.15). The crystal 
structure of the M. Haemolytica Gly1 paralogue shown in Figure 3.16 has the final 
cysteine highlighted and shows the antiparallel beta strands forming a barrel like 
structure. The paralogue protein comprises an YSC region rather than the FSC region 
used for identification initially, and the FSC can be seen in the N. gonorrhoea structure 
(Figure 3.4). alongside the neisserial structures generated by Magda Weirzbicka/ Jason 
Wilson (Department of Molecular Biology and Biotechnology, TUOS, 2014) and Arvidson 
et al (Arvidson et al., 2003).     
         
Figure 3.15 M. haemolytica Paralogue Crystal Dimer 
The protein was crystallised in dimer formation as seen above. It is not known whether 
this is the natural state of the protein or an artefact of the crystallisation procedure. 
Cysteine residues in orange, carbon atoms white, oxygen atoms red and nitrogen atoms 
blue. Rendered in PyMol. 
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Figure 3.16. M. haemolytica Gly1 Paralogue Crystal Structure.  
Panel A shows the antiparallel beta sheet structure of MHpara with a minority made up 
of alpha helix viewed from the x axis. Beta strands numbered from the N- terminal. Panel 
B and Panel C show views from the y and z axes, and how the two highlighted regions 
interact with one another. The FMC and C terminal cysteine are highlighted in magenta. 
Panel D shows the disulphide bridge formed between the two cysteines, with the C 
terminal cysteine this time highlighted in blue. Structure rendered in PyMol. 
  
An overlay of the crystal structures of N. gonorrhoeae Gly1ORF1 and the MHpara protein 
(Figure 3.17) highlights the similarities despite the low protein sequence identity of 
16.4% at the amino acid level.  
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Figure 3.17 Overlay of M. haemolytica Paralogue and N. gonorrhoea Gly1ORF1 
Structures. 
 
N. gonorrhoeae Gly1ORF1 in green and MHpara in cyan. Three orthogonal views of the 
overlayed structures with the FSC and C of N. gonorrhoeae Gly1 in purple and YMC and 
C of MHpara in orange in panel B. 
 
Phyre2 was used to predict the tertiary structure of the proteins of interest that were 
not solved during the course of the project (Figure 3.18). Proteins had their signal 
peptides removed prior to input, as those purified for this study lacking the polyhistidine 
tag underwent N terminal sequencing, and this showed they had been processed. 
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Figure 3.18. Predicted Tertiary Structure of Gly1 Homologues.  
A. MHA_0579 confidence of 48.9% over 45% coverage B. MHA_1205 confidence of 
44.8% over 46% coverage, both based on part of structure 2XZZ C. P. multocida 
confidence of 27.8% over 44% coverage, component of structure 1F1S D. APP 56.4% 
confidence and 66% coverage also based on human transglutaminase 1 beta barrel 
domain 2XZZ E. SARI 25.5% confidence and 56% coverage based on galactose binding 
protein 1DLC. Structure predicted by Phyre2 server and model edited in Pymol. PDB 
reference numbers used for identification.  
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The confidence in the predicted tertiary structure of the M. haemolytica Gly1 
homologues was very low. The models only covered a small percentage of the amino 
acid sequences leaving a lot of missing information (Figure 3.19). They do, however, go 
some way to support the predicted secondary structures as they are mainly composed 
of beta strands.  
 
Figure 3.19 Areas Covered by Tertiary Structure Prediction of M. haemolytica Proteins. 
 
Sequences used to create predicted tertiary structures with the Phyre2 server. The 
sections highlighted in bold are those used for tertiary structure prediction. The key 
regions (FSC, YEYS, C) are not included in these predictions.  
 
This also highlights the novel structure of this family of proteins as there was nothing 
appropriate to model them against in the database used by the Phyre2 server. It is 
interesting to note that MHA_1205, MHA_0579 and APP were all modelled on the same 
crystal structure- PDB reference 2XZZ, the crystal structure of the human 
transglutaminase 1 beta-barrel domain, which is an eighth of the 817 a.a. protein. This 
is involved in protein cross linking such as the clotting factor XIII. The active site residues 
in the human clotting factor XIII form a triad of Cys-His-Asp. These three residues are 
not adjacent to each other in the amino acid sequence but are brought together in the 
tertiary structure (Yee et al., 1994).  The proteins modelled on this section of 
transglutaminase contain the three residues that form the active site, however, the 
histidines were not included in the region for which the partial predicted tertiary 
structure was generated so we cannot be sure if they are located in positions creating 
an active site.
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Figure 3.20. Predicted Tertiary Structure of MHpara.  
Panels A, B, and C show three orthogonal views of the MHpara model (yellow) aligned 
with the structure solved by Jason Wilson (cyan). The predicted structure was based on 
the template of protein 3OE3 from the PDB site, the crystal structure of PliC-st with 
96.8% confidence of 60% coverage.  
 
 
 
 
 
Figure 3.21 Predicted Tertiary Structure of PhuT. 
ShuT from Shigella dysenteriae (blue) aligned with the predicted PhuT structure of M. 
haemolytica (yellow) based on 2R97, a P. aeruginosa haem PBP. The haem molecule in 
red is shown as seen in the crystal structure of the ShuT protein (Ho et al., 2007). This 
crystal structure was solved as a four protein complex. Proteins modelled in Phyre2 and 
edited in PyMol. 
 
Confidence in the MHpara tertiary structure model was 96.8% over a coverage of 60% 
of the amino acid sequence. This can be seen in Figure 3.20, where the solved structure 
is aligned with the predicted structure. The general shape and secondary structure of 
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the predicted MHpara aligns to the actual solved structure, although the beta strands 
are shorter in reality and the helical regions are missing in the predicted structure. The 
pore is also partially occluded by disordered loops, which could potentially be flexible or 
involved in protein interactions as has been described for a number of hemoproteins. 
The model is based on periplasmic lysozyme inhibitor of c-type2 lysozyme PliC from 
Salmonella typhimurium, which as the name states is a lysozyme inhibiter, which was 
shown to dimerise (Leysen et al., 2011). The amino acid sequences share only 18.42% 
identity. PhuT models had 100% confidence over 90% coverage, suggesting that these 
predictions give a good indication of the likely protein structure. The predicted structure 
of PhuT was based on a haem PBP from P. aeruginosa, however its close alignment with 
ShuT of S. dysenteriae enabled an insight into the possible haem binding cleft for this 
protein (Figure 3.21). 
3.2.5 Predicted Cellular Locations of Gly1-like Proteins 
The location of the proteins within the cell can indicate whether the putative function 
of the protein is feasible. Initially, an online programme called PSORT (Nakai and Horton, 
1999), a cellular location prediction tool, was used. This analysed the probability of the 
proteins of interest being in either the outer membrane, the periplasm (as is 
hypothesised for PhuT), secreted or in other regions of the cell. Table 3.4 shows a 
summary of the predicted locations.  
As previously mentioned, the Gly1 family of proteins share the feature of an N- terminal 
signal peptide which would direct the protein into at least the periplasmic space. 
However, it is currently unknown as to whether this is where the different proteins 
remain or if the function of the proteins require embedding in the outer membrane or 
secretion. We know PhuT is predicted to be a periplasmic haem binding protein based 
on the similarities to other PBP’s such as ShuT, and the high degree of certainty shown 
by this programme supports this that it is indeed a periplasmic protein.  
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Protein Periplasm Outer Membrane 
Certainty 
MHA_0579 0.365 0.826 
MHA_1205 0.524 0.252 
MH0603 0.655 0.252 
COI_1584 0.655 0.252 
L280_13705 0.699 0.183 
MHpara 0.229 0.177 
APP  0.104 0.775 
NM Gly1 0.268 0.934 
NG Gly1 0.228 0.832 
PhuT 0.929 0.211 
HmbR 0.131 0.922 
SARI 0.300 0.937 
 
Table 3.4. PSORT Results for Proteins of Interest.  
 
The closer the number to one, the higher the likelihood of the protein being targeted to 
that location based on signal peptide presence, and basic and hydrophobic regions. 
Those in bold are the higher numbers giving the estimated cellular location. 
 
The neisserial Gly1 proteins are all predicted to be localised to the outer membrane of 
the bacteria, as are the APP, SARI and MHA_0579 Gly1’s. Investigations by Sathyamurthy 
et al did not identify any OM protein motifs in the N. meningitidis Gly1 (Sathyamurthy, 
2011). The neisserial Gly1 in the Sayers lab was, however, believed to be present on the 
outer membrane as the Gly1 gene knock-out bacteria was less susceptible to 
complement mediated bacterial killing than the wild type, and further analysis showed 
the Gly1 present on OM blebs (Arvidson et al., 1999, Weirzbicka, 2014, Sathyamurthy, 
2011).  This again could support the evidence collected so far that the proteins of 
interest are involved in different cellular functions. Also included is the M. haemolytica 
HmbR, a known outer membrane receptor that was predicted by the PSORT software as 
being in the outer membrane, as expected.  The MHpara protein was not conclusively 
predicted to reside in either of these locations, while the results suggest that MHA_1205 
and its highly similar M. haemolytica Gly1s are in the periplasm. Further studies would 
be required to state this with any confidence.  
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3.3  Discussion 
3.3.1 Identification of Potential Homologues 
The method of homologue identification was inclusive, as previously stated, with 
differences between the key FSC motifs being accepted, such as FMC and YSC. Tyrosine 
(Y) and phenylalanine (F) are both aromatic amino acids, only differing by the hydroxyl 
group present on the benzene ring of tyrosine. Tyrosine is more reactive to non- protein 
atoms than phenylalanine as a result of this and is also more soluble. Both are often 
buried within the protein due to their hydrophobic nature. Serine (S) and methionine 
(M) are both aliphatic. Methionine is hydrophobic, and again is often found buried 
within the protein. Serine however, is polar, and can be found in many positions within 
the protein. The initial drawback in searching for homologous proteins was that using 
online databases was hampered by the limited availability of genome sequences for 
strains of M. haemolytica when the project began. Although more have been added 
since, the majority currently available belong to one of three serotypes. An additional 
issue is the annotation of the putative open reading frames as predicted proteins which 
can be misinterpreted based on previous sequence annotations. The shorter MHpara 
proteins annotated in error in certain M. haemolytica genome sequences shows it is 
worth ensuring the hypothetical proteins presented are true to the DNA sequence. 
Proteins identical to APP Gly1 were also recently found in strains of A. equii and A. suis, 
which could be a result of input error in the database, contamination of samples, or 
horizontal gene transfer. These strains with the ‘multispecies’ protein were added to the 
database in late 2014 and March 2015, after the completion of many structure-function 
experiments with the synthetic APP protein. The possibility of A. pleuropneumoniae 
culture contamination is greater with A. suis as it is also a cause of porcine disease, which 
is less pathogenic and often misdiagnosed as A. pleuropneumoniae. It is also a pathogen 
found in the porcine lung and could have been co-isolated. This may also provide a 
reason for the APP Gly1 protein only being present in one database strain of A. 
pleuropneumoniae if it is not truly native to this species.  
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An additional search revealed the presence of an A. pleuropneumoniae protein with low 
levels of sequence identity to Gly1 homologues (between 15- 20% amino acid identity). 
Further analysis showed that although the protein had an N terminal signal peptide, it 
did not contain the FSC or YEYS amino acid motifs or similar variants of these. Secondary 
and tertiary structure prediction was performed and this showed 54% alpha helical 
structures when analysed with Phyre2 although SABLE predicted mostly disordered or 
random coil with just 16% alpha helix and 20% beta strands (see figure 3.22).  
The predicted tertiary structure was based on only 7% of the amino acid sequence which 
showed an alpha helical region (not shown). The PSORT cellular location prediction tool 
could not estimate where the protein exists in the bacterial cell with confidence. It is 
possible based on this new information that A. pleuropneumoniae does not contain a 
Gly1-like protein, and that the protein ‘APP’ used in the experiments in this thesis 
belongs to another Actinobacillus species. 
 
Figure 3.22 A. pleuropneumoniae Protein Dissimilar to Gly1 Homologues.  
The signal peptides are underlined and the FSC region of the APP protein described 
throughout (APPo) is highlighted in the first box. The latter two boxes highlight the C 
terminal cysteines respectively. APPn accession number WP_005604137.1. 
 
S. enterica arizonae (IIIa) is the only salmonella species containing a Gly1 homologue 
candidate to date. This subspecies was found to be the most distant relative when 
comparing salmonella species (Chan et al., 2003), which could provide an explanation 
for this. There is a protein with low level sequence identity (13.9%) to this S. enterica 
arizonae Gly1 in S. enterica pomona. While this protein does have an N terminal signal 
peptide of 26 amino acids in length, it does not possess the FSC or C terminal cysteine 
motifs (or variations) that we used to identify potential homologues (Figure 3.23). 
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Figure 3.23 Salmonella enterica Protein Dissimilar to Gly1 Homologues.  
 
Signal peptides are underlined in red, FMC region of S. enterica arizonae and C of S. 
enterica pomona (accession number WP_000148339.1) in the first box and the C 
terminal cysteine of S. enterica arizonae in the final box.   
 
 
3.3.2 Sequence Differences Between Homologues 
The differences between the amino acid sequences of the MHpara proteins include the 
F78I polymorphism, and in the ‘shorter’ version, a K39E. This latter polymorphism causes 
the signal peptide region to differ upstream of residue 39 as predicted by ORF Finder 
using the DNA sequence as illustrated in Figure 3.4 sequence 184. This short sequence 
is the result of a frame shift early on due to a deletion, F78I is a change from a 
hydrophobic aromatic residue to a hydrophobic aliphatic residue. The phenylalanine 
residue, as expected from a larger aromatic residue, blocks the slight pore within the 
protein barrel to a greater extent than isoleucine and causes a change in the predicted 
surface of the protein (Figure 3.24). Both lysine and glutamate are polar hydrophobic 
residues, although lysine is a little bigger and is charged. The lack of knowledge about 
the function of this protein prevents us from knowing whether this would affect the 
proteins’ interactions. The shorter protein lacks the standard signal peptide cleavage 
site and is therefore not likely to function in the same manner to the other paralogues 
if at all. There is a possibility that it has an unusual signal peptide not recognised by the 
prediction software. 
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Figure 3.24 Amino Acid Substitutions in MHpara.  
 
A. shows isoleucine in blue, and B. shows phenylalanine in yellow. C. and D. show the 
surface changes as a result of this substitution. Mutagenesis generated in Pymol and is 
therefore an estimation of the position of the Phe. Protein structure solved using the 
isoleucine variant. 
 
 
3.3.3 Prediction Software 
Prediction software was used as a substitute to in vitro assays, however, there are 
varying levels of accuracy of these predictions as identified by the confidence limits. In 
terms of signal peptide prediction, signalP was chosen based on a study (Choo et al., 
2009), who found it to be the most accurate prediction tool. The predicted signal 
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peptides in APP and MHpara were processed as shown by N terminal sequencing, and 
the other proteins were assumed to be processed too, although any differences 
between the predicted MW to that seen on the SDS-PAGE gels could be due to the 
manner of protein folding. 
The secondary structure prediction software, SABLE is quoted to have an accuracy of 
around 78% based on the protein reference sets used. Phyre2 has an accuracy of 75- 
80% when predicting secondary structure.  This potential for error was highlighted in 
some of the regions in the M. haemolytica, where homologues with identical amino acid 
sequences differed from each other in the predicted secondary structure. The residues 
IKKAV were predicted by SABLE to be alpha helical in two of the proteins, with a beta A 
or AV in two of the others. This mostly agreed with the results seen with Phyre2, with a 
small number of differences as stated; Phyre2 predicts the region IKKAV to be helical for 
all proteins with none of the beta strands suggested by SABLE. This highlights the 
limitation of the predictive methods, and that these results should be used in 
conjunction with other analytical procedures.  
While PSORT is reported to be the most accurate cellular localisation prediction 
software at 97.3% accuracy, it is still limited by the selection of reference proteins 
available.  The MHpara results could indicate a dual location protein, but further work is 
required to find out how this protein functions. 
3.3.4 Circular Dichroism 
Circular dichroism is a technique used to estimate the secondary structure of the 
proteins. While software such as DichroWeb provides a good indication of the 
percentage of the protein that is alpha helical or beta strand, it is not 100% accurate and 
is again dependent on the proteins within the reference set.  
This could explain why the PhuT secondary structure was estimated to be mainly beta 
strands, when the predicted secondary and tertiary structures suggested a majority of 
alpha helical structures with 6 or 8 short beta strands. Additionally, both secondary 
structure predictive software results showed around 46% alpha and 14% beta. This was 
not seen with the DichroWeb results, even when analysed with different reference sets. 
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The double negative peak of the spectrum suggests alpha helical structure, however, 
the wavelength of the peak is 217 nm rather than the 222 nm seen with the average 
alpha helical protein. It does have the second dip at the same location as alpha helical 
proteins, along with the positive peak. The higher level of disordered region/ turns/ coils 
could suggest that the protein had not refolded correctly, although as seen in Chapter 
4, the protein still functioned in a haem binding capacity. 
Although both proteins purified from the supernatant and re-solubilised fraction were 
observed to bind haem, further analysis could be performed on the protein purified 
from the supernatant that was soluble under different conditions to ensure the results 
have not been affected by the re-solubilisation procedure. Additionally pH, temperature 
and solvent can affect the structure, and although the protein was stored in the same 1 
x PBS at -20°C, the temperature differed between experiments, and was considerably 
lower for the CD spectra, at between 18 and 20°C compared to the 37°C of the 
peroxidase activity assay and 20- 25°C of the hemin absorbance spectra.  
3.3.5 Crystallography 
While SARI C-His and MHA_1205 C-His crystals did not diffract at all, MHA_0579 C-His 
did diffract, however, Jason Wilson was unfortunately not able to solve the structure in 
its ‘apo’ form. The phasing proved more difficult than hoped because of the lack of 
sequence similarity to previously solved structures, including the neisserial Gly1s. 
Attempts were made to solve the structure in its ‘holo’ form with hemin soaked crystals 
but to date it has been impossible to recreate the crystals to optimise this.  This may be 
worth attempting for the MHA_1205 and SARI as they could be involved in haem 
binding, which may stabilise the proteins for longer periods of time and possibly allow 
these crystal to diffract. 
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3.4 Conclusion 
Potential Gly1 homologues appear to be present across a wide range of Gram-negative 
bacteria, and the list is growing as more and more genomes are sequenced in their 
entirety and added to databases. Some homologues are present in the majority of 
bacterial isolates within a species, where others are limited to one or two serotypes. The 
former could present potential novel vaccine targets in the face of increasing antibiotic 
resistance.  
Further investigations need to be conducted to confirm the cellular location of these 
proteins but the predicted locations suggest that MHA_0579 may indeed have a similar 
role to the neisserial Gly1 proteins and potentially SARI, whereas the more similar M. 
haemolytica homologues were predicted to remain in the periplasm. It is possible that 
these proteins could form different parts of a nutrient uptake system, rather than all 
having the same function. 
The MHpara protein structure was a similar antiparallel beta strand structure to the 
neisserial Gly1 proteins. Unlike these neisserial Gly1 proteins there is a structure in the 
PDB database that is believed to be similar to the MHpara protein and could provide an 
indication of the role of this protein as a lysozyme inhibitor. The secondary structures of 
all other Gly1 proteins appeared to have a large percentage of beta strands, which was 
in agreement with them being a family of bacterial proteins. Further experiments to 
obtain structures of those putative Gly1 homologues, and the PhuT haem binding 
protein would be interesting and could provide informative insights into their functions. 
Clues have been uncovered throughout the sequence and structural analysis in this 
chapter providing guidance as to where to begin functional characterisation of these 
proteins, with haem interactions providing the most interesting starting point. It is also 
of interest to note that some of the flanking genes of these proposed Gly1 homologues 
have been implicated in antibiotic resistance such as ICE proteins and acetyltransferases, 
which could provide clues towards the protein function in a broad sense.  
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4. Haem Interactions 
4.1 Introduction 
Iron uptake is vital for bacterial cellular survival. In low-iron environments such as the 
respiratory tract, bacteria use a number of mechanisms to enhance the likelihood of 
accessing host iron, which is often sequestered in high affinity proteins as summarised 
in the introduction. Haem is a major source of iron that bacterial cells can utilise. A 
number of haem uptake pathways in Gram-negative bacteria have been characterised 
to date, however, this is by no means an exhaustive list and the discovery of new 
proteins involved in these pathways is ongoing.  
Haem acquisition as an iron source is a known virulence factor in many bacteria (Anzaldi 
and Skaar, 2010), therefore identification of haem binding proteins could provide 
potential new targets in the struggle against antibiotic resistance. Haem uptake genes 
have been discovered within a ‘haem transport locus’ in a number of bacteria, such as 
S. dysenteriae which contains eight open reading frames (ORFs) including genes for 
ShuA- a haem receptor and ShuT a periplasmic haem binding protein (Wyckoff et al., 
1998). The presence of such a locus could be used to identify currently uncharacterised 
proteins as potentially involved in haem uptake.  
There is no single amino acid motif consistently associated with the binding of haem to 
known hemoproteins, and both the method and affinity of haem binding vary depending 
upon each proteins’ particular functional requirements. This is an important aspect of 
the haem uptake system, both enabling the movement of the haem ligand between 
proteins and in energy-providing mechanisms. Not all contacts between haem and 
protein are covalent, with non-bonded contacts also providing important interaction 
sites to stabilise the binding, for example electrostatic bonds.  
A collection of residues have been identified as important in protein-haem binding on a 
regular basis. As mentioned in the introduction, one use of haem in a bacterial cell is 
incorporation into the cytochrome C protein of E. coli which occurs covalently using the 
sulphurs from two cysteines and a histidine with the motif ‘CXXCH’, although the 
histidine can be substituted and the motif still bind haem (Allen et al., 2005). Alternative 
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binding sites include the haem binding pockets of the PBPs ShuT and HasA which 
coordinate haem with a tyrosine residue (Ho et al., 2007, Wolff et al., 2008). Further 
haem interactions have been shown to occur between a histidine residue and the NPDL 
motif in the HmuR in P. gingivalis (Liu et al., 2006). Haem- protein interactions have also 
been seen via Arg and Met residues, however, alternate motifs all incorporate cysteines, 
for example a CXXCK and CXXXCH.  
The function(s) of the Gly1 family of proteins as a whole is currently unknown. The novel 
protein fold of the neisserial Gly1’s does not provide any further clues, as no similar 
proteins have previously been characterised. A possible starting point was to analyse 
the genes flanking each gene of interest. In the neisserial species containing Gly1, the 
flanking genes code for proteins involved in haem biosynthesis (see Chapter 3, Figure 
3.5). In addition to this, N. meningitidis has been shown to interact with both haem and 
components of erythrocytes in previous studies in the Sayers lab group (Sathyamurthy, 
2011).  
The analysis of flanking genes of potential M. haemolytica Gly1 homologues in Chapter 
3 showed that the gene for MHpara is located downstream of  genes coding for a 
possible haemoglobin receptor, a potential periplasmic haem binding protein and hemin 
ABC transporter proteins in a putative haem uptake locus (Chapter 3, Figure 3.5). This 
points to a possible role in haem uptake, therefore we hypothesise that Gly1 proteins 
are involved in haem acquisition.  
In a study looking at the consequences of iron limitation on gene expression in M. 
haemolytica, genes coding for potential haemoglobin receptors, a PBP and hemin ABC 
transporters were upregulated, as was mh0603, a putative Gly1 homologue (Roehrig et 
al., 2007). While this could indicate that the Gly1 homologue is involved in haem uptake, 
other genes that were upregulated in the study were involved in iron uptake from a 
variety of alternate sources. These findings further support the results observed by 
(Sathyamurthy, 2011) in the hypothesis that Gly1 proteins are involved in bacterial iron 
uptake, with haem the likely source.  
The aim of this chapter is to investigate whether or not the newly proposed Gly1 
homologues are also hemoproteins.  
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4.2 Results 
4.2.1 Hemin Agarose Binding Assay 
The hemin agarose ‘pull down’ assay has been widely used to demonstrate the ability of 
proteins to bind haem (Lin et al., 2013). Initial hemin pull down assays performed in the 
Sayers lab group with N. meningitidis Gly1 showed that it was enriched after incubation 
with hemin agarose beads. It was therefore used as a positive control for these assays 
when testing proteins of unknown function. PhuT, predicted to be a periplasmic haem 
binding protein of M. haemolytica, was successfully cloned and expressed, and was 
therefore also assessed for haem binding ability.  
The SDS-PAGE gel analysis of the pull-down assays were studied on a gel-by-gel basis to 
eliminate gel-related variability and to uniformly interpret protein-binding ability. 
ImageJ software was used to measure protein band intensity in each individual lane to 
elucidate the ratio of BSA: protein of interest, with the two proteins together making 
100% of the lane total.  
BSA was used as a non-specific control to demonstrate that the hemin agarose beads 
had been sufficiently washed to remove any non-specifically bound proteins as 
evidenced by an almost total loss of BSA in each ‘pellet’ lane. Results were therefore 
seen as change in the percentage of the lane total comprised by the protein of interest. 
An enrichment of this protein in the ‘pellet’ lane compared to that in the ‘stock’ lane 
suggests hemin binding, while no increase, or a decrease, suggests no hemin binding by 
the protein in question (Figure 4.1 and 4.2). 
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Figure 4.1. Hemin Agarose Binding Assay.  
SDS-PAGE gels on the left of each panel show the pull-down, BSA is the 60 kDa band and 
the protein of interest is the lower MW band. The graphs show the percentage of the 
lane total made up by the protein of interest in the stock (black bar) and the pellet (grey 
bar) respectively. Of the Gly1 proteins of interest, only MHA_1205 C-His showed a 
significant enrichment (** indicates P < 0.005), with MHA_0579 C-His and SARI C-His a 
slight, yet non-significant, enrichment was observed. PhuT was significantly enriched (* 
indicates P < 0.05). An independent T- test was used.  
 
117 
 
 
Figure 4.2 Hemin Agarose Binding Assay Controls.  
Panels G-J show the controls used for this assay. N. meningitidis Gly1 has previously 
been shown to bind haem, and here was significantly enriched (*** indicates P < 0.001). 
Lysozyme was not enriched as a negative control. However, as a predicted further 
negative control, hGH C-His was significantly enriched (** indicates P < 0.01). An 
additional polyhistidine tagged protein, tFEN C-His, was therefore used (Panel J). This 
also showed unexpected significant enrichment (again, ** indicates P < 0.01). N = 3. 
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As predicted based on previous results of the Sayers group, the N. meningitidis Gly1 
protein was significantly enriched, with the lane percentage increasing from 
approximately 10% Gly1 and 90% BSA in the stock lane, to approximately 55% Gly1 and 
45% BSA in the bound fraction. PhuT was also found in the pellet fraction and was 
consistently enriched, a result shown to be statistically significant which supported the 
hypothesis that PhuT is a haem PBP of M. haemolytica. This binding also demonstrated 
that the protein had refolded correctly.  
Lysozyme does not bind haem and was therefore used as a negative control. In this assay 
the percentage of lysozyme in the lane total decreased as expected for a non-haem 
binding protein. Contrary to the overall hypothesis for Gly1 proteins, neither the 
MHpara protein nor the APP Gly1 protein showed any binding to the hemin beads. 
MHA_0579 C-His protein showed a slight level of enrichment, however, this was not 
found to be significant. MHA_1205 C-His and SARI C-His both displayed a significant 
enrichment when incubated with the hemin beads, supporting the hypothesis that these 
proteins are involved in haem binding.  
4.2.2 Haemoglobin Agarose Binding Assay  
As the haem binding ability of proteins analysed using this assay was not conclusive, the 
hypothesis that the Gly1 proteins may act as hemophores was still uncertain, therefore 
haemoglobin agarose beads were used with the same protocol as the hemin agarose 
bead binding assays.  
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Figure 4.3. Haemoglobin Agarose Binding of Gly1 Proteins.  
The panels show SDS-PAGE separation of the stock protein used comprised of Gly1 and 
BSA, which was incubated with haemoglobin agarose beads, the subsequent pellet after 
three washes and the first supernatant. Samples were incubated both with and without 
glutaraldehyde. The protein band at approximately 13 kDa was the haemoglobin 
monomer (HbM). No binding was seen. The images are representative of three repeats. 
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This experiment was an attempt to identify whether the proteins of interest had any 
haemoglobin binding ability, as they could potentially form haemoglobin receptors. 
Glutaraldehyde was used to immobilise any transient interactions to visualise any 
binding that may have otherwise been missed, as was hypothesised with the neisserial 
Gly1 protein. This has been observed in haemoglobin receptors to allow haem transfer 
from the haemoglobin and into the cell periplasm. If the proteins bound the 
haemoglobin even transiently we would expect to see the protein in the pellet lane 
along with the haemoglobin monomer. In this case, the results showed no interactions 
with the immobilised haemoglobin, however, no haemoglobin binding proteins were 
available as a positive control, as attempts to overexpress the cloned M. haemolytica 
HmbR protein in E. coli cells were not consistently successful (Figure 4.4). 
The low MW band around 13 kDa seen in the pellet lane of each experiment was the 
dissociated haemoglobin monomer. Some of the haemoglobin was seen forming higher 
MW bands in the experiments without glutaraldehyde, but this does not suggest any 
interactions with the Gly1 proteins. Instead, the higher molecular weight band appears 
to be protein dimers based on the MW of around 26 kDa. Haemoglobin readily forms 
multimers, and is found in tetramer form in vivo. Glutaraldehyde was used at a high 
concentration to stabilise any transient interactions. M. haemolytica and S. enterica 
arizonae (IIIa) Gly1 proteins are known to form multimers (see Figure 5.5, Chapter 5), 
and this may have led to the Gly1 protein monomers being at too low a concentration 
to be observed easily in the supernatant. Only the APP protein monomer was observed 
in the supernatant after glutaraldehyde incubation. Densiometry was again used, 
however, the results showed no proteins in any of the pellet lanes other than the 
haemoglobin monomers.  
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Figure 4.4 Haemoglobin Receptor Expression 
The M. haemolytica HmbR was cloned and expressed in E. coli BL21 (DE3) cells. HmbR 
MW 79.5 kDa. The lanes show protein expression in empty pUC19 vectors and in those 
containing the HmbR receptor, separated by SDS-PAGE. 
  
 
Expression of the HmbR protein in E. coli was seen in initial cloning, however, repeated 
attempts at expressing the protein in whole cells for Gly1 interaction analysis using 
techniques shown to work with the N. meningitidis proved unsuccessful (Figure 4.4). 
122 
 
4.2.3 Hemin Absorbance Spectra 
The hemin absorbance spectrum has been widely used as a tool to examine haem- 
protein interactions, and to identify new hemoproteins. The maximum absorbance 
(Amax) of hemin alone is around 385 nm, also known as the Soret Band or Peak. This 
maximum absorbance peak alters when hemin forms complexes with hemoproteins. 
The formation of bonds alters the spin of the iron atom within the hemin molecule and 
causes a shift in the Amax, for example haemoglobin is characterised by its Amax of 420 
nm and cytochrome P450 by its Soret Peak at 450 nm when in complex with haem. This 
is known as a red shift or a ‘bathochromic shift’ to a longer wavelength.  
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Figure 4.5. Changes to Hemin Absorbance Spectra When Incubated with Gly1 Proteins. 
  
There was no change in the Amax of hemin with MHA_1205 C-His and APP, which was 
maintained at 385 nm with all protein concentrations. Hemin with SARI C-His had an 
average Amax at 385 nm with 10 µM protein increasing to 388.75 nm at 50 µM protein. 
MHA_0579 C-His increased the Amax from 391.25 nm to 402 nm on average with an 
increase in protein concentration. Graphs are representative of a minimum of 3 repeats. 
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Figure 4.6. Changes to Hemin Absorbance Spectra when Incubated with Non-Gly1 
Proteins of Interest.   
 
The MHpara- hemin spectra averaged a maximum absorbance at 385 nm with 10 µM, 
20 µM and 30 µM, 386.25 nm at 40 µM, and 50 µM of protein. PhuT had a maximum 
absorbance at 400 nm with 80 µM protein and lysozyme (negative control) had a 
maximum absorbance at 386.25 nm with 50 µM protein. N = 3 
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The results showed an increased Amax for hemin incubated with PhuT at the higher 
protein concentrations used (Figure 4.6), which is in agreement with the hemin agarose 
pull down data, further supporting the prediction of PhuT functioning as a hemin PBP. 
The MHA_0579 C-His protein, conversely to what was anticipated following the hemin 
pull-down assay, showed a concentration-dependent increase in the Amax (Figure 4.5), 
with concentrations up to 80 µM of protein being used (data not shown). All 
concentrations of protein, from 10 µM upwards, caused a clear change in the shape of 
the curve in addition to the change in the wavelength of the maximum absorbance at 
higher protein concentrations (see Figure 4.7).  
 
Figure 4.7 Change in Amax of Hemin with Increasing Protein Concentration. 
The graph shows the change in Amax compared to hemin alone at each concentration of 
protein tested. Each value is an average over a minimum of 3 repeats. 
 
As expected following the hemin agarose pull down, neither APP nor MHpara displayed 
any change in Amax and the spectra closely mirrored that of the hemin along the entire 
wavelength scan. This was similar to the spectra seen with the negative control, 
lysozyme, which does not bind haem but had an average maximum absorbance of 
386.25 nm over three repeats. None of the marginal increases were found to be 
concentration dependent. 
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The spectra of hemin incubated with various concentrations of SARI C-His did not vary 
in shape from that of the hemin alone, however, the Amax increased with the protein 
concentration to 388.75 nm, which could indicate that some interactions were occurring 
to slightly alter the spin on the hemin iron. Hemin incubated with MHA_1205 C-His gave 
interesting results; although there was no shift in the Amax, the shape of the spectra 
differed slightly from that of hemin alone. This was most notable at the 400 - 450 nm 
region, where compared to lysozyme the hyperchromic shift resembled that seen with 
PhuT and MHA_0579 C-His. A bathochromic- hyperchromic shift in chromophores has 
previously been noted under differing solvent solutions, occasionally caused when the 
chromophore is conjugated to a ligand causing the local environment to change. This 
change in the shape of the curve could therefore indicate an interaction, although no 
binding was seen in the hemin agarose experiment after the removal of the polyhistidine 
tag.  
Hemin is known to form complexes with itself which can affect its ability to interact with 
proteins e.g. the µ-oxo dimer that forms at basic pH. Haem can exist in equilibrium 
between the dimer and monomer state depending upon the surrounding environment, 
and some hemoproteins have been shown to bind both forms (Smalley et al., 2001). 
Hemin can be re-suspended in Triton-X or DMSO to reduce this aggregation, however, 
as binding was seen in the universally used PBS solution at pH 7.5 with both the PhuT 
positive control and the MHA_0579 C-His protein, this was not deemed necessary.  
4.2.4 Haem Absorbance Spectra 
The difference between haem and hemin is the oxidation state of the iron at the centre 
of the molecule. In hemin, the oxidation product of haem, the iron is in ferric form, i.e. 
Fe3+, while haem contains ferrous iron, Fe2+. Ferric iron is more stable than ferrous as it 
is already oxidised. To ensure the oxidation state of the hemin did not affect the 
interactions, the absorbance assays were also performed under reducing conditions 
using sodium dithionite and de-gassed buffers.  
While the maximum absorbance of hemin alone shifted from 385 nm to 390 nm when 
reduced to haem, haem incubated with APP and MHpara again showed no change in 
the Amax compared to that of the haem alone. The average Soret Band with SARI C-His 
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present showed a hypsochromic shift, decreasing slightly to 387.5 nm (see Figure 4.8). 
This has been observed in the haem binding protein Irr from Bradyrhizobium japonicum, 
which works in a manner similar to Fur to regulate haem biosynthesis (Qi et al., 1999). 
MHA_0579 C-His again caused a bathochromic shift to 400 nm with haem, however, 
PhuT did not change the Amax. This could be attributed to the fact that similar PBPs (e.g. 
ShuT) interact with hemin Fe3+-O via a tyrosine residue (Eakanunkul et al., 2005) rather 
than haem. MHA_1205 C-His incubation with haem caused a slight red shift to 392.5 nm 
on average, suggesting an interaction was occurring. 
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Figure 4.8. Absorbance Spectra of Haem when Incubated with Recombinant Proteins of Interest.  
The Amax of haem in this study was at 390 nm. The Amax of APP and MHpara also remained at 390 nm. MHA_1205 C-His showed a slight Amax shift 
to 392.5 nm on average, SARI C-His shifted to 387.5 nm and MHA_0579 C-His to an average Amax of 400 nm. The Amax of PhuT remained a 390 
nm. N = 3. 
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4.2.5 Hemin Peroxidase Activity 
Hemin has intrinsic peroxidase activity due to its redox potential. This is maintained 
when bound by proteins and has been used to characterise novel hemoproteins (Lin et 
al., 2013, Lee et al., 2007). An ELISA-style method was used to analyse any binding to 
the proteins of interest. By coating the 96-well plate with the proteins of interest and 
adding hemin to this, any unbound hemin would be removed by the washing process, 
leaving only protein-bound hemin to react with the TMB substrate. Therefore an 
increase in absorbance compared to the hemin-only control would suggest hemin-
protein interactions (Figure 4.9).  
 
Figure 4.9. Hemin Binding as Demonstrated by Peroxidase Activity.  
 
Peroxidase activity shown here as a change in absorbance normalised to the hemin only 
value. The peroxidase activity of haem increased in a concentration-dependent manner 
with MHA_0579 C-His, MHA_1205 C-His, SARI C-His and PhuT. Each showed a significant 
increase at 8 µg protein compared to lysozyme (P<0.0001). The negative control of 
lysozyme showed no activity, and MHpara and APP proteins showed low levels of 
peroxidase activity (P<0.01 and P<0.001 at 8 µg protein respectively). N = 3, graph is 
representative of repeats, each performed in triplicate. Independent T test used.  
 
Lysozyme was again used as a negative control, showing no change in absorbance when 
normalised to hemin alone. MHpara and APP showed very little change in absorbance 
which supports the results of the previous experiments where no clear binding to haem 
or hemin was observed. The wells pre-incubated with PhuT showed a very significant 
increase in peroxidase activity after addition of hemin compared to hemin alone, in 
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accordance with the binding to hemin agarose beads and the shift in absorbance spectra 
seen in previous experiments.  
Samples containing MHA_0579 C-His showed a significant concentration-dependent 
increase in peroxidase activity, again supporting the hemin and haem absorbance 
spectra which showed binding. The SARI C-His also displayed a concentration dependent 
increase in peroxidase activity, albeit to a lesser degree. Interestingly, MHA_1205 C-His 
also showed a significant increase in peroxidase activity which was not anticipated 
following the absorbance spectra results.  
4.2.6  Hemin Agarose Binding Assay after Enterokinase Treatment 
A number of amino acids are known to be involved in forming complexes with haem. 
Among these is histidine, which has been repeatedly shown to associate with haem via 
nitrogen to the iron axial ligand (Wolff et al., 2008, Izadi-Pruneyre et al., 2006). To 
investigate whether the polyhistidine tag on either the MHA_0759 C-His, SARI C-His or 
the MHA_1205 C-His was interacting with the hemin agarose beads, human growth 
hormone cloned with a polyhistidine tag (hGH C-His) was initially used as a negative 
control. Human growth hormone has not been shown to bind haem, unless broken 
down by pepsin and in this instance only the N terminal 1-44 fragment is able to bind 
haem (Spolaore et al., 2005). Interestingly, hGH C-His was significantly enriched in the 
pull down experiment suggesting that it was binding to the hemin agarose beads (see 
panel I, Figure 4.2). This could indicate that the polyhistidine tag was interacting with 
the hemin agarose beads in a manner that cannot be dissociated with 500 mM NaCl 
washes.  
To further investigate this observation, a polyhistidine-tagged, truncated, human flap 
endonuclease (tFEN C-His) was also tested (donated by Sarah Oates of the Sayers lab 
group). As a well characterised DNA binding protein this has not been shown to interact 
with haem in a biological setting, however, in this assay the tFEN C-His protein was also 
significantly enriched suggesting binding was occurring.  
To investigate whether it was indeed the polyhistidine tag that was interacting with the 
hemin agarose beads, enterokinase was then used to cleave the polyhistidine tag off the 
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Mannheimia and Salmonella Gly1 proteins. hGH and tFEN proteins lacking the 
polyhistidine tag were obtained from members of the Sayers Lab.  
As shown in Figure 4.10, any enrichment seen with C-terminal polyhistidine-tagged 
versions of hGH, SARI and MHA_0579 proteins (see Figures 4.1 and 4.2) was completely 
abolished with the removal of the polyhistidine tag, suggesting the tag was interacting 
with the beads. Interestingly, the tFEN protein still appeared to bind the hemin agarose 
beads, showing significant enrichment comparable to that of the polyhistidine tagged 
version. MHA_1205 C-His showed significant enrichment yet when the histidine tag was 
cleaved, this enrichment did not occur. A previous member of the Sayers lab tested N. 
meningitidis Gly1 lacking the C terminal polyhistidine tag and found that this did not 
affect the haem binding in this experiment (Sathyamurthy, 2011).  
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Figure 4.10 Investigating Interactions of a Polyhistidine Tag with Hemin Agarose 
Beads. 
 A repeat of the hemin agarose pull down using the same recombinant proteins either 
cloned with no tag or with the polyhistidine tag cleaved using enterokinase treatment. 
The tFEN wt protein was significantly enriched (P < 0.005), however, SARI wt, MHA_0579 
wt, MHA_1205 wt and hGH were not. N = 3. 
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4.2.7 Secondary Structure of Proteins Incubated with Hemin 
Circular dichroism can be used as a tool to analyse any changes in secondary structure 
that may arise from proteins interacting with ligands. Hemin alone does not have a CD 
signal, as was tested in each new experiment, therefore the only spectral effect it can 
generate is if its interactions alter the protein environment in some way. The results 
show that there was no great change in the shape of each proteins’ absorbance 
spectrum when incubated with hemin, the only differences being in the slight increase 
or decrease in the amplitude of some curves.  
DichroWeb was again used to estimate the percentages of alpha and beta structures 
along with the turns and disordered regions in each sample both alone and after 
incubation with hemin. Averages were made of at least 3 individual repeats for each 
condition and protein. The estimated percentage of MHpara secondary structure 
comprised of alpha and beta did not change at all between the two conditions. The 
percentage of alpha helices purported to comprise the PhuT protein decreased slightly 
from 18.9% to 13.99%. As discussed in Chapter 3 (section 3.1.3) the proportion of alpha 
estimated to form the majority of the PhuT structure by CD spectral analysis was not in 
agreement with either that reported by predictive software, or the similar amino acid 
sequence to other proteins with a high alpha content. The average percentage of alpha 
forming SARI C-His increased by approximately 5%, whereas the beta decreased from 
34.67% to 31.44%. When incubated with hemin, MHA_0579 C-His saw an increase in the 
percentage of beta strands from 34.87% to 38.57%, whereas the alpha content 
decreased by 5%.  The percentage of beta strands estimated to form MHA_1205 C-His 
increased by 5% and the alpha helix proportion decreased by 3.6% following incubation 
with hemin. The percentage of disorder and random coils did not change by more than 
2% (Figure 4.11). 
APP had shown no interactions with haem or hemin throughout the previous 
experiments so was not included for secondary structure analysis with hemin. MHpara 
was included as the structure has been solved by X-ray crystallography, and we 
therefore had a better idea of the accuracy of the secondary structure analysis than for 
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the other proteins.  This did not change secondary structure at all when incubated with 
hemin (Figure 4.12). 
 
 
  
 
Figure 4.11 Gly1 Homologues Seondary Structure when Incubated with Hemin.  
 
The CD spectra of Gly1 homologues was analysed with and without hemin. N = 3. 
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Figure 4.12. Comparison of Secondary Structure of PhuT and MHpara when Incubated 
with Hemin.  
The CD spectra of proteins both with and without hemin. N = 3. 
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4.3 Discussion 
4.3.1 Hemin Agarose Binding Ability of Gly1 Homologues 
Immobilised hemin beads are widely used as a measure of protein-hemin interaction, 
but the assay is not without its limitations. The Sigma hemin agarose beads used (see 
Chapter 2, section 2.2.1) have the hemin immobilised via a carboxyl group (one of the 
propionate arms) with a spacer of 12 Å in length. A literature search revealed that the 
propionate arms are involved in haem binding, such as that occurring with the catalytic 
activity of haem oxygenase (HO) (Peng et al., 2012). With PhuT from P. aeruginosa, one 
carboxyl group of hemin is hydrogen bonded to an Arg residue (Ho et al., 2007) although 
the ShuT protein in the aforementioned paper did not form this bond. P. aeruginosa 
PhuT has a very similar structure to that predicted for the M. haemolytica PhuT which 
was enriched in this assay. The carboxyl group used for association to the agarose beads 
may therefore not always be essential for binding, but could interfere with the binding 
to different proteins, possibly explaining the lack of binding seen with other Gly1 
homologues. 
The overexpressed, purified M. haemolytica PhuT in its native form did not have a 
polyhistidine tag, so any enrichment shown with the protein in this assay supports the 
idea that it is indeed a M. haemolytica hemin PBP. The fact that no polyhistidine tag-
cleaved Gly1 homologues nor the hGH protein were enriched after incubation with the 
hemin beads suggests that either these proteins do not interact with hemin (as expected 
with hGH), that the enterokinase damaged the proteins, or that the method with which 
the hemin is immobilised onto the agarose beads hindered any binding. The pH of the 
protein solution after enterokinase treatment was checked and was found to be pH 8, 
and therefore should not have affected the reaction. 
An interesting finding was that of the non-tagged tFEN enrichment on the hemin beads. 
Investigations revealed the potential cause to be the presence of three histidine-rich 
regions in the tertiary structure (see figure 4.13), which could be associating with the 
hemin agarose beads, discrediting this protein as a negative control for haem binding 
assays, further highlighting limitations of this experiment. In addition to the histidine 
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rich nature, the protein also contains a number of cysteines that could act as non-
specific hemin agarose ligands under theses experimental conditions. 
 
Figure 4.13 Histidine Rich Regions in FEN-1.  
Panels A, B and C show the three histidine rich regions of the human FEN in complex 
with DNA (histidines in purple). Structure taken from RCSB PDB reference 3Q8K and 
image edited in PyMol. 
 
A number of the previous studies in the literature do not use the control of a non-haem 
binding protein such as BSA or lysozyme to ensure any binding seen is specific, rather 
than weak interactions with hydrophilic regions of the hemin. In addition, during the 
optimisation of this protocol it was discovered that to achieve maximum reduction of 
non-specific binding of BSA to the hemin beads, a high concentration of NaCl in the wash 
buffer solution was necessary. This was shown by the almost complete removal of BSA 
from the pellet fractions when compared to the stock fraction. 
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4.3.2 Haemoglobin Agarose Binding 
The limitations of the haemoglobin agarose pull down assay again included that the 
method by which the haemoglobin was linked to the bead matrix was via an amine bond, 
although more specific information was unavailable. The immobilisation of the 
haemoglobin could have interfered with interactions with other hemoproteins, or 
possibly the quaternary structure of the haemoglobin itself. After attempts to clone and 
express the M. haemolytica HmbR were unsuccessful, no positive control was available 
to confirm the assay was functional. The conclusions that can be drawn from this are 
that the proteins of interest do not bind to haemoglobin when immobilised on these 
particular beads.  
Further haemoglobin interaction experiments were not conducted at this time due to, 
firstly, the predicted locations of the proteins of interest being either periplasmic or 
outer membrane (see Figure 3.4, Chapter 3). Secondly, while OM proteins could present 
plausible receptors for haemoglobin, the single unit haemoglobin receptors discovered 
to date are much larger than the Gly1 homologues (around 70 kDa) , and those that are 
smaller form bipartite receptors with other proteins. Some bipartite receptor single unit 
proteins can interact with haemoglobin on their own, such as HgbA in APP, however, 
this is again a much larger protein than the Gly1 homologues (approximately 100 kDa).   
4.3.3 Hemin/ Haem Absorbance Spectra 
To support results seen in the hemin agarose pull down study, further haem binding 
experiments were performed. Proteins alone had their absorbance spectra measured to 
ensure they were not contributing to each spectrum (data not shown), as some 
hemoproteins are purified in their holo-form. Although this would show haem binding, 
it would not be controlled within the confines of the experiment. 
Previous work in the Sayers lab suggested that the N. meningitidis Gly1 bound hemin in 
a 2:1 ratio of Gly1: hemin (Sathyamurthy, 2011), therefore this ratio was used as the 
basis of this assay. Many hemoproteins bind haem in a 1: 1 ratio, however, this is not 
universal and, as previously mentioned, some proteins are also able to bind haem 
dimers. HasA has been suggested to bind in a 1:1 ratio but is secreted as both a 
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monomer and dimer, with the dimer domain swapping to complex the hemin (Czjzek et 
al., 2007). Therefore the concentration of protein used in the studies was varied from 1: 
2.5 ratio of protein: hemin, to 2: 1 to encompass these potential variations in binding 
stoichiometry.  
A decrease in the peak absorbance between 350 and 450 nm seen in hemin incubated 
with APP and PhuT (Figures 4.5 Panel D and 4.6 Panel E, respectively) could be attributed 
to an increase in aggregation of hemin over time (Srinivas and Rao, 1990). However, all 
spectra were measured within minutes of each other when incubated with each protein, 
and the only difference that may therefore have affected the results is the lower overall 
absorbance at these wavelengths when compared to hemin alone. This should not have 
affected the wavelength at which the Amax occurred, just the value of the Amax itself. An 
overall decrease of the absorbance spectra could indicate pipetting error when adding 
the hemin, however, this was not seen in the replicates performed.   
The sharp dip in absorbance observed in all spectra including that of hemin and haem 
alone, between 380 and 382 nm, can be attributed to an artefact of the 
spectrophotometer at the point of transition from visible to UV light. The spectrum was 
found to be the same in both quartz and plastic cuvettes, and the dip did not interfere 
with the Amax in any of the spectra as checked by reducing the wavelength step to 0.5 
nm from 5 nm (data not shown).  The Amax in these experiments was 385 nm for hemin 
only- a higher wavelength than the dip. 
The slight shift in the spectral shape of hemin and MHA_1205 C-His could be showing 
some non-covalent interactions that do not involve the iron of the hemin, such as the 
hydrophobic interactions that are often present to stabilise the covalently bound hemin 
into the haem binding pocket of proteins such as haemoglobin. The decrease in the Amax 
of hemin with SARI C-His could be indicative of a hexa-coordinate binding rather than 
penta-coordinate interaction, possibly exhibiting this unexpected spectral change. The 
discrepancies between the results of the two hemin binding assays discussed so far 
could be explained by the limitations of each experimental procedure, so a further 
experiment was conducted to add to the previous results. 
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4.3.4 Hemin Peroxidase Activity Assay 
The increase in peroxidase activity of PhuT and MHA_0579 C-His when incubated with 
hemin support binding data from the hemin absorbance assays. PhuT has shown positive 
results indicating hemin binding with all three experimental techniques. MHA-0579 C-
His, however, displayed results consistent with hemin binding in two of the three, 
showing no binding to the hemin agarose beads. MHA_1205 C-His, which only showed 
binding before removal of the polyhistidine tag in the pull down assay and minor 
changes in the absorbance spectra of haem and hemin, showed an increase in 
peroxidase activity. This indicated haem binding as neither the protein alone nor hemin 
alone showed peroxidase activity. As binding was seen in this assay, conducted in the 
same PBS buffer as the hemin absorbance assay, we can conclude that aggregation of 
the hemin, if present, did not interfere with interactions and is unlikely to be causing the 
different results observed with the absorbance spectra. The lack of peroxidase activity 
of APP and MHpara proteins supports the previous binding data, and together they 
suggest that these proteins are not involved in bacterial haem/ hemin uptake. 
The concentration-dependent increase in peroxidase activity seen with SARI C-His is at 
odds with the lack of binding seen in the pull down assay post polyhistidine tag-cleavage, 
however, there was some enrichment with the tag still present. In addition, there was a 
slight increase in the Amax of the hemin absorbance spectra with SARI C-His, which could 
suggest some interaction. The maximum ratio of protein: hemin used in the peroxidase 
activity assay was 1: 2.5, which is consistent with the lowest concentration of protein 
used in the absorbance spectra assays, therefore this difference in binding results 
cannot be attributed to an excess of hemin in the peroxidase activity assay. A possible 
contributing factor is that in the hemin peroxidase assay, the higher temperature of 37°C 
is favourable to the haem binding reaction. The spectrophotometry had to be conducted 
at room temperature which fluctuated between 18 and 21°C.  
The enterokinase used to cleave the polyhistidine tag off the proteins specifically 
recognises the DDDDK sequence, cleaving after the lysine residue. This should not have 
targeted any other section of the protein and should therefore not have affected the 
haem binding ability of SARI to the agarose beads, however, it is still a possibility worth 
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some consideration as a theory explaining the differences in binding seen between 
assays.   
4.3.5 Secondary Structure Changes in Hemoproteins  
We know that the tertiary structure of proteins changes upon haem binding, as seen in 
HasA, where the loops between beta sheets move to complex the haem molecule (Izadi-
Pruneyre et al., 2006). The secondary structure of some proteins has been shown to vary 
when they are in the holo form or ligand free state, such as cytochrome b562 which 
displays a higher proportion of disorder in helix IV in the apo form compared to the holo 
form (D'Amelio et al., 2002). The data shows that if there is any hemin binding to the 
proteins of interest, the interactions do not cause dramatic changes in the secondary 
structure. 
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4.4 Conclusion 
These haem binding studies have provided evidence for the functional activity of PhuT 
which had not yet been characterised. This supports the hypothesis that based on amino 
acid sequence, secondary structure estimation and predicted tertiary structure this is a 
Mannheimia haemolytica periplasmic haem binding protein. Further studies to 
investigate this mechanism could look at the binding affinity of PhuT for haem and 
subsequent interactions with ABC transporter proteins, as the genes coding for both this 
and the likely HmbR protein are predicted to reside in the same genetic locus.  
The haem binding data presented in this chapter overall (See summary Table 4.1) 
provide evidence to support the hypothesis that MHA_0579, MHA_1205 and SARI 
interact with haem or hemin in some way, and are therefore involved in bacterial haem 
uptake. Despite the indications provided by the flanking genes that it may be situated in 
a putative haem uptake locus in the genome, MHpara did not display any haem binding 
activity. In addition, no haem binding activity of the APP protein has been observed, 
suggesting it has a different function.  
 
 
Table 4.1 Summary of Haem Binding Data. 
Hemin pull down data taken from proteins post polyhistidine tag removal.  
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Steric hindrance may have played a role in the discrepancies between hemin agarose 
interactions and those seen in the other assays. It cannot be ruled out that the 
polyhistidine tag had an effect on the absorbance and peroxidase binding studies, 
however, insufficient materials were available to conduct the absorbance assays with 
non-tagged proteins. Repeating these with native proteins would be valid further work 
to ensure the binding seen was not an artefact.  
While the N. meningitidis Gly1 and SARI C-His proteins were observed in the culture 
supernatant after overexpression in E. coli cells, which initially hinted at it being secreted 
and therefore a possible bacterial hemophore, the M. haemolytica Gly1 proteins were 
not secreted from E. coli cells. This secretion was not observed in wild type N. 
meningitidis culture when the supernatant was analysed by western blot, although the 
protein was also not shown to be expressed in the cells under the growth conditions 
used.  (Sayers lab, unpublished). The protein was secreted from N. gonorrhoeae and was 
also found in membrane fractions (Arvidson et al., 1999). Further to this, no Salmonella 
enterica arizonae (IIIa) was available to analyse wild type Gly1 expression so conclusions 
regarding secretion could not be drawn.  
As E. coli is not the natural host for the putative M. haemolytica Gly1 proteins, the 
isolates donated by the AHVLA and the RVC were analysed for secreted proteins. The 
protein was not observed in the supernatant, again using western blot, in any of the 
strains that had been shown to carry the genes for one or more Gly1 (data not shown). 
However, the western blots were not able to detect the proteins in all of the isolates 
that had Gly1 genes detected in PCR screening (Section 6.2.3, Chapter 6).  The M. 
haemolytica strains were grown in iron replete conditions, and the transcription of 
genes coding for Gly1 proteins could therefore have been repressed due to lack of 
cellular requirement for iron acquisition. 
Most haem binding proteins are made up of a high percentage of α- helical structure (Li 
et al., 2011), however, as this is not seen in the predicted structures of the Gly1 proteins, 
it is worth considering other possible functions, as they could still present valid 
antimicrobial targets as well as those that look to bind haem based on this data. 
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5. Protein Interactions 
5.1 Introduction 
Haem uptake pathways are comprised of proteins of different function to bring 
scavenged haem to the bacterial cell, transport it across the outer membrane, through 
the periplasm and the cytoplasmic membrane and into the cytoplasm, where it is utilised 
or stored. While many consist only of a single component, some outer membrane 
receptors involved in iron acquisition are bipartite, such as the transferrin receptor 
which is made of two separate proteins (Yang et al., 2011) or HpuAB, a bipartite 
haemoglobin receptor analogous to the TbpAB receptor. 
PhuT is a suspected periplasmic hemin binding protein of M. haemolytica, a key 
component in bacterial haem uptake (Eakanunkul et al., 2005). The mechanisms of 
action in terms of haem uptake in M. haemolytica have not yet been experimentally 
demonstrated. Proteins of similar predicted structure and function bind haem in a 1:1 
or 1:2 protein: haem ratio. With regards to protein oligomerisation, the haem PBP from 
S. dysenteriae has been crystallised as a dimer whereas the PBP for P. aeruginosa was 
found to exist as a hexameric homooligomer. The crystallisation process can, however, 
result in the artificial formation of dimers, so care needs to be taken when interpreting 
these data.  
Gene duplication events can lead to protein paralogues that function in a different 
manner to the original protein. The MHpara protein did not appear to be functionally 
related to the putative Gly1 homologues based on haem interaction studies, which could 
be explained by divergence from the ancestral gene. The predicted function of this 
protein was annotated as an adhesin on the NCBI database (see Table 3.2) with the NCBI 
Prokaryotic Genome Annotation Pipeline (released 2013). This was based on homology 
with similar genes/ proteins already within the database, but as this method relies on 
other annotations being correct it is therefore important to experimentally investigate 
the potential of the protein acting as an adhesin.  
Adhesins are considered one of the major virulence factors of M. haemolytica along with 
leukotoxin, LPS, capsule and the ability to acquire nutrients from the host. As 
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mentioned, M. haemolytica is surrounded by a polysaccharide capsule to protect itself 
from the host immune system. This capsule can mask some proteins leading to differing 
levels of OM protein exposure, which can affect their recognition by the host. Adhesins 
of M. haemolytica identified to date include the proteins OmpA, and Lpp1, which have 
been found to bind to bovine epithelial cells of the upper respiratory tract (Kisiela and 
Czuprynski, 2009).  
To adhere to respiratory epithelial cells, M haemolytica are known to use a variety of 
mechanisms, including fimbriae and OM proteins which interact with the extracellular 
matrix of the host cell, such as bacterial OmpA and host fibronectin (Lo and Sorensen, 
2007). The capsule may also act as a non-specific adhesin as seen in A. 
pleuropneumoniae.  
Bacteria can also remain within the mucous layer or degrade the layer to improve 
adhesion using specific enzymes, for example in M. haemolytica neuraminidase 
degrades components of the mucous layer (Straus et al., 1993). The polysaccharide 
capsule of M. haemolytica is differentially expressed in log and stationary phases, and 
in A. pleuropneumoniae down-regulation of the genes coding for the capsule was 
observed in cells in planktonic growth compared to when adhered to epithelial cells 
(Auger et al., 2009). This reduction in capsule has been suggested as a method of 
improved host colonisation, although it could also expose the bacterial cell to attack by 
the host defence mechanisms. 
Vaccines for BRD have a wide scope of potential infections to contend with. As each 
outbreak can be caused by multiple factors, vaccines for young feedlot animals would 
ideally cater to the major components involved in bacterial and viral causes of disease. 
Antibodies to proteins that are conserved between species would make these proteins 
prospective targets. 
In this chapter the results of investigations into the interactions of the putative Gly1 
proteins with molecules, proteins, or cells other than those related to haem binding and 
uptake are discussed. The previous chapter touched on Gly1-haem interactions showing 
possible roles for MHA_0579, MHA_1205 and SARI in bacterial haem uptake systems. 
Many proteins involved in haem binding function as homodimers or homomultimers for 
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example the tetramer haemoglobin. It is possible that these Gly1 proteins work together 
to form a haem uptake pathway. 
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5.2 Results 
5.2.1 Cross Reactivity 
Due to the variable level of amino acid sequence identity between the Gly1 proteins and 
to investigate their potential as therapeutic targets, the ability of protein-specific 
antibodies to recognise other Gly1 proteins was assessed. Cross reactivity of the M. 
haemolytica Gly1 antibodies was analysed initially with the MHA_1205 C-his rat 
antisera, the SARI C-his rat antisera and APP mouse antisera prior to acquisition of 
further protein-specific rabbit antisera. Anti-polyhistidine antibodies were used to both 
detect the polyhistidine tagged proteins for which no specific antisera were available, 
and also as a positive control to show the protein concentration was sufficient to elicit 
a response. Gly1 proteins from the four bacterial species were assessed for cross-
reactivity to the aforementioned antisera. BRD is a multifactorial disease caused in part 
by multiple bacterial strains containing genes for potential Gly1 homologues. Thus the 
cross reactivity of antisera could be of huge interest in terms of drug development.  
Cross-reactivity was seen between the MHA_1205 C-His antisera and one other protein 
homologue- N. meningitidis Gly1. Further cross reactivity studies using each available 
antisera and each available protein showed that the APP antisera, MHA_0579 C-His and 
MHpara antibodies did not cross react with any of the Gly1 proteins other than their 
respective targets, and in turn none of the other antisera reacted with the MHpara or 
APP proteins (Figure 5.1).  
148 
 
 
 
Figure 5.1. Cross Reactivity of Gly1 Antisera.  
Antisera or antibodies used are stated above each image. Lanes as follows: 1 = 
MHA_1205 C-his, 2 = MHA_0579 C-his, 3 = MHpara, 4 = APP, 5 = SARI C-his, 6 = NM C-
his, 7 = hGH C-his. Here hGH C-His was used as a negative control. In each sample, 1 mg 
of protein was used, diluted 1:2 with loading dye and separated by SDS-PAGE. Higher 
molecular weight bands observed were protein multimers, as confirmed by anti-His 
antibodies reacting with SARI-C-His high MW band in the red box. N=3, representative 
images used.  
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Interestingly, when exposed for a longer period of time or when using an increased 
concentration of protein, cross reactivity was seen using both the MHA_1205 C-His and 
the SARI C-His antisera to one or more other polyhistidine tagged proteins. The SARI C-
His antisera reacted a lot more with the proteins possessing a polyhistidine tag than the 
MHA_1205 C-His antisera which only recognised N. meningitidis polyhistidine tagged 
Gly1 (Figure 5.1). The antibodies present in these antisera stocks had not been 
quantified therefore volumetric dilutions were made of each. In addition, neither of 
these antisera were affinity purified, so it is possible that the proteins were being 
recognised in a non-specific manner. The anti-SARI C-His antisera also reacted with the 
negative control of human growth hormone (hGH), suggesting that the polyhistidine tag 
was being recognised to some extent as the non-tagged proteins were not recognised.  
In order to eliminate the polyhistidine tag as a cause of non-protein specific antibody 
binding in the anti-SARI C-His antisera, enterokinase was used to cleave the polyhistidine 
tag off said proteins. Cleavage was confirmed by SDS-PAGE separation, showing SARI C-
His with a MW of approximately 17 kDa and SARI wt a MW of approximately 16 kDa (See 
Appendix). This resulted in a decrease of the positive results observed in Figure 5.1 in 
terms of recognition of the N. meningitidis Gly1 and MHA_0579 proteins. MHA_1205 
was detected to a greater extent than MHA_0579, and N. meningitidis Gly1 detection 
was low to non- existent across repeats. No further hGH lacking the polyhistidine tag 
was available to assess the cross reactivity in a non- specific capacity in this assay. The 
SARI wt protein and the SARI C-His displayed equivalent strong reactions with the 
antisera. This showed that the enterokinase did not damage the protein in terms of 
antibody recognition (Figure 5.2).   
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Figure 5.2. Cross Reactivity of Gly1 Antisera After Protein Enterokinase Treatment.  
Proteins with polyhistidine tags removed detected using anti-SARI C-His antiserum. NM 
is N. meningitidis Gly1 wt. Protein concentrations used were 2 mg/ml for SARI wt and 
SARI C-His, 1 mg/ml MHA_0579 wt and MHA_1205 wt and 0.9 mg/ml NM wt. Proteins 
were diluted 1:2 with loading dye and separated by SDS-PAGE. N = 3. 
   
5.2.2 Dimerisation Properties 
Protein homo-dimerisation and multimer formation can occur between two or more 
monomer units of the same protein. The associations can drastically affect the function 
of the protein, for example haemoglobin comprises 4 monomer units to make a 
functional structure. As seen in the antibody cross reactivity assay, additional protein 
bands at higher molecular weights with the SARI C-His and MHA_0579 C-His proteins 
could indicate dimerization. The proteins were separated on denaturing protein gels, 
using SDS and heat uniformly, and DTT to reduce disulphide bonds for comparison. 
N. gonorrhoea Gly1 was crystallised as a dimer (as shown in Figure 3.2) and recent work 
in the Sayers lab confirmed N. meningitidis Gly1 dimers and higher order oligomers in 
solution (Weirzbicka, 2014). N. meningitidis Gly1 was shown to bind haem in a 2:1 ratio 
(Sathyamurthy, 2011), suggesting its function is related to this dimerisation. The 
structure was solved by the Artymiuk and Sayers labs (Jason Wilson and Magda 
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Weirzbicka (Weirzbicka, 2014)) and had an almost identical structure to the N. 
gonorrhoea Gly1 protein (Arvidson et al., 2003), even crystallising with the same dimer 
interface. Purified samples of each M. haemolytica Gly1 protein were therefore assessed 
for homo-dimerisation properties to further investigate any similarity to the original 
Gly1 proteins.  
Dimers can be formed by intermolecular disulphide bonds connecting cysteine residues 
on individual monomers. For SDS-PAGE separation, protein dimers stabilised in this 
manner can be disrupted using dithiothreitol (DTT) to enable greater accuracy in 
interpretation of purity and size. The initial dimerisation experiment consisted of 
separating the protein on an SDS-PAGE gel after being boiled in SDS-PAGE loading dye 
containing either fresh DTT or no DTT. Omitting this DTT revealed the formation of 
possible multimers in a number of the pure protein stocks at neutral pH (Figure 5.3).  
MHA_0579 C-His formed what appeared to be dimers of approximately 32 kDa in size. 
The protein required a much higher concentration per sample to give visible dimers on 
the Coomassie stained gel compared to MHA_1205 C-His and PhuT. SARI C-His also 
showed some higher molecular weight bands, potentially dimers. PhuT, with a 
monomeric molecular weight of 30.7 kDa, formed visible multimers at low protein 
concentrations on the SDS-PAGE gel seen as a band at approximately 60 kDa. No 
multimers were observed with APP or MHpara proteins.
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Figure 5.3. Oligomerisation State of Gly1 Homologues Mediated by Disulphide Bonds.  
Higher molecular weight bands in samples without DTT (approximately 30-35 kDa) 
suggested dimer formation of MHA_1205 C-His, MHA_0579 C-His and SARI C-His and 
PhuT. MHpara and APP Gly1 did not have additional protein bands. Lysozyme was used 
as a negative control. Proteins boiled for 3 minutes at 100 °C in loading dye with or 
without DTT prior to loading onto gel then separated by SDS-PAGE. Images are 
representative of 3 repeats.  
 
To ensure that the higher molecular weight bands seen on the SDS-PAGE gels were in 
fact the proteins of interest rather than contaminants, SARI C-His and MHA_1205 C-His 
antisera, specific MHpara and MHA_0579 C-His antibodies and anti-polyhistidine 
antibodies were used for western blotting (see figure 5.4). APP Gly1 showed a higher 
molecular weight band in the presence of DTT, which was believed to be a contaminant. 
The MHA_1205 C-His antisera detected higher molecular weight bands at approximately 
30 kDa with both the MHA_1205 C-his specific antisera, suggesting the dimerisation was 
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real and not contamination of the sample. The MHA_0579 C-His antibody detected the 
higher MW bands in the sample lanes confirming their identity as MHA_0579 C-His 
dimers. The band of MHA_0579 C-His monomer with DTT present was at the expected 
size. In the absence of DTT, the intensity of the monomer band seen on the western blot 
diminished. This was also observed with APP Gly1, where neither dimers nor monomers 
were detected at all in the absence of DTT. This could be because of multimer formation 
at concentrations too low to be detected by the antibody, which decreased the amount 
of protein in monomer form.  
The dimers detected in SARI C-His samples were much more intense than those 
observed on the SDS-PAGE gel. Again, no dimers were observed in the MHpara western 
blot in the samples lacking DTT. However, at the highest dilution a higher molecular 
weight band was observed in the samples with DTT present. This may be a result of the 
higher concentration of protein used allowing visualisation of these dimers. The higher 
MW band in the APP Gly1 Coomassie gel was not detected in the western blot, 
confirming it as a contaminant. The samples lacking DTT ran at a slightly lower molecular 
weight than those with DTT.
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Figure 5.4. Western Blot Confirmation of Protein Dimerisation. 
Confirmation of multimer formation using custom made antibodies to each protein. 
Protein concentration 1 mg/ml in ‘Neat’ lanes, dilutions made of this. Proteins diluted 
1:2 in loading dye and separated by SDS-PAGE. Cognate antibodies or antisera used for 
each. Proteins boiled for 3 minutes at 100 °C in loading dye with or without DTT prior to 
loading onto gel. N = 3.  
 
As dimerisation may not necessarily occur through these cysteine disulphide bridges, 
glutaraldehyde was also used to stabilise any other interactions between these putative 
homologue monomers by creating cross-links between residues in close proximity. At 
sufficiently high concentrations, glutaraldehyde can cause artificial binding, so lysozyme 
was again used as a negative control.  
Dimers were observed in the MHA_1205 C-His, MHA_0579 C-His and SARI C-His at a 
glutaraldehyde concentration lower than that required for lysozyme dimerization, 
supporting the results observed in the disulphide assay. MHpara and APP Gly1 also 
showed dimerization at this concentration of glutaraldehyde, suggesting that the dimer 
interface involves residues other than cysteine (Figure 5.5).  
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Figure 5.5. Analysis of Multimer Formation of Gly1 Homologues Subjected to Cross 
Linking.  
Multimer formation was analysed using increasing concentrations of glutaraldehyde to 
stabilise protein interactions. Lysozyme was used as a negative control. Glutaraldehyde 
percentage stated above each lane. Protein concentration used 1 mg/ml, diluted 1:2 in 
loading dye containing DTT and separated by SDS-PAGE. Images representative of three 
repeats. 
 
Confirmation of these higher molecular weight bands as the protein of interest was 
again performed using protein-specific antibodies (Figure 5.6). DTT was added to the 
protein samples prior to boiling after glutaraldehyde incubation. The higher percentages 
of glutaraldehyde (0.5% and 1%) created many species of oligomeric protein throughout 
the protein solutions analysed, but these were unlikely to be naturally occurring as 
lysozyme also formed multimers at these concentrations of cross-linker. The Gly1 
homologues did, however, form higher oligomers more readily at the high 
glutaraldehyde concentrations than lysozyme. 
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Figure 5.6. Confirmation of Multimer Identity by Western Blot.  
Confirmation that the higher MW bands were indeed the protein of interest in multimer 
form (where antibodies were available). Percentage of glutaraldehyde added shown 
above each lane. N = 3. 
 
5.2.3 Putative Gly1 Protein Interactions 
As discussed in the introduction, bacterial haem uptake systems involve a number of 
proteins located in different areas of the cell, each with differing functions. To further 
investigate the function of these putative Gly1 proteins of M. haemolytica, the 
polyhistidine tagged MHA_0579 and MHA_1205 were immobilised to a metal chelate 
probe on the BLItz (ForteBio). Antibodies were used as positive controls to ensure initial 
binding or ‘loading’ of the protein had occurred.    
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Figure 5.7. MHA_0579 C-His - M. haemolytica Protein Interactions.  
A Ni-NTA probe was used to immobilise the polyhistidine tagged proteins (loading). Non-
tagged proteins were then added to assess interactions (association) and washed 
(dissociation). No binding was seen between Mannheimia proteins. The Kd of anti-
MHA_0579 C-his antibodies was estimated to be 4.2 x 10-8 M ± 3.13 x 10-8 SD, at 
0.1mg/ml.  PhuT and MHpara alone did not bind to the probe (data not shown). N = 4. 
 
As MHA_0579 was predicted to be an outer membrane protein, it is conceivable that it 
is involved in the initial cellular binding of haem from exogenous sources such as host 
hemoproteins or the bacteria’s own hemophores for example. To see if MHA_0579 
interacted with PhuT or MHpara these proteins were added to the probe after pre-
loading with MHA_0579 C-His. No additional binding was witnessed with either of these. 
The anti-MHA_0579 C-His antibody did display binding to the immobilised protein with 
a mean Kd of 4.2 x 10-8 M ± 3.13 x 10-8 SD (Figure 5.7).  Quantification of haem binding 
by this method was not possible at this time. 
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Figure 5.8. MHA_1205 C-His - M. haemolytica Protein Interactions.  
The Kd of MHA_1205 C-His antisera binding to the Kd was not calculated due to an 
unknown antibody concentration. PhuT appeared to show a weak interaction with the 
MHA_1205 C-His giving a mean Kd of 5.6 x 10-3 M ± 3.37 x 10-3 SD. PhuT and MHpara 
alone did not bind to the probe (data not shown). N = 3. 
 
MHA_1205 C-His displayed binding to the probe and subsequently to antibodies within 
the rat antisera. A slight increase in the curve when PhuT was incubated with the pre-
loaded probe gave an indication of MHA_1205- PhuT interaction, with an estimated Kd 
of 5.56 x 10-3 M ± 3.37 x 10-3 SD on average (Figure 5.8).  
5.2.4 MHpara as a lysozyme Inhibitor 
The predicted tertiary structure of MHpara was based on that of a lysozyme inhibitor, 
PliC. These lysozyme inhibitors are an important factor in bypassing the host defence 
system. To assess whether the MHpara protein was also involved in lysozyme 
interactions, the two proteins were incubated together in the presence of 
glutaraldehyde.  
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Figure 5.9 Lysozyme Interactions with MHpara  
The first two lanes show MHpara and lysozyme alone, followed by the individual 
proteins incubated with 0.1% glutaraldehyde. The latter two lanes show the proteins 
incubated together in the absence and presence of glutaraldehyde, respectively. 
Proteins of 1 mg/ml were used and diluted 1:2 in loading dye and separated by SDS-
PAGE. Image representative of three repeats.  
 
The MHpara protein and chicken egg lysozyme both displayed the formation of a small 
proportion of dimers when incubated with 0.1% glutaraldehyde. The monomers 
together in the absence of glutaraldehyde did not show any higher molecular weight 
bands indicative of binding. The higher molecular weight band at approximately 28 kDa 
was observed when the two proteins were incubated together (final lane, Figure 5.9) to 
a greater degree than that seen MHpara alone but appears to have migrated through 
the SDS-PAGE gel at the same speed, suggesting a similar MW. 
5.2.5 Interactions of MHpara with Respiratory Tract Tissue 
During the course of this project, the annotated name of the MHpara protein on the 
NCBI database was updated to ‘adhesin’. Based on this and the facts that 1) the 
predicted interactions with haem, hemin or haemoglobin were not seen in any of the 
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experiments performed, and 2) the lysozyme interaction results did not convincingly 
suggest binding, the MHpara protein was tested for its ability to interact with respiratory 
tract tissue of pigs. M. haemolytica generally infects cows and sheep, however serotypes 
A1, A2 and A9 have been isolated from the porcine lung on occasion (Fodor et al., 1999).  
 
Figure 5.10 Alignment of Mature Protein Sequences of MHpara and ACP N. 
meningitidis Adhesin.  
The two amino acid sequences aligned highlighting the identical 42% amino acid identity 
in the mature protein. Residues shaded black are identical, those shaded grey are similar 
residues but not identical. 
 
The predicted tertiary structure of ACP was deduced using the Phyre2 server and this 
predicted structure was then aligned with the solved structure of MHpara (Figure 5.11). 
The structures had a high degree of similarity displaying the same characteristic 
antiparallel beta sheets of the Gly1 family. The predicted structure was based on the 
same protein used for the predicted structure of MHpara, PliC (Chapter 3, Figure 3.16).  
If these proteins are indeed structurally this similar it is possible that they also share a 
common function, shown to be adhesion in the case of ACP. 
MHpara       1 AGEQSDAREAHESTVKTSTVKYSCQNGKKLSVKYGFNKQGIPTYAEAKLSGKKRFMPINL 
ACP          1 AGTDN-------PTVAKKTVSYVCQQGKKVKVTYGFNKQGLTTYASAVINGKRVQMPVNL 
consensus    1 **           **   ** * **.***. * *******. *** * . **. .**.** 
 
MHpara      61 YTTDATGTNFGDENNFSLYGDPMEFTNHRKASVNIQSPASEILYKGCTPQK 
ACP         61 DKSDNVETFYGKEGGYVLGTGVMDGKSYRKQPIMITAPDNQIVFKDCSPR-        
consensus   61   .*   * .* *  . *    *.    **  . *  *  .*. * *.* 
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Figure 5.11 Predicted Structure of ACP and Aligned with MHpara.  
Panel A, B and C show the predicted structure of ACP generated by the Phyre2 server in 
three orthogonal views rendered in Pymol. Panel D and E show ACP (cyan) aligned with 
MHpara (magenta) from two orthogonal views. The predicted tertiary structure of the 
N. meningitidis adhesin ACP was based on the crystal structure of PliC, periplasmic 
lysozyme inhibitor of c-type2 lysozyme from Salmonella typhimurium. The motif 
YGFNKQG is highlighted in yellow on MHpara and red on ACP in panels D and E. 
 
M. haemolytica infections are known to take hold in the lower respiratory tract and lung 
as a result of inhalation of bacteria from the upper respiratory tract following excess 
growth in an immunocompromised animal. Adhesion is an important virulence factor, 
and targeting this method of colonisation could potentially prevent infection. Based on 
this new information, adhesion studies of the MHpara protein were conducted. An initial 
optimisation assay using a range of dilutions led to the use of MHpara at 20 µg/ml in 1 
x PBS for interactions with the porcine respiratory tract transverse sections. The initial 
concentration of FITC-labelled BSA used in the protocol was in excess at 2 mg/ml. The 
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labelling of the proteins with FITC was assessed prior to use. Both labelled proteins 
fluoresced under UV light while the proteins alone did not, showing successful FITC 
labelling (data not shown). Sections of upper and lower trachea and lung were stained 
with haematoxylin and eosin (H and E) to highlight the different structures present in 
the cross-sections (top panel, Figure 5.12). Upper trachea sections were taken from the 
region inferior to the larynx whereas the lower trachea sections were taken from the 
area superior to the bronchial bifurcation. This staining clearly shows the epithelial layer 
on the inside of the trachea section and the cartilage on the outer edge of the upper 
trachea. The tough texture of the cartilage was problematic during sectioning of the 
tissue which led to some damage, however, sufficient slides had areas containing an 
intact epithelium which were focussed on in each of the repeats.  
Figure 5.12 shows a section of upper trachea incubated with FITC labelled BSA. DAPI was 
used to stain the cell nuclei throughout. One small point of green fluorescence was 
visible in the FITC-BSA control in one repeat, but the trachea was otherwise unstained. 
When compared to the section incubated with FITC labelled MHpara the difference was 
very apparent, with widespread staining seen throughout the epithelia and, to a lesser 
degree, fluorescence in the mucosa. These images are representative of three repeats 
and support the theory that MHpara is able to adhere to animal epithelial tissue. 
Unfortunately, no bovine trachea samples were available at the time to allow for inter 
species comparisons, however, different sections of the porcine respiratory tract were 
investigated to assess interactions with the different surfaces potentially exposed to the 
bacteria during infection.  
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Figure 5.12. MHpara Adhesion to Porcine Upper Trachea Tissue.  
The top panel shows an H and E stained section of the upper trachea of the pig, 
highlighting the epithelial lining. The lower left panel shows the FITC labelled BSA control 
and the lower right panel, the FITC labelled MHpara lighting up the tissue. The scale bar 
is 0-75 µm, and the same magnification was used for each section. Repeats were 
performed on similar sections of tissue and the above images are representative of 
these. N = 3. 
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Sections were also taken from the lower respiratory tract of the porcine tissue superior 
to the bronchus branching. This area of the respiratory system has slightly different 
morphology to the upper respiratory tract, as the epithelial layer contains fewer goblet 
cells and the height of the epithelial cells decreases towards the bronchi. The negative 
controls were the same as for the upper trachea, displaying no detectable green 
fluorescence at all. The labelled MHpara protein displayed some interactions with this 
section of the respiratory tract as shown by a low level of green fluorescence. However, 
this was barely visible on the image, which suggests that binding was not occurring to 
the same degree (Figure 5.13). No binding was seen between MHpara and the porcine 
lung tissue (Figure 5.14)
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Figure 5.13 MHpara Adhesion to Porcine Lower Trachea Tissue. 
No MHpara staining was seen in the control slides. Faint green colouring is visible on the 
outer edge of the epithelial layer of the MHpara-FITC incubated section (to the right 
hand side of the blue DAPI staining). The scale bars in the lower right corners are 0-50 
µM. 
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Figure 5.14 MHpara does not Adhere to Porcine Lung Tissue.  
No staining was observed after incubation of porcine lung sections with MHpara-FITC 
protein. N = 3, images are representative of repeats. Scale bars 0- 75 µm. 
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To analyse the location of fluorescent labelling on the cells, confocal microscopy was 
used within the departmental core facility. This showed that the MHpara-FITC 
fluorescence was mainly located on the lumen side of the epithelial layer (Figure 5.15). 
This supports the theory that MHpara is an adhesin of the upper respiratory tract.  
 
 
Figure 5.15 Confocal Microscopy of Porcine Respiratory Tract Sections.  
Comparison between the PBS negative control and the MHpara-FITC labelled protein. 
40x magnification. 
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5.3 Discussion 
This chapter demonstrated that polyclonal Gly1 antisera in general showed no cross-
reactivity for the putative Gly1 proteins analysed across species, reducing their potential 
as broad antibacterial targets. An exception to this was the SARI C-His Gly1 antisera, 
which demonstrated cross reactivity to MHA_1205, MHA_0579 and to a lesser extent N. 
meningitidis Gly1. Antibodies against the M. haemolytica putative Gly1 proteins did not 
cross react with other M. haemolytica Gly1 proteins, possibly due to the limited 
similarity between the amino acid sequences. 
The putative Gly1 homologues displayed different homo-multimer formation to each 
other, suggesting that they each have different biological functions. Homo-multimers 
were observed in the absence of DTT with MHA_0579 C-His, MHA_1205 C-His and SARI 
C-His. Dimers of MHA_1205 C-His were observed at a higher proportion relative to those 
of MHA_0579 C-His when compared to the intensity of the monomer band, which could 
suggest that it forms these dimers more readily. SARI C-His also formed dimers although 
these were more evident in the western blot than the SDS-PAGE gel, which is possibly 
due to the high sensitivity of the antibodies to the protein present compared to the 
Coomassie stain. Disulphide bonds between cysteine residues can be intermolecular or 
intramolecular, and breaking these intramolecular bonds possibly led to the protein 
opening out and passing through the gel more slowly than the relatively compact 
bonded protein. 
The differences in dimerisation seen between the proteins could be a result of the 
location of the two cysteines in the processed protein tertiary structure, or simply the 
lower percentage identity to each other leading to differing interactions, suggesting 
again that these proteins behave in a different manner. The high proportion of dimers 
formed suggests that dimerisation may be important for the function of MHA_1205.  
Due to the lack of structural information about these proteins at the time of writing we 
cannot judge how these disulphide bridges may form in terms of amino acid residue 
proximity, and therefore how the monomers may interact with each other. This 
interaction could provide clues as to the mechanism of haem binding of these proteins, 
such as creation of binding pockets, and also further information of their role within this 
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nutrient uptake system. Czjzek et al discovered a dimeric form of the HasA hemophore 
in S. marcescens where each monomer bound haem in a 1:1 ratio (Czjzek et al., 2007). 
The dimer was a proposed haem reservoir as it had to revert to the monomer form to 
interact with the receptor, HasR, to deposit the haem. This dimerisation was found to 
occur by domain swapping, which cannot be ruled out as the dimerisation mechanism 
between the putative Gly1 homologues as the disulphide bridges could form as a result 
of this movement. 
Neither MHpara nor APP proteins formed dimers in the absence of DTT, and as neither 
of these proteins displayed any interactions with haem this provides more evidence to 
suggest that they are not closely related to the other putative Gly1 homologues in terms 
of behaviour. Transient interactions are possible, but the glutaraldehyde cross linking 
should have accounted for this and again this showed the protein was negative for 
multimers at the optimal glutaraldehyde concentration. PhuT on the other hand 
appeared to form dimers very readily, which has been observed with other Gram-
negative bacterial haem PBPs even when interacting with haem in a 1:1 ratio, providing 
further support for PhuT as a haem PBP (Mattle et al., 2010, Ho et al., 2007). With a high 
initial protein concentration, dimers of MHpara were observed as seen with 0.1% 
glutaraldehyde, but this was a low proportion compared to the monomers present. 
A limited number of solved crystal structures of haemoglobin and hemin outer 
membrane receptors have been published to date, and all of these are in monomer 
form. It is interesting therefore that the predicted OM protein MHA_0579 C-His, which 
has been shown to interact with hemin, was also seen to form dimers. The dimers were 
only visible on SDS-PAGE gels when loading higher concentrations of protein. It is 
possible that the lower proportion of dimers seen were an artefact of the experimental 
conditions and the MHA_0579 protein does not form dimers to a physiologically 
relevant extent in vivo. It would be interesting to compare the production of this protein 
under different growth conditions as a large up-regulation of transcription could provide 
clues as to the likelihood of dimerisation to a meaningful extent in vivo.  
As shown by the bipartite OM receptor in the lactoferrin uptake system, both proteins 
can bind iron to enable uptake into the cell but have different roles in the uptake 
process. The predicted cellular locations of MHA_1205 and MHA_0579 possibly suggest 
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different haem uptake roles. It is possible that the identified potential Gly1 homologues 
and paralogues work within the haem uptake system but have different roles. Sprencel 
et al identified interactions between the siderophore, OM receptor and PBP of the Fep 
iron uptake system of E. coli (Sprencel et al., 2000). The predicted cellular location of the 
proteins was the outer membrane for MHA_0579, and the periplasm for MHA_1205 and 
PhuT. The cellular location of MHpara was not conclusively predicted (Chapter 3, Table 
3.4). This again points to different roles within the cell. It is unknown whether PhuT is 
the PBP used by the system involving any of the M. haemolytica Gly1’s; one of these 
Gly1 homologues could be a haem PBP itself. The weak interaction between PhuT and 
MHA_1205 C-His provides some evidence to further support the theory that MHA_1205 
is involved in the haem uptake pathway as a whole, although it does not provide any 
indication on the particular role within the system. In the presence of an interaction 
partner such as hemin this binding affinity may change.  
Outer membrane proteins tend to be larger than 20 kDa in size, however, the 
MHA_0579 protein was predicted to be around 13.7 kDa in its processed form. We know 
that transferrin and lactoferrin outer membrane receptors are bipartite, formed of two 
distinct monomers, each of around 75- 100 kDa. It has also been demonstrated that the 
hemophores, e.g. HasA, interact with an outer membrane receptor such as HasR. The 
results of the interaction studies performed in this project suggested that the Gly1 
proteins of interest did not interact with each other. This does not rule out the possibility 
that they function as part of different haem uptake systems, as some bacteria are known 
to have multiple acquisition methods as seen with the multiple haemoglobin receptors 
in N. meningitidis (Tauseef et al., 2011). It is also possible that the proteins require haem 
to interact, as this can induce conformational changes. Interestingly, PhuT was observed 
to interact with MHA_1205 C-His, which may indicate MHA_1205 as having a chaperone 
type role in the periplasm. 
In addition to analysing individual interactions with known proteins using the BLItz 
technology, use of a bacterial two-hybrid system to screen a greater number of potential 
binding partners for these proteins would provide further insight. Again, confocal 
microscopy using specific antibodies would provide important information to clarify the 
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cellular location of the individual proteins, and from this a greater idea of the function 
of said proteins. 
The comparison of the solved and predicted tertiary structures of MHpara highlighted 
the structure as similar to that of PliC from S. typhimurium, a lysozyme inhibitor. This 
protein shares a high degree of similarity in terms of the overall structure with MliC of 
P. aeruginosa despite only sharing 27% identity in the aligned regions (Leysen et al., 
2011). Based on this, glutaraldehyde was used to analyse any interactions between 
MHpara and chicken egg lysozyme. The results of this did not show binding but were not 
fully conclusive, with a higher MW band detected but no way of confirming the presence 
of lysozyme in the dimer at this point. If this higher molecular weight protein band was 
the product of lysozyme and MHpara, it would potentially be a lower MW than that seen 
faintly in the MHpara alone lane than a MHpara dimer depending upon the manner of 
interaction. This did not appear to be the case, suggesting that it was not the product of 
MHpara and lysozyme interacting with each other. Chicken egg lysozyme and bovine 
lysozyme are the same class (C class) but only share around 20% sequence identity, 
which could present a reason for the lack of perceived interaction. A lysozyme antibody 
could also be used to check for protein co-localisation. 
Further analysis revealed that the MHpara protein had an entirely different function. In 
N. meningitidis, an adhesin of similar size to the MHpara protein was described by Hung 
et al (Hung et al., 2013). This highly conserved 124 a.a., 13.3 kDa Adhesin Complex 
Protein (ACP) is the product of gene NMB20925 in Neisseria meningitidis strain MC58 -
the same strain used in the Sayers lab for Gly1 investigations. Meningococcal cells 
expressing ACP were shown to adhere in vitro to Chang, Hep2, HUVEC and meningioma 
cells significantly more than ACP knock out strains, with the highest level of adhesion 
observed to epithelial cell lines. This protein has a predicted 22 a.a N-terminal signal 
peptide and shares approximately 25.6% identity with the unprocessed MHpara protein, 
and 42% when comparing the mature proteins (see Figure 5.10). The ACP protein also 
demonstrated significant complement-mediated bactericidal activity in the same study.  
This protein was found in the OM and OM vesicles, and was upregulated in conditions 
of iron paucity (Grifantini et al., 2003). Antibodies to ACP promoted complement 
mediated killing and one of three types of ACP identified was found in all investigated 
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strains (Hung et al., 2013). Adhesion studies were therefore conducted with the MHpara 
protein.  
Porcine respiratory tract was used, which bears similarity to bovine and ovine 
respiratory tract in terms of epithelial cell types. It has been shown that M. haemolytica 
displays species specificity in terms of colonisation and pathogenicity. However, the 
aims of this study were to assess protein- epithelial cell binding. The host species 
specificity is thought to be due to differences in bacterial OM proteins and recognition 
by alveolar macrophages in terms of bovine and ovine infection (Hounsome et al., 2011). 
Adhesion of the MHpara protein was observed in the trachea but not in the lung. The 
main differences between these sections of the respiratory tract are the epithelial lining 
and the presence of either mucous or pulmonary surfactant in the trachea and lung 
respectively. The binding seen in vitro of MHpara to the epithelial cells of the trachea 
occurred on formaldehyde preserved tissue. It is likely that the mucous layer normally 
present on airway epithelial cells was lost during the tissue fixation process which may 
have influenced the results, therefore it would be beneficial to do further work using 
air- liquid interface (ALI) techniques to recreate an environment closer to that occurring 
in vivo to deduce whether or not this binding still occurs, or in an appropriate animal 
model. 
The most reliable method of assessing M. haemolytica infection in vivo is using bovine 
models of disease, however, use of this method is limited by cost. Mouse models of 
disease have had variable success (Gatto et al., 2006, Jian et al., 1991). A ‘bovinised’ 
mouse model of M. haemolytica infection has recently been described (Stellari et al., 
2014) although this concentrates on bovine IL-8 expression within the mouse. Issues 
with the murine model included rapid clearance of bacteria, and different types of lung 
lesions to those observed in larger mammals. An animal model of infection would be 
useful to observe the differences between infection with wild type and MHpara null 
mutant strains. 
While small animal disease models are available for A. pleuropneumoniae infection 
(Bhatia et al., 1991), Katribe et al published a study showing that S. enterica arizonae 
strains IIIa and IIIb were unable to infect the murine host, possibly due to the preference 
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for cold blooded animals, and therefore were not a viable infection model to study knock 
out strains of these organisms in the future (Katribe et al., 2009, Chiang et al., 2009).  
In conclusion, MHpara appears to be a bacterial adhesin based on the respiratory tract 
interaction study. The other M. haemolytica putative Gly1 proteins do not interact with 
each other. They were, however, shown to form dimers by disulphide bridges where the 
MHpara and APP proteins did not, and could comprise different parts of a haem uptake 
system in M. haemolytica, A. pleuropneumoniae and S. enterica arizonae. While 
MHA_1205 interacted with PhuT, the significance of this needs further investigation. 
The function of APP Gly1 remains elusive. 
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6. Screening BRD Bacterial Isolates for Gly1 homologues 
6.1  Introduction 
The genome sequences of M. haemolytica available on the NCBI database are of known 
invasive isolates- A1, A2 and A6. This is a limited selection considering that 12 strains 
have been identified to date after a number of reclassification events within the genus 
as a whole. These three strains are, however, the most clinically significant as they are 
the most common serotypes isolated from diseased animals, with A1 making up the 
majority of disease cases. The NCBI database also describes an A1/A6 cross-reactive 
isolate; a proposed novel strain of M. haemolytica taken from the spleen of a pneumonic 
white tail deer (Lawrence et al., 2014).  
The prevalence of different M. haemolytica isolates has been studied in countries such 
as Hungary, Denmark, USA, and Canada. Of these, the serotypes of strains found in 
cattle, sheep and goats have been deduced where possible, although some remain 
untypable.  Similar strains are predominant in different countries, for example in both 
Northern Ireland and Hungary strains A1 and A2 were most commonly isolated, 
comprising approximately 60% and 20% of isolates, respectively (Fodor et al., 1999, Ball 
et al., 1993). This is a trend repeated in many regional studies. Pasteurellosis in sheep is 
most commonly caused by serotype A2, but the ovine host is also colonised by a much 
wider range of M. haemolytica serotypes than cattle or goats and A6 and A9 have also 
been found to contribute to the ovine bacterial fauna in high percentages (Odendaal 
and Henton, 1995). There has been an increase in the number of the ‘less common’ 
serotypes being isolated globally, although it is unclear if this is as a result of a wider 
research interest in BRD or to an actual increase in the prevalence of these strains. The 
serotypes differ mainly in the makeup of their capsule, outer membrane proteins and 
LPS types (McCluskey et al., 1994).  
Sequence analysis for this project showed that one or more of the potential Gly1 
homologues of M. haemolytica was found in 16 out of the 20 available genomes on the 
NCBI database. The paralogue was identified in all but one; the presumed M. 
haemolytica strain isolated from deer that displays a clear variation from others 
characterised to date. The only strain of A. pleuropneumoniae that had a potential Gly1 
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was 6 FEMØ out of the 20 strains on the database. In Salmonella, of all the hundreds of 
genome sequences currently available, only one serotype had a possible candidate as a 
Gly1 homologue- S. enterica arizonae (IIIa).  
For Gly1 proteins to be a plausible target for a vaccine they would have to be expressed 
in a high percentage of the known pathogenic serotypes and their various isolates to 
allow for Gly1 specific antibodies to direct killing of the cells in question. The aims of this 
chapter are to assess the prevalence of the Gly1 genes as potential vaccine targets by 
screening a selection of Mannheimia field isolates. Therefore the aim of the work 
described in concentrated on M. haemolytica, aiming to investigate the presence of Gly1 
proteins in a variety of isolates from England. Isolates were obtained from the RVC and 
AHVLA, and their identity investigated by culture techniques and 16S gene analysis. 
Primers were designed to detect Gly1-like genes within these isolates, and any 
sequences obtained were analysed.
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6.2 Results 
6.2.1 Isolate Identification 
Confirmation of the identification of donated isolates as M. haemolytica was carried out 
prior to screening. As the samples were mainly bovine isolates obtained from 
pneumonic animals, there was a risk of contamination with other Pasteurellaceae 
species such as others implicated in BRD complex. Original identification methods of the 
individual strains (where labelled) were not known due to the age of the samples 
received from the Royal Veterinary College (RVC) and uncertainty over the methods 
used on the samples from the Animal Health and Veterinary Laboratories Agency 
(AHVLA). Initial growth on horse blood agar plates was assessed alongside growth on 
MacConkey agar plates. M. haemolytica colonies appear small, circular and grey on 
blood agar plates, and as the name suggests display some weak beta-haemolytica 
activity caused by leukotoxin, which is especially prominent on sheep blood agar. When 
streaked on MacConkey agar plates M. haemolytica either does not grow or forms very 
small circular pink colonies after 48 hours. This is due to the ability to ferment lactose, 
albeit weak. Lactose fermenting bacteria internalise the neutral red pH sensitive dye 
found in the MacConkey agar and as a result turn pink.  
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Figure 6.1. Confirmation of Identity of Isolates by 16S RNA PCR Screening.  
16S primers (see Primer Table 2.4) were used to show that sufficient genomic DNA was 
present in the colony boilate, and confirm PCR success. PCR with Lkt primers showed 
that isolates 234, 351 and 362 were positive for M. haemolytica, while 292, 296, 311 and 
414 were not. Samples separated by agarose gel electrophoresis. This was repeated with 
all RVC isolates. Negative controls lacking either the genomic DNA or primers were also 
used throughout (data not shown). 
 
Based on these results, the AHVLA isolates 234, 235, 351, 362 and 428 were positively 
identified as Mannheimia species. Strains 296 and 311 grew as large, yellow, E. coli- like 
colonies, suggesting either contamination of the samples received or incorrect samples. 
Isolate 411 did not grow at all and 414 did not grow in liquid culture preventing the 
creation of freezer stocks for further growth-based analysis. This initial screening was 
repeated for the RVC isolates, of which all but A7, A10 and MH9 A2 grew on MacConkey 
agar appearing as small pink colonies.  
Further identification procedures were based on the paper by (Alexander et al., 2008). 
Universal 16S primers were used to confirm PCR success, and M. haemolytica Lkt-
specific primers were used to identify the M. haemolytica positive samples (Figure 6.1). 
PCR was performed on the extracted isolate DNA and products were purified and sent 
for sequencing allowing for sequence comparison. The 16S sequencing for the strain 
named A10 did not align with the M. haemolytica 16S sequences in the database. The 
bacterial isolate was named A10 when it was isolated and characterised in 1975, prior 
to a number of reclassification events. The strain was subsequently called T10 when the 
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Pasteurella species was split into A and T biovars, followed by further reclassification as 
B. trehalosi. The isolate named A10 was confirmed by a BLASTn search of the amplified 
gene sequence to be this species, which showed sequence identity with a 303 bp 
fragment of B. trehalosi 16S. Using this method, isolate p28 was identified as M. 
varigena.  Isolate 414 16S sequencing shared 100% identity with E. coli, a result that was 
confirmed by the 23S sequencing. The 23S primers were also used as a further aid to 
identification of the strains, and all 23S sequences supported the 16S results.  A 
summary of the isolate identification results is displayed in Table 6.1.
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 16S Lkt Lkt2 23S Growth on 
MacConkey 
M. 
haemolytica? 
A10 * - -  N B. trehalosi 
A12   -  Y* Y 
P28 * - -  Y* M. varigena 
A1   -  Y* Y 
A7   -  N Y 
A9   -  Y* Y 
CO2392   -  Y* Y 
CO0600   -  Y* Y 
CO4178   -  Y* Y 
CO3983   -  Y* Y 
CO3916   -  Y* Y 
Gilly   -  Y* Y 
CO0353   -  Y* Y 
MH4 A8   -  Y* Y 
MH8 A5   -  Y* Y 
MH9 A2   -  N Y 
A6   -  Y* Y 
CO2008   -  Y* Y 
CO1250   -  Y* Y 
234   -  Y* Y 
235   -  Y Y 
292 * - -  Y Acinetobacter 
296 * - -  Y mix 
311 * - -  Y E. coli 
351   -  N Y 
362   -  N Y 
411 N/A N/A N/A N/A N/A ? 
414 * - -  N E. coli 
428     N M. glucosida 
 
Table 6.1 Isolate Identification Summary.  
A summary of the genes present in each isolate according to PCR and growth on 
MacConkey agar plates. The 16S* refers to genes that were amplified but do not 
correspond to Mannheimia 16S genes in the NCBI database. If small pink colonies grew 
on MacConkey agar, Y* is denoted. N/A here indicates that the 411 strain did not grow 
at all, even after repeated attempts with fresh stocks. 296 was a contaminated stock of 
M. haemolytica. 
 
Sequencing of the gene fragments amplified by the 16S, Lkt, Lkt2 and 23S primers 
assisted with further identification of the isolates. The primer set designed to amplify 
the Lkt2 fragment of the leukotoxin gene in Mannheimia species was used to identify 
180 
 
M. glucosida.  Isolates 234, 235, 351 and 362 of the AHVLA set were determined to be 
M. haemolytica based on BLASTn searches of the sequenced PCR products, as were all 
the RVC isolates that were positive for Lkt. Isolate 428 from the AHVLA was deemed to 
be M. glucosida as 16S sequencing reported matches to both M. haemolytica and M. 
glucosida, Lkt sequencing suggested Mannheimia species but the presence of the Lkt2 
gene fragment confirmed M. glucosida was present within this sample (Figure 6.2).   
  
 
Figure 6.2. Mannheimia Isolate Identification.  
The Lkt2 primers amplified a fragment of approximately 160 bp in isolate 428. 
Sequencing results used in a BLASTn search matched the Mannheimia glucosida strain 
PH290 lktCABD operon, aligned with the 428 Lkt2 sequences above (accession number 
AF314517). 
 
Lkt2_428R    1 --------------------------CGTAGTCGATCTTCTTCCGATGA-TCGTTAAATTCGGTTTTAGATA 
LktABCDop    1 ATTGCTCCTCAATTAAGTGTTTAATACGTAGTCGATCTTCTTCCGATGAATCGTTAAATTCCGTTTTAGATA 
Lkt2_428F    1 ATTGCTCCTCAATTAAGTGTTTAATACGTAGTCGATCTTCTTCCGATGAATCGTTAAATTCGGTTTTAGATA 
consensus    1 ..........................***********************.***********.**********     
 
 
Lkt2_428R   73 AATCAATCACCGGCAATGACTCGTTTTCAATGGCAGTCAGTAATGTTTGGTAGCGATAGTT 
LktABCDop   73 AATCAATCACCGGCAATGACTCGTTTTCAATGGCAGTCAGTAATGTTTGGTAGCGATAGTT 
Lkt2_428F   73 AATCAATCACCGGCAATGACTCGTTT-CAATGGCAGTCAGT-------------------- 
consensus   73 **************************.*** 
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6.2.2 PCR Screening  for Gly1 Homologues 
Once isolates had been identified as Mannheimia strains, PCR sequencing was 
performed with sets of gene-specific primers designed using information from the NCBI 
database genomes (Chapter 2, Table 2.4). This method was chosen as initially only the 
Mannheimia isolates donated by the AHVLA were available for screening. The RVC 
isolates were then also screened using this method with the same primer sets for 
continuity. A summary of the screening results can be seen in Table 6.2.  
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 A (MHA_0579) D  H (MHpara) J (COI_1584) L  M  PhuT HmbR 
A12  COI_1584  ?  MHA_1205   
A1    ?  COI_1584   
A7 - -  - - -   
A9  -  ?  COI_1584   
CO2392 - - * - - - -  
CO0600 -   I to F ?  MHA_1205   
CO4178    ? MHA_1205 MHA_1205   
CO3983   - ? MHA_1205 MHA_1205   
CO3916 - -  - - -   
Gilly     ? MHA_1205 MHA_1205   
CO0353   - ? MHA_1205 MHA_1205   
MH4 A8 * COI_1584  ?  COI_1584   
MH8 A5  -  ?  COI_1584   
MH9 A2 - -  - - -   
A6   - ? MHA_1205 MHA_1205   
CO2008    ? MHA_1205 MHA_1205 -  
CO1250    ? MHA_1205 MHA_1205   
234 - COI_1584  *  * COI_1584   
235  - - -  -   
296 - COI_1584 - - - - - - 
351 - COI_1584    COI_1584   
362 - - * - MHA_1205 -   
428 - - - - MHA_1205 - - - 
Table 6.2 Summary of Positive PCR Screening for gly1 Genes.  
Results of screening donated bacterial isolates for genes of interest. Full sequencing of the HmbR PCR products was not performed. Partial 
sequencing confirmed the gene identity.  Ticks indicate the presence of the expected gene with each particular primer set, alternative genes 
found with each primer set are stated in the corresponding box, and those with slight differences are indicated with an asterisk. D, L and M 
sets designed to detect MHA_1205, COI_1584 and L280. Sets A-M were designed to detect homologues and the paralogue.
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Isolate 428 was identified as Mannheimia glucosida rather than M. haemolytica which 
could explain the lack of positive results for gly1 genes such as MHpara and HmbR. M. 
glucosida is found primarily in sheep and along with M. haemolytica is a cause of ovine 
mastitis.  
No whole M. glucosida genomes have been uploaded to the NCBI database at present 
(July 2015), and all M. glucosida genes that have been uploaded have been the target of 
a specific study e.g. that of the transferrin binding receptor (Lee and Davies, 2011). This 
study also investigated the process of horizontal gene transfer between M. haemolytica, 
M. glucosida and P. trehalosi, although the transferrin binding protein ‘tbpA’ gene is 
believed to be conserved due the evolution of the species from a common ancestor 
potentially supporting the theory that putative gly1 genes are present in these 
pasteurellaceae species. Sample 428 was isolated from sheep which may explain why a 
positive result was seen with primer set L, with the sequence of the PCR product showing 
the MHA_1205 gene. The NCBI searches may not have identified a gly1 gene within M. 
glucosida due to lack of information on the database. Horizontal gene transfer may 
indeed have led to the presence of an exact copy of the MHA_1205 Gly1 gene in the M. 
glucosida strain that was analysed. Alternatively it could suggest that the sample was 
contaminated with M. haemolytica due to co-isolation, although prior screening did not 
detect this.  
Isolate 362 was identified as M. haemolytica, yet was negative for the gly1 genes 
screened for. It does contain the paralogue and both the haemoglobin receptor HmbR 
and the periplasmic hemin binding protein PhuT showing that it is M. haemolytica. This 
isolate was bovine in origin, whereas 351 was isolated from an ovine host. There are 
reports of differences between Mannheimia isolated from the two host species at 
protein level, for example with OmpA proteins. The serotype of both isolates was 
unknown.  The differences observed between M. haemolytica isolates found in different 
hosts could account for this variation, as could the serotype of the isolates.  
Isolate 296 was contaminated with another bacterial strain. It presented as large 
colonies that outgrew M. haemolytica. PCR using primers for the MHA_1205 gene 
resulted in the corresponding sequence, indicating that M. haemolytica was present in 
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the culture. Sequencing was performed with primer set D, intended to screen for the 
gene coding for MHA_1205. It instead amplified the gene COI_1584, although this has 
two silent mutations at the gene level compared to that sequence (Figure 6.3). 
 
Figure 6.3 Screening Isolate 296 for MHA_1205.  
Silent mutations in the D296 isolate shown in green with corresponding amino acid in 
capitals below. The sequence aligned with COI_1584 (Genbank accession: CP004753) 
rather than MHA_1205. 
 
Primer set ‘M’ was one of the sets designed to detect the protein designated 
L280_13705, however, the sequencing showed that although there was a substitution 
at the gene level, this was silent and the translated nucleotide sequence exactly 
matched that of MHA_1205 in nine of the isolates, with identical or similar sequences 
for COI_1584 in a further six (Figure 6.4). This was the same for sets D, J and L in isolate 
351, suggesting they were identifying the same gene.  
 
 
 
 
D296                                                                  g 
COI_1584 1 atgcgtaaattattagtaattactgctcttacactctgcacgaccacggagggaaaaccacttactgttaaa 
           M  R  K  L  L  V  I  T  A  L  T  L  C  T  T  T  E  G  K  P  L  T  V  K   
       
 73  cgggtaggaaatgattacgaatattcgtatgacaaaacaaccttcaaaaatccgattaaaaaggcagtcactaatgac 
     R  V  G  N  D  Y  E  Y  S  Y  D  K  T  T  F  K  N  P  I  K  K  A  V  T  N  D   
 
 151 ggctcaattatcgccagaggttcaggttttacaacgtatgcattagagctggaaaatgatggattgaagtatttggtc 
     G  S  I  I  A  R  G  S  G  F  T  T  Y  A  L  E  L  E  N  D  G  L  K  Y  L  V   
 
 229 ggctttgttcagccaaatggcaatgcaaaagaatttattgagccgggagcaacgattagccaaagtaaagaacaacca 
     G  F  V  Q  P  N  G  N  A  K  E  F  I  E  P  G  A  T  I  S  Q  S  K  E  Q  P   
D296                                                                        t 
 307 agtatcggctctgttgattgtgatactcgtaaaaaaatccattataagtttgatgttcatttgatgaatacattataa    
     S  I  G  S  V  D  C  D  T  R  K  K  I  H  Y  K  F  D  V  H  L  M  N  T  L  *  
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Figure 6.4. Sequence Alignment of 351 Aligned with COI_1584.  
Genomic sequencing of the 351 gene amplified by primer set M aligned with the 
COI_1584 (top panel) showed a single substitution A-G. The substitution was shown to 
be silent with the base and corresponding amino acid in green. This is shown with the 
amino acid sequence alignment (bottom panel). 
 
The primers designed to detect the MHA_0579 gene did not generate any PCR products 
when reactions were tried under a number of conditions on the AHVLA isolates. As a 
positive control, the original genomic DNA from Mannheimia haemolytica (from which 
the MHA_0579 protein was cloned for this project) was used to ensure the fault was not 
with the primers. This produced bands of an appropriate MW on the agarose gel as 
expected with primer sets A, B and C (see Figure 6.5). Subsequent reactions using this 
set of primers on the RVC isolates were more successful, identifying identical genes in 
12 out of 19 isolates. 
COI_1584 1  atgcgtaaattattagtaattactgctcttacactctgcacgaccccagtatttgcagcagataaaaacgta 
            M  R  K  L  L  V  I  T  A  L  T  L  C  T  T  P  V  F  A  A  D  K  N  V   
 
   72 atattttcctgtaccagcacggagggaaaaccgcttactgttaaacgggtaggaaatgattacgaatattcgtatgac 
      I  F  S  C  T  S  T  E  G  K  P  L  T  V  K  R  V  G  N  D  Y  E  Y  S  Y  D   
  
  150 aaaacaaccttcaaaaatccgattaaaaaggcagtcactaatgacggctcaattatcgccagaggttcaggttttaca 
      K  T  T  F  K  N  P  I  K  K  A  V  T  N  D  G  S  I  I  A  R  G  S  G  F  T   
 
  228 acgtatgcattagagctggaaaatgatggattgaagtatttggtcggctttgttcagccaaatggcaatgcaaaagaa 
      T  Y  A  L  E  L  E  N  D  G  L  K  Y  L  V  G  F  V  Q  P  N  G  N  A  K  E   
 
  306 tttattgagccgggagcaacgattagccaaagtaaagaacaaccaagtatcggctctgttgattgtgatactcgtaaa 
      F  I  E  P  G  A  T  I  S  Q  S  K  E  Q  P  S  I  G  S  V  D  C  D  T  R  K   
M351                                        t 
  384 aaaatccattataagtttgatgttcatttgatgaatacattataa 429     
      K  I  H  Y  K  F  D  V  H  L  M  N  T  L  * 
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Figure 6.5. PCR Screening for MHA_0579.  
Primer sets A, B and C were designed to detect the gene coding for the MHA_0579 Gly1 
homologue. ‘M’ indicates the 1 kb marker used, ‘G’ indicates the original genomic DNA 
control and 234, 351 and 362 were the isolates screened. The 16S primers showed that 
the PCR was a success. No MHA_0579 gene was found in the AHVLA isolates. The 
primers detected the gene in the original genomic DNA, proving that they functioned. 
Samples separated by agarose gel electrophoresis. 
 
One fraction of interest amplified by primer set A was observed in isolate MH4 (see 
Figure 6.6) with a number of substitutions at the gene level leading to a slightly different 
amino acid sequence. The alignment highlights the substitutions N38D, I95V, Q96K and 
D103S. As the structure of this protein is currently unknown, it was impossible to judge 
whether the substitutions were in regions of importance to its structure or function. 
Isolate A1 also had the D103S substitution. Isoleucine and valine are both hydrophobic, 
and commonly found in substitutions due to their similar properties. The other changes 
in properties due to the amino acid polymorphisms are alterations in charge status 
caused by variations in the amino acid side chains, which could conceivably alter protein 
structure or function. 
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Figure 6.6 MHA_0579 Alignment with MH4 and A1 Genes.  
MH4 had four amino acid polymorphisms from asparagine to aspartic acid N50D, 
isoleucine to valine I107V, glutamine to lysine Q108K and aspartic acid to serine D115S. 
A1 had a single amino acid alteration from aspartic acid to serine D115S. 
 
Primers designed to identify the genes coding for proteins MHA_1205, COI_1584 and 
L280_13705 (Sets D, L and M) showed a lot of cross-over. MHA_1205 was detected by 
the primers in 10 of the 25 isolates with primer set D as anticipated (Figure 6.7). The 
gene was also detected by Set L (in 9 of 25) and Set M (in 9 of 25). The majority of 
sequences found with sets D and M correspond to one another, with the exception of 
Set D detecting MHA_1205 in A1, where the other primers found COI_1584. Set M also 
detected COI_1584 in strain A9 and MH8 where Set D did not. Set L detected COI_1584 
in 9 of the isolates and MHA_1205 in another 9, although these differed slightly from 
those found with the other two primer sets. Primer sets did not detect any genes 
corresponding to L280_13705. See Table 6.3 for a summary of these results.  
A1         1 MKKMAIVALSAFFSMNAFANNNVVYSCTTTDNQTLKVTKEGGNYVYSHGNTTFKNPVKEALKNPASEIAGGS 
MH4        1 MKKMAIVALSAFFSMNAFANNNVVYSCTTTDNQTLKVTKEGGNYVYSHGDTTFKNPVKEALKNPASEIAGGS 
MHA_0579   1 MKKMAIVALSAFFSMNAFANNNVVYSCTTTDNQTLKVTKEGGNYVYSHGNTTFKNPVKEALKNPASEIAGGS 
Consensus  1 ************************************************************************ 
 
A1        73 QFTTISLELRNAGKSYIVGHIEADPKSPFEASVQIQDIKTGNSITSFECRSDKPIRHNFDRKLMRKSGFAA 
MH4       73 QFTTISLELRNAGKSYIVGHIEADPKSPFEASVQVKDIKTGNSITSFECRSDKPIRHNFDRKLMRKSGFAA 
MHA_0579  73 QFTTISLELRNAGKSYIVGHIEADPKSPFEASVQIQDIKTGNDITSFECRSDKPIRHNFDRKLMRKSGFAA 
Consensus 73 ****************************************** ****************************             
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Table 6.3. Summary of PCR Screening with Primer Sets D, L and M. 
This table summarises the sequencing results of the PCR products of primer sets D, L 
and M. Identical genes are coloured in green (MHA_1205) and blue (COI_1584). Genes 
with polymorphisms are identified with *. In 234, each gene had a different sequence 
hence multiple *, **, ***. Those left blank did not detect a gene. 
  
 
 
D L M
A12 COI_1584* COI_1584 MHA_1205*
A1 MHA_1205 COI_1584 COI_1584
A9 COI_1584 COI_1584
CO0600 MHA_1205 COI_1584 MHA_1205*
CO4178 MHA_1205 MHA_1205 MHA_1205
CO3983 MHA_1205 MHA_1205 MHA_1205
Gilly MHA_1205 MHA_1205 MHA_1205
CO0353 MHA_1205 MHA_1205 MHA_1205
MH4 A8 COI_1584 COI_1584 COI_1584*
MH8 A5 COI_1584 COI_1584
A6 MHA_1205 MHA_1205 MHA_1205
CO2008 MHA_1205 MHA_1205 MHA_1205
CO1250 MHA_1205 MHA_1205 MHA_1205
234 COI_1584* COI_1584** COI_1584***
235 COI_1584
296 COI_1584*
351 COI_1584 COI_1584* COI_1584
362 MHA_1205
428 MHA_1205
Primer set
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Figure 6.7. MHA_1205 Isolate Screening.  
Primer set D was used to screen the isolate genomes for the gene coding for protein 
MHA_1205. The PCR amplified a section in isolates 234 and 351 initially believed to be 
the MHA_1205 gene. Subsequent screening showed that in isolate 351 this gene was 
actually that coding for COI_1584. The negative control here was the identical PCR mix 
to that used for Set D minus DNA. 
  
Primer set M detected a similar gene to COI_1584 seen in isolate 234 although a number 
of substitutions were found. The majority of these were within the predicted signal 
peptide up to the predicted cleavage site with the exception of isoleucine- valine 
substitutions. As mentioned previously, this substitution is common as these amino 
acids share similar properties (Figure 6.8).  
 
 
Figure 6.8. Sequencing of 234 with Primer Set M.  
The translated nucleotide sequence generated by primer set M was different to that of 
the expected protein. The first 4 amino acid substitutions were within the signal peptide 
region (up to AFA or VFA respectively). The A20T substitution was within the processed 
protein but situated just after the predicted cleavage site. A further substitution I25V 
was also present. Predicted signal peptide underlined in red. 
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Primer Set J was designed to screen the isolates for COI_1584 as found in the A2 ovine 
strain on the NCBI database, which appeared to differ in the flanking regions when 
compared to other sequences available in the database. The expected product was a 
631 bp band as visualised on an agarose gel. However, what was seen was actually two 
DNA bands of approximately 650 bp and 2.5 kbp. The lower band was extracted from 
the gel, the DNA purified and sent for sequencing. The sequence of the lower MW band 
was poor for the majority of the isolates; in 234 and 351 the sequence was sufficiently 
clear to allow comparison with known genes (Figure 6.9). The gene detected in isolate 
234 did not match any sequences from the database, however, it was identical to 
COI_1584 from position 26 onwards. This was the same sequence identified with primer 
Set M (Figure 6.8), so it was possible that primer set J was amplifying the same gene.  
 
 
Figure 6.9. Sequencing of 234 with Primer set J.  
This primer set was designed to detect the gene coding for protein COI_1584. In all 
positive reactions, two bands were seen, one at approximately 2.5 kbp and one at the 
anticipated size of approximately 650 bp. Sequencing was attempted on other genomes 
but was unsuccessful.  
 
234          1 MRKLLGITVLTLCTTSAFATDKNVVFSCTSTEGKPLTVKRVGNDYEYSYDKTTFKNPIKK 
COI_1584     1 MRKLLVITALTLCTTPVFAADKNVIFSCTSTEGKPLTVKRVGNDYEYSYDKTTFKNPIKK 
MHA1205      1 MRKLLVITALTLCTTPVFAADKNVIFSCTSTEGKPLTVKRVGNDYEYSYDKTTFKNPIKK 
mh0603       1 MRKLLVITALTLCTTPVFAADKNVIFSCTSTEGKPLTVKRVGNDYEYSYDKTTFKNPIKK 
L280_13705   1 MRKLLGITVLTLCTTSAFATDKNVVFSCTSTEGKPLTVKRVGNDYEYSYDKTIFKNPIKK 
consensus    1 *****.**.******..**.****.*********************************** 
 
 
234         61 AVTNDGSIIARGSGFTTYALELENDGLKYLVGFVQPNGNAKEFIEPGATISQSKEQPSIG                                                 
COI_1584    61 AVTNDGSIIARGSGFTTYALELENDGLKYLVGFVQPNGNAKEFIEPGATISQSKEQPSIG 
MHA1205     61 AVTNDGSIIARGSGFTTYALELENDGLKYLVGFVQPNGNAKEFIEPGATISQSKEQPSIG 
mh0603      61 AVTNDGSIIARGSGFTTYALELENDGLKYLVGFVQPNGNAKEFIEPGATISQRKEQPSIG 
L280_13705  61 AVTNDGSIIARGSGFTTYALELKNDGLKYVVGFVQPNGNSKEFIEPGATISRDNDQPSIG 
consensus   61 ****************************************************.******* 
 
 
234        121 SVDCDTRKKIHYKFDVHLMNTL                       
COI_1584   121 SVDCDTRKKIHYKFDVHLMNTL                       
MHA1205    121 SVDCDTRKKSHYKFDVHLMNTL 
mh0603     121 SVDCDTRKKSHYKFDVHLMNTL 
L280_13705 121 SVDCDPYKKIYL---------- 
consensus  121 *********.************ 
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Identical or very similar genes to the MHpara sequence identified in the initial screening 
were detected in 17 of the 25 isolates. Of the 8 that did not contain MHpara genes, only 
4 were M. haemolytica. Two of the MHpara genes that were detected had different 
amino acid sequences (Figure 6.10). The isoleucine-phenylalanine change observed in 
the database genome sequences was only detected in one of the 15 MHpara genes that 
were identical at all other points. This shows that in the samples collected the isoleucine 
variant was the most common.  
As mentioned in Chapter 3 Section 3.2.1, a potential homologue of MHpara was 
discovered with a ‘frame shift’ caused by a GA deletion at the gene level resulting in a 
shorter N terminal region but a near-identical sequence from the proposed cleavage site 
of the signal peptide on the longer protein. The shorter protein was not predicted to 
have a signal peptide at the N terminal, which would prevent the protein from being 
directed to the correct location within the cell. As errors can sometimes occur on the 
database it was not known if this variation in sequence was truly found in nature, yet 
sequencing of isolate 362 uncovered this same phenomenon. The putative RBS for this 
gene was discussed in Chapter 3. The genes on the database were flanked by the genes 
coding for HmbR and PhuT, suggesting it was in the same locus as the full-length version. 
It is unknown whether this shorter protein would be functional, and the predicted 
tertiary structure using the Phyre2 server does not cover the full length of the amino 
acid sequence to allow for comparison. 
 
Figure 6.10. MHpara Alignment with 362 and CO0600 Translated Genes.  
ORF finder was used to translate the genomic sequence where GA was missing from the 
sequenced PCR product at position 84-85 along with an A-G substitution at position 171. 
These account for the initial change in the N terminus and the lysine to glutamic acid 
difference at amino acid level. No signal peptide was predicted with the 362 MHpara, 
and the non-matching segment was not found in the NCBI database. This was the same 
as CO2392. Primer set H was used. 
 
H362       1--------------------MQQVNKVMQEAHESTVKTSTVKYSCQNGKKLSVKYGFNEQGIPTYAEAKLSGK 
MHpara     1 MKKLMIFATTAMIVSNLAHAAGEQSDAREAHESTVKTSTVKYSCQNGKKLSVKYGFNKQGIPTYAEAKLSGK 
CO0600     1 MKKLMIFATTAMIVSNLAHAAGEQSDAREAHESTVKTSTVKYSCQNGKKLSVKYGFNKQGIPTYAEAKLSGK 
consensus  1 ............................*****************************.************** 
 
H362      73 KRFMPINLYTTDATGTNFGDENNFSLYGDPMEFTNHRKASVNIQSPASEILYKGCTPQK 
MHpara    73 KRFMPINLYTTDATGTNFGDENNFSLYGDPMEFTNHRKASVNIQSPASEILYKGCTPQK  
CO0600    73 KRFMPFNLYTTDATGTNFGDENNFSLYGDPMEFTNHRKASVNIQSPASEILYKGCTPQK 
consensus 73 *********************************************************** 
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Further to the above sequencing, a brief investigation into the genomic location of the 
MHpara gene compared to the hmbr gene of the isolates was performed. As seen in 
Chapter 3 in the flanking gene analysis (Figure 3.5) it was noted that one of the 
interesting genes found in the M. haemolytica genome, the MHpara gene, was adjacent 
to a haemoglobin receptor gene, hmbr. 
To ascertain if this genomic arrangement was repeated in the isolates screened, PCR 
was performed using the forward primer for MHpara, initially used to clone this gene, 
and the forward primer for hmbr, again used for cloning. If the two genes were located 
in a similar position to those seen in the database, the product size would equal 
approximately 2.7 kbp consisting of each gene and a 210 bp linker region. As can be seen 
in Figure 6.11, the product band created by PCR using the HmbR primers alone was a 
lower molecular weight (approx. 2.1 kbp) than the product band created by using both 
the MHpara and HmbR forward primers (approx. 2.7 kbp). This suggested that in the 
isolates that contain both genes they were situated close to each other and in the 
expected orientation as described in the database genome sequences. Confirmation of 
the presence of both MHpara and hmbr genes was performed by partial sequencing of 
the PCR products with the primers used for the initial reaction.
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Figure 6.11. MHpara and HmbR PCR Results.  
Panel A. shows the PCR products using the HmbR primers only as analysed by agarose 
gel electrophoresis. Panel B. shows the products created with both HmbR and MHpara 
primers. Those not found to have MHpara in initial sequencing were not included in 
panel B. The ‘Primers’ lane had no DNA in the reaction mix.  
 
The possible Gly1 proteins discovered in the database searches were putative 
homologues of the neisserial Gly1 proteins. Genomic screening of the donated 
Mannheimia haemolytica isolates revealed that the majority of them contained at least 
two of the potential Gly1 homologues. Exceptions were isolates found to be other 
bacterial species and isolates A7, CO2392, CO3916, 362 and MH9 A2.  
This trend was supported by the database findings, which overall placed two or three 
Gly1 proteins along with the MHpara protein in each genome sequence with one 
exception. These homologues were not within the same genetic locus and were 
separated by between approximately 8 kbp and 500 kbp based on the database 
numbering system. The database A2 isolates had either the MHpara gene alone or with 
one COI_1584 gene. No A7 genomic sequence has been deposited in the NCBI database 
with which to compare the isolate screening results, and the serotypes of CO2392 and 
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CO3916 were not known. If the genes identified using primer sets D and L were in fact 
the same gene, the results supported the database genome findings (Figure 6.12). 
 
Figure 6.12. A Summary of the Presence of Genes of Interest in Available Genome 
Sequences.  
Gly1 was not present in every sequence on the NCBI database. All but one M. 
haemolytica isolate contained MHpara in some form. Fifteen isolates contained 
MHA_0579, fourteen MHA_1205, three COI_1584, and three L280_13705. The genes of 
interest were not found within similar genomic locations to each other as indicated by 
the broken lines. 
 
MHA_0579 MHA_1205
MHA_0579
MHA_0579
COI_1584
MHA_1205
MHpara
MHpara
MHparaL280_13705
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6.2.3 Protein Expression 
In order to further investigate the presence of these genes, the M. haemolytica isolates 
were grown in a rich medium (BHI) overnight at optimum temperature. The liquid 
cultures were normalised by measuring optical density and 1 ml of each was centrifuged 
down to pellet the bacteria. The cell pellets were lysed and the proteins separated by 
SDS-PAGE. Western blots were performed using rat anti-MHA_1205 C-His whole 
antisera, and purified rabbit anti-MHpara and rabbit anti-MHA_0579 C-His to detect any 
Gly1 protein expression. 
MHpara was detected in the Gilly strain, which was isolated due to its enhanced 
pathogenicity. It was also detected in the A1 and A6 serotyped strains which again are 
known to be the major isolates involved in bovine respiratory disease (Figure 6.13). The 
strains of M. haemolytica that were of unknown serotype in which the antibodies 
detected proteins of interest were CO3983 in two out of three repeats, and CO2392, 
CO4178 in one of three repeats. In both MH8 (serotype A5) and MH9 (serotype A2) 
MHpara was also detected in one of three repeats.  
            
 
Figure 6.13. Western Blot on Whole Cell Lysate of Isolates to Detect MHpara.  
Proteins were separated by SDS-PAGE prior to analysis by western blot. MHpara was 
detected in A6 and Gilly in each repeat. It was detected in A1 and CO3983 in two out of 
the three repeats. Cells were grown in iron replete conditions. The panel to the right 
showed a repeat of the western blot but with the anti-MHpara pre-incubated with 
MHpara protein. N = 3. 
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Pre-incubation of the antibodies with purified MHpara or MHA_0579 C-His proteins 
reduced or eliminated the detection of the protein of interest on the western blots. This 
was also seen with the cell lysates that were positive for MHpara, supporting the idea 
that the proteins detected were indeed MHpara. A number of strains that were found 
to contain the gene for MHpara after PCR screening did not show positive results for the 
protein. Nor was any MHA_0579 protein detected by the specific antibodies in any 
isolate (Figure 6.14). PCR screening had shown that MHA_0579 was present in a 
minimum of thirteen of the isolates. As we have shown some evidence suggesting 
MHA_0579 interacts with hemin in Chapter 4, it could be suggested that the expression 
is down-regulated under iron replete conditions. This is a common occurrence with 
proteins involved in haem uptake and storage, which are often tightly regulated. 
Additionally, mh0603 was observed to be upregulated in conditions of iron paucity 
(Roehrig et al., 2007).  
 
 
Figure 6.14. MHA_0579 Expression in Isolates Under Iron Replete Conditions.  
Western blot detection was carried out on proteins separated by SDS-PAGE. No 
MHA_0579 was detected in any of the lysed samples. N = 3.  
 
MHA_1205 protein was detected using whole rat serum. This led to a fair amount of 
non-specific binding. The antisera was pre-incubated with E. coli whole cell lysate, which 
decreased the additional protein bands (Figure 6.15, panels B and 3). This suggested that 
the remaining bands present on the western blot were MHA_1205 or COI_1584. The 
PCR screenng did not detect either of these or any similar proteins in isolates A10, A7, 
CO2392, CO3916 or MH9. MHA_1205 was detected in isolate 235 in the PCR screening 
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however no protein band was seen in the western blot. The size of the band was a lower 
MW in the isolate lysate than the pure MHA_1205 C-His protein. This difference could 
be attributed to the linker region and polyhistidine tag, which is an additional 14 amino 
acids, with an approximate MW of 1.8 kDa. 
 
 
Figure 6.15 MHA_1205 and COI_1584 Expression in Isolates Under Iron Replete 
Conditions.  
Antisera against MHA_1205 C-His was used to identify expression in the M. haemolytica 
isolate whole cell lysate of MHA_1205 and COI_1584 High levels of background (Panel 
A. and 1.) were reduced by pre-incubating the antisera with E. coli cell lysate along with 
MHA_1205 C-His (Panel B. and 2.). Antisera incubated with both E. coli cell lysate and 
MHA_1205 C-His (Panel 3.). The MW of the proteins detected was marginally lower than 
MHA_1205 C-His.  
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6.3 Discussion  
At one stage, Mannheimia species such as M. haemolytica, M. varigena and M. glucosida 
were all classified as serotypes of the biovar ‘A’ of Pasteurella haemolytica. 
Reclassification and analysis based on phenotypic and 16S typing showed that M. 
haemolytica and M. glucosida are the most similar of the Mannheimia species, although 
their 16S sequences do differ slightly (Angen et al., 1999).  While other Mannheimia 
species are also found as commensals in cattle, sheep and, in the case of M. varigena, 
pigs, M. varigena is associated with disease such as pneumonia and septicaemia and M. 
glucosida with ovine mastitis.  
It is interesting to note that M. varigena (235) and M. glucosida (428) were found to 
contain COI_1584 or MHA_1205 genes, respectively. There were four assemblies of M. 
varigena available on the NCBI database, and a BLASTp search uncovered potential Gly1 
homologues in isolates 1261 (accession number AHG73145.1) and 1388 (accession 
number AHG79471.1). These protein sequences were identical to those found in 
numerous other bacteria including P. multocida and B. trehalosi, which could suggest an 
annotation error. The genes identified share 88% identity with COI_1584 and from this 
information it was not clear if these sequences were reliable evidence of the presence 
of a Gly1 gene in these species. The COI_1584-like protein found in isolate 235 was 
identical to the Mannheimia protein. Contamination of the sample is possible, as the 
leukotoxin sequence was identical to that found in M. haemolytica, which was not the 
sequence found in M. varigena on the database. The database Lkt sequences between 
Mannheimia species share 94% identity overall but just 83% at the short region of 66 
amino acids sequenced with the Lkt primers used in this study, which supports the idea 
that the sample was either contaminated or had been mis-labelled at isolation. This was 
further reinforced by the fact that bacterial growth was seen on MacConkey agar which 
would not be expected with M. varigena, although the morphology of the colonies 
besides this is reported to be very similar between species. 
The M. glucosida leukotoxin sequence was very similar to that of M. haemolytica, with 
97% identity (see Figure 6.16). The section of gene used for screening with the ‘Lkt’ 
primers is 100% identical to the M. haemolytica sequence, however further screening 
199 
 
over a more diverse section of the gene named ‘Lkt2’ was able to differentiate between 
these two species. This found that the sample was indeed M. glucosida. The lack of 
whole genome sequences in the NCBI database makes it difficult to know whether this 
proposed gly1 gene is commonly found in this species or if this is an unusual event. M. 
haemolytica is naturally competent as described by Gioia et al based on the discovery of 
genes involved in DNA uptake (Gioia et al., 2006). The fact that M. glucosida is believed 
to be so similar to M. haemolytica based on other sequencing results could indicate 
genetic element transfer in the opposite direction from M. haemolytica, and provide an 
explanation for the identical gene for MHA_1205. 
 
Figure 6.16. Alignment of Leukotoxin or ‘Hemolysin D’ from M. haemolytica (MH), M. 
varigena (MV) and M. glucosida (MG).  
The sequence identity of the leukotoxin proteins (also known as hemolysin D) in 
mannheimia species. MH Lkt accession AAL12786.1, MV accession WP_025235106.1, 
MG accession AAL12798.1. The section underlined in red was Lkt2 for MG screening and 
in black for MH screening. 
 
MH        1 MKIWLSGIYEFFLRYKNIWAEVWKIRKELDHPNRKKDESEFLPAHLELIETPVSKKPRLIAYLIMLFLIVAI 
MG        1 MKIWLSGIYEFFLRYKNIWAEVWKIRKELDHPNRKKDESEFLPAHLELIETPVSKKPRLIAYLIMLFLVVAI 
MV        1 MKIWLSGIYEFFLRYKNIWVEVWKIRKELDHPNRKKDESEFLPAHLELIETPVSKKPRLIAYLIMLFLAVAI 
consensus 1 *******************.************************************************.*** 
 
MH        73 VLASVSKVEIVATAPGKLTFSGRSKEIKPIENAIVQEIFVKDGQFVEKGQLLVSLTALGSDADIKKTMASL 
MG        73 VLASVSKVEIVATAPGKLTFSGRSKEIKPIENAIVQEIFVKDGQFVEKGQLLVSLTALGSEADIKKTIASL 
MV        73 VLASVSKVEIVATAPGKLTFSGRSKEIKPIENTIVQEIFVKDGQFVEKGQLLVSLTALGSDADIKKTITSL 
consensus 73 ********************************.***************************.******..** 
 
MH        143 SLAKLENYRYQTLLTAIEKESLPVIDLSRTEFKDSSEEDRLRIKHLIEEQYTTWQKQKTQKTLAYKRKEA 
MG        143 SLEKLENYRYQTLLTAIENESLPVIDLSKTEFNDSSEEDRLRIKHLIEEQYTTWQKQKMQKTLAYKRKDA 
MV        143 SLAKLENYRYQTLLTAIEKESLPVIDLSNTEFKDSSEEDRLRIKHLIEEQYTTWQKQKTQKTLAYKRKDA 
consensus 143 **.***************.*********.***.**** *********************.********.* 
 
MH        213 EKQTIFAYVRKYEGATRIEQEKLKDFKALYKQKSLSKHELLAQENKLIEAQNELAVYRSKLNELENDLLN 
MG        213 EKQTTSAYVRKYEGATRIEQEKLKDFKALYQQKSLSKHELLSQENKAIEAQNELAVYRSKLNELENDLLN 
MV        213 EKQTISAYVRKYEGATRIEQEKLKDFRKLYQQKSLSKHELLSQENKAIEAQNELAVYRSKLNELESDLLN 
consensus 213 ****..********************..**.**********.****.******************.**** 
 
MH        283 VKEELELITQFFKSDVLEKLKQHIENERQLRLELEKNNQRRQASMIRAPVSGTVQQLKIHTIGGVVTTAE 
MG        283 VKEELELITQFFKSDVLEKLKQHIENERQLRLELEKNNQRRQASMIRAPVSGTVQQLKIHTIGGVVTTAE 
MV        283 VKEELELITQFFKSDVLEKLKQHIENERQLRLELEKNDQRRQASMIRAPVSGTVQQLKIHTIGGVVTTAE 
consensus 283 *************************************.******************************** 
 
MH        353 TLMIIVPEDDVLEATALVQNKDIGFVAAGQEVIIKVETFPYTRYGYLTGRIKHISPDAIEQPNVGLVFNA 
MG        353 TLMIIVPEDDVLEATALVQNKDIGFVAAGQEVIIKVETFPYTRYGYLTGRIKHISPDAIEQPNVGLVFNA 
MV        353 TLMIIVPEDDVLEATALIQNKDIGFVAAGQEVIIKVETFPYTRYGYITGRIKHISPDAIEQPNLGLVFNA 
consensus 353 *****************.****************************.****************.****** 
 
MH        423 TIAIDRKNLTSPDGRNIDLSSGMTITAEIKTGERSVMSYLLSPLEESVT 
MG        423 TIAIDRKNLTSPDGRNIDLSSGMTITAEIKTGERSVMSYLLSPLEESVT 
MV        423 TISIDKQALSSPDGHKIELGSGMTITAEIKTGERSVMSYLLSPLEESVT 
consensus 423 **.**...*.****..*.*.***************************** 
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Isolate 235 did not contain a MHpara-like protein sequence but both 235 and 428 
contained PhuT and HmbR. This supports the idea that 235 was actually M. haemolytica, 
although there is insufficient information available on the NCBI database to know 
whether M. glucosida contains these two proteins or similar homologues.  
An interesting observation was that the phenylalanine form of MHpara was only 
observed in one of the MHpara isolates screened, with the isoleucine form predominant. 
The larger amino acid, phenylalanine, was predicted to partially occlude the pore of the 
MHpara protein tertiary structure (Chapter 3, Figure 3.24). This could indicate that the 
larger amino acid is not the common biological one and supports the hypothesis that it 
is a rare single nucleotide polymorphism from an A to a T and may lead to a 
malfunctioning protein. The protein used throughout the project for structure-function 
experiments was the isoleucine form. It could be interesting to produce and label the 
phenylalanine form and analyse interactions of this protein compared to the isoleucine 
version.  
The strain labelled ‘Gilly’ was a particularly virulent strain that caused a bad pneumonia 
outbreak on a farm (verbal communication from Prof. Rycroft, RVC). While the serotype 
of this strain was unknown, it can be assumed that it was A1, A2 or A6 as these are the 
most commonly occurring isolates involved in pathogenesis and disease as discussed in 
Chapter 1 section 1.2.2.1.  
On the NCBI database, the strain isolated from deer was a novel isolate. It does not 
appear to have even distant Gly1 homologues or paralogues, and only bears 86% 
identity to the coding sequences of other strains of M. haemolytica (Lawrence et al., 
2014). This could explain the lack of Gly1 homologues identified in this particular strain.  
Results of the PCR isolate screening with different primer sets detected a gene more 
than once as multiple primer sets were used to account for up/ down stream variability 
in genome sequence. While it is possible that the gene was duplicated within the 
genome, the primer sequences could be detecting the exact same gene in the DNA. The 
primer sets A, B and C, (MHA_0579) and D, L and M (MHA_1205 and similar) were 
designed to cover the differences observed in the flanking regions of the database 
genomes available at the time, and it is possible these detected the same gene. Gene 
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duplication is an important mechanism in the adaptation and evolution of species, with 
examples observed in the bovine commensal Mannheimia succiniciproducens (Hong et 
al., 2004).  
While the majority of the potential duplicate genes were identical to each other, five of 
the isolates had different genetic sequences that when translated gave rise to identical 
protein sequences. Subsequent genome additions to the NCBI database showed that 
these primer sets identify similar regions of the genome on the database available. This 
explains the ‘identical’ genes discovered as being the same gene, but not the lack of the 
gene in some or differences observed between others. If the genes were duplicated, the 
duplication event possibly included the regions up- and down-stream of the coding 
region, as the primers were situated either around 50 bp or 100 bp up- or down-stream 
from the start and stop codons. As illustrated in Figure 6.12, the genomes available on 
the database have multiple copies of Gly1 homologues. It was initially hypothesised that 
the MHA_1205, COI-1584, mh0603 and L280 proteins were actually the same protein 
that had undergone minimal mutations. The presence of a number of versions of these 
similar genes in the screening results is in line with the database information, as half of 
the isolates showed different sequences. Further investigations would clarify whether 
the remaining 9 isolates had multiple copies of the gene within their genomes of if it was 
in fact the same gene being detected multiple times.  
Primer set J was designed to detect COI_1584 based on the A2 ovine strain on the NCBI 
database, which had slightly different flanking regions of DNA. These primer sets 
amplified multiple bands in the majority of isolates, and the only isolates that sequences 
were able to be deduced for were two ovine strains- 234 and 351. This may be a result 
of the differences observed between ovine and bovine strains (Hounsome et al., 2011).  
The detection of MHpara in all M. haemolytica strains except A10, A6, CO3983, CO0353, 
235 and 428 using PCR, but not in all western blots of the cell lysates was interesting; 
even more so because the antibodies used in the western blot detected MHpara in A6 
and CO3983. This could be due to differences in the DNA sequences flanking the genes, 
as the primers designed were specific to the sequences in the NCBI database, and 
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changes in the DNA could alter the binding of these, preventing the reaction from 
occurring. 
The PCR screening protocol was informative however, due to the nature of primer 
specification, it is liable to give false negatives when screening genomic sequences for 
the presence of genes. Mismatches may occur within the base pairing region. Southern 
blotting and FISH hybridisation methods can probe for the sequences and do not rely on 
primer specification for regions of DNA surrounding the gene.  
The cultures were grown in the same incubator in 37° C with 5% CO2 on a shaker in 25 
ml universal containers. BHI medium was used throughout. The cultures grew at 
different rates, and although efforts were made to adjust the density of the cell culture 
to approximately A600 0.5 for each experiment, it is possible that there was some 
variation in cell density. The cells were harvested at stationary phase after around 16 
hours of growth. Alternatively, the differing growth rates could be related to the 
serotype of the bacterial isolate with some expressing these possible adhesins and 
others not. As discussed in Chapter 1, Section 1.2.2.2, there are differences between the 
serotypes, even between those found in different hosts, and especially in the 
pathogenicity of each. A known virulence factor is cellular adhesion, and if MHpara is 
indeed an adhesin there could be some correlation between the MHpara gene and 
pathogenicity. This would be very interesting as a potential target for new BRD 
therapies.   
Screening of the field isolates of M. haemolytica revealed that the majority (19 of 25) 
contained one or more of the highly similar Gly1 homologues. This suggests that these 
proteins play an important role in M. haemolytica biology and potentially pathogenesis. 
They could therefore present possible therapeutic targets if antibodies raised against 
the proteins confer complement mediated killing. Further investigations into the 
prevalence and expression of these proteins in the common pathogenic strains is 
required to understand the full potential of these putative Gly1 proteins.   
In conclusion, the screening of these isolates has shown that the Gly1 homologues or 
paralogue could have potential in terms of new targeted therapies to prevent or tackle 
the main bacterial cause of BRD.  
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7. Conclusion 
The basis of this project was to investigate the putative Gly1 homologues uncovered via 
NCBI BLAST database searches of available genomes. No similar sequences to the 
bacterial Gly1 proteins have been uncovered to date in eukaryotic organisms, enhancing 
the potential of this proposed family of proteins as novel specific bacterial targets to 
prevent disease in the mammalian hosts. Neisserial proteins have previously been 
shown to bind to haem and erythrocytes, and antibodies against these demonstrated 
complement mediated killing of the bacteria. Our hypothesis was that putative Gly1 
proteins found in other animal pathogens shared similar cellular functions, such as haem 
binding, and could therefore play an important role in the biology of a wide range of 
Gram negative organisms.   
7.1 Identification of Gly1 Homologues and Structural Investigations 
Database analysis uncovered proteins of similar sequence in many Gram-negative 
bacteria, all with unknown function. Initial studies therefore centred on analysis of key 
pathogens and the structural similarity of their proteins. This showed that the proteins 
shared a secondary structure composed of majority beta strands. In addition to this, 
MHA_0579 and MHA_1205 of M. haemolytica and SARI of S. enterica arizonae IIIa 
readily formed dimers, as was previously observed with the neisserial Gly1 proteins. 
Higher oligomers were also detected in the concentrated protein stocks. APP Gly1 and 
MHpara did not oligomerise, the first indication that these two proteins differed from 
the rest of those under investigation. The multimers were formed primarily by 
disulphide bonds. It was proposed that the dimers observed in N. meningitidis Gly1 were 
the result of domain swapping of the two beta sheets forming the tertiary structure, 
although this was not observed in the crystal structure solved by a collaboration at The 
University of Sheffield.  
Disulphide bonds generally stabilise the protein, and the ability of these proteins to form 
multimers in this manner may give an indication of the method of binding the ligand i.e. 
Gly1 in N. meningitidis interacted in a 2:1 ratio with hemin (Sathyamurthy, 2011). The 
oligomerisation occurring via disulphide bonds can also help provide evidence for the 
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predicted cellular location of the protein. The bacterial cytoplasm is a reducing 
environment, therefore it is not common for proteins to form bonds which can, as 
demonstrated with the reducing agent DTT, be readily broken down in this fashion. 
To further analyse the similarities between these proteins and build on the information 
provided by tertiary structure prediction software, optimisation of the X-ray 
crystallography attempted would be beneficial. The project to deduce tertiary structures 
of the proposed Gly1 homologues investigated in this thesis is ongoing. The MHpara 
protein tertiary structure was solved and found to resemble the anti-parallel beta barrel 
seen with both N. meningitidis and N. gonorrhoeae Gly1 proteins. The central pore of 
the MHpara protein was smaller at less than 10 Å in diameter and with loops appearing 
to partially occlude it in the form crystallised. These protein loops may be mobile and 
involved in the function of MHpara. As the holo forms of proteins are in some cases 
more stable, continuing with the haem soaked crystals could allow diffraction to occur 
to a sufficient degree for the structure to prove solvable. It would be of interest to both 
compare to known Gly1 structures and to database proteins. The cellular location of the 
Gly1 homologues was predicted as OM for MHA_0579, the neisserial Gly1s and SARI, 
however, MHA_1205 and COI_1584 were predicted to be periplasmic. This again 
suggests that these proteins have differing cellular functions.  
7.2 Studying the Function of Gly1-like Proteins 
The initial studies by Arvidson et al showed that certain isolates of N. gonorrhoeae were 
associated with haemolytic activity not commonly observed with this species, one of 
which was found to contain Gly1. This provided another indication that the protein may 
be involved in haem acquisition, although subsequent haemolytic activity observed in 
the E. coli cells overexpressing this protein may have been an artefact of the 
overexpression itself.  
In M. haemolytica, as the name suggests, β-hemolysis is a method used by the bacteria 
to acquire haem from host erythrocytes. The leukotoxin produced by M. haemolytica is 
known to be the causative factor of this weak haemolysis (Murphy et al., 1995). Bacteria 
can produce multiple haemolytic toxins; α, β, γ and δ hemolysis has been described, 
opening this avenue as a potential direction of investigation.  
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7.2.1 Haem Interactions 
This project found that MHA_0579 interacted with haem or hemin in the majority of 
assays conducted, with MHA_1205 and SARI proteins demonstrating interaction with 
haem or hemin in one fewer experiment. These results were suggestive of the proteins 
functioning as haem binding proteins in the bacterial haem acquisition system.  
Investigations into protein expression in the M. haemolytica isolates found that while 
the MHA_0579 protein was not detectable under iron replete conditions, MHA_1205 
(or one of the very similar homologues) was detected in each of the isolates under the 
same growth conditions. It would be interesting to assess this on a transcriptional level 
to quantify up- or down- regulation of these and other gly1 genes under differing growth 
conditions. mh0603, one of the proteins similar to MHA_1205 was observed to be 
upregulated under conditions of iron paucity, suggesting a role in iron acquisition 
(Roehrig et al., 2007). The original level of transcription was not stated, so it is possible 
that there was a low level of expression under iron rich conditions as observed with the 
positive results of the western blots detecting MHA_1205 in the isolated analysed in this 
thesis.  
While the results of the absorbance spectra and peroxidase activity assays suggested 
haem binding, any positive results observed in the hemin agarose pull down were 
abolished upon cleavage of the polyhistidine tag. Unfortunately there was insufficient 
material to perform enterokinase cleavage on a large scale, and attempts to overexpress 
and purify MHA_1205 in its wild type form were unsuccessful due to poor expression 
and low solubility. MHA_1205 C-His did not show a shift in the absorbance spectra 
suggesting that the polyhistidine tag was not interfering with the results of this assay, 
and only a minor shift was recorded in the hemin spectra when incubated with SARI C-
His. This suggests that while the interactions observed in the hemin agarose assay 
resulted from the presence of the polyhistidine tag on the protein, this was not the cause 
of positive results for other assays. Aggregation has been observed in MHA_1205 C-His 
under certain conditions (Sayers lab, unpublished), and it is possible that the solid 
surface of the agarose beads encourages this. Alternatively, the immobilised haem may 
have prevented natural binding, whereas this steric hindrance was not an issue in the 
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other assays performed. MHpara and APP Gly1 proteins, neither of which were cloned 
with a polyhistidine tag, were not observed to interact with haem or hemin in any 
experiments conducted. MHA_0579 is involved in bacterial haem uptake, and we can 
hypothesise that it is down-regulated during growth in iron rich environments. It is 
unlikely that it is a storage protein based on this, yet it is possible that MHA_1205 or 
COI_1584 proteins are as the western blots show these in all isolates. 
Due to the diversity of haem binding sites and mechanisms it is very hard to analyse the 
interactions occurring based on predicted structures, and even to predict interactions in 
the first place. Solving the tertiary structure of these potential haem binding proteins 
would enable a more in-depth investigation into the binding properties of Gly1 proteins 
that look to interact with haem. However, even then the binding clefts can vary slightly 
from protein to protein, so attempts would need to be made to solve the structure of 
the holo-protein to discover the exact means of binding.    
Ideally we would have liked to create Gly1 knockouts in the isolates that contain said 
genes in order to analyse growth on different media, however, this was not possible due 
to the time constraints of getting ethical approval for genetic modification once the 
haem interactions had been reported. It would be interesting to investigate the knock 
out versions for both the haem binding proteins and MHpara and cellular adhesion (see 
Chapter 5). 
7.2.2 M. haemolytica Paralogue Function 
MHpara did not interact with haem, however it did show structural similarity to a 
lysozyme inhibitor from E. coli, PliC. The MHpara-lysozyme interaction assay was 
inconclusive, showing a higher percentage of the lane total formed by the higher MW 
band, although this may have resulted from variability between samples. Time 
constraints precluded probing with lysozyme antibodies at the time of investigation 
therefore it was not clear whether the higher MW bands were composed of both 
proteins, as could be deduced by western blot. It may be that the presence of lysozyme 
encouraged the formation of MHpara multimers, which were not observed in the 
dimerisation experiments in Chapter 5.  
207 
 
Lysozyme inhibitors can be periplasmic or membrane lipoproteins, and while the cellular 
location remains unknown, MHpara does not contain the lipoprotein motif in the signal 
peptide as there is an absence of cysteines (Hayashi and Wu, 1990). Subsequent 
investigations showed that MHpara in fact acts as an adhesin. This potential function 
was investigated due to the identification of the N. meningitidis putative Gly1 paralogue 
‘ACP’ as an adhesin, which shares some identity with the MHpara protein as discussed 
in Chapter 5. In the PliC paper the flanking genes of both PliC and MliC were identified 
as those involved in bacterial macrophage survival, which would function in conjunction 
with the lysozyme inhibitor to defeat the host defence systems (Callewaert et al., 2008).  
MHpara, as mentioned in Chapter 3, was located upstream of an apparent haem uptake 
locus of M. haemolytica and downstream of a collection of transporter proteins. Based 
on this evidence it is more likely that the MHpara protein is an adhesin than a lysozyme 
inhibitor. As discussed in Chapter 1, adhesins are known virulence factors for bacteria. 
If expressed when the bacteria are attempting to colonise the host the MHpara could 
present an attractive target. In addition to this proposed important function, genome 
screening showed that genes coding for MHpara were present in the majority of isolates, 
and, while this could allow for an effective vaccine, western blot analysis did not detect 
protein expression in all isolates with the gene. If it is periplasmic like PliC then it is 
unlikely to be a real adhesin. It is worth considering multiple functions which, although 
rare, are increasingly being described. This may be in the form of proteins with multiple 
ligands (pleiotropism) or moonlighting proteins as discussed in a review by  Huberts et 
al (Huberts and van der Klei, 2010). It is plausible that the protein could both be involved 
in adhesion and, as a result of this placing of the bacterial cell in a region containing 
lysozyme, also protecting the bacteria from this particular host defence mechanism. 
7.2.3 Predicting Protein Function Related to Cellular Location 
When considering the potential function of each protein, it is interesting to refer back 
to the flanking genes annotated on the NCBI database. These showed hypothetical 
membrane proteins down stream of both MHA_1205 and MHA_0579. It is possible that 
these as yet uncharacterised proteins are involved in the bacterial haem uptake system. 
As mentioned, MHA_0579 is predicted to be an outer membrane protein, however, as 
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a small protein it is unlikely that MHA_0579 is an outer membrane receptor in its own 
right. It could therefore interact with the larger putative membrane protein located 
adjacent in the genome to bring haem into the cell. SignalP could not identify 
transmembrane domain motifs on any Gly1 proteins. These membrane proteins do not 
have any similarity to currently described haem or haemoglobin receptors, but as 
further haem uptake mechanisms with a variety of different protein sequences and 
structures are being discovered this does not discount them as being involved in haem 
acquisition. MHA_1205 is predicted to be a periplasmic protein. Again, MHA_1205 is 
smaller than the haem PBP’s characterised from Gram-negative bacteria to date. It was 
observed to interact with PhuT in the BLItz experiment, which could suggest it acts as a 
periplasmic storage protein or chaperone. Optimisation of haemoglobin receptor 
expression in the competent E. coli cells may shed some light on Gly1 activity in the 
haem uptake system. 
For further work to corroborate the results from the software in Table 3.4, a potential 
step is separation of the periplasm from the outer and inner membranes of the cell of 
isolates found to express the proteins of interest (Chapter 6). This would enable 
identification of the cellular location of these proteins. Alternatively, labelled antibodies 
could be used with fluorescence microscopy on fixed bacterial cells.  
7.3 The Potential of Gly1 Homologues as Vaccine Targets 
Studies into N. meningitidis Gly1 highlighted its potential as a target for antimicrobial 
activity. It is believed to be an outer membrane protein, giving it potential as a surface 
antigen of the bacteria and allowing for easier detection by antibodies. It is understood 
that the capsule of M. haemolytica can mask some of these surface antigens. There is 
evidence that this capsule can interfere with complement mediated bactericidal activity, 
as demonstrated by capsular/ acapsular mutant comparisons, which would potentially 
reduce the efficacy of this method (McKerral and Lo, 2002). N. meningitidis, however, 
also boasts a capsule amongst its defence repertoire, which could interfere with the 
bactericidal effect of the membrane attack complex formed via the complement 
cascade. Investigations in the Sayers lab showed that neisserial Gly1 antibodies induced 
complement mediated bacterial killing, reinforcing the notion that the protein is 
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situated on the OM and also providing evidence that the capsule does not prevent this 
process from occurring (Weirzbicka, 2014). 
The viability as a vaccine candidate would again depend upon the expression levels of 
these potential target proteins. As observed in the western blots, no MHA_0579 was 
detected although MHA_1205 or similar appeared to be throughout, and MHpara was 
detected inconsistently in a number of isolates. It would be revealing to analyse the 
serotypes of the isolates to identify whether these proteins are expressed in the more 
pathogenic isolates; A1, A2 and A6. Additionally, quantification of expression in different 
growth conditions could further investigate the necessity of the individual proteins in 
cellular survival. It is possible that the proteins already induce antibody production 
during host infection and it would therefore be interesting to analyse serum of naïve, 
infected and convalescent animals. OmpA is highly immunogenic and is the major known 
protein of M. haemolytica that antibodies are raised against. Trials of OmpA as a vaccine 
candidate showed immune responses in both mice and cattle along with complement 
mediated killing when incubated with serum from the vaccinated animals (Ayalew et al., 
2011).   
The putative Gly1 homologue from S. enterica arizonae IIIa, SARI, was also found to bind 
haem and is therefore hypothesised to be involved in haem acquisition. While this was 
initially thought to have less potential as a basis for a vaccine as the proportion of 
disease caused by this bacteria is very low, the antisera cross reactivity showed that rat 
anti-SARI antisera was able to detect the wild type varieties of MHA_1205, MHA_0579 
and even slightly N. meningitidis Gly1. This antigen therefore presents a potential broad-
range vaccine component. Further studies investigating the immunogenicity and 
bactericidal activity would be required to corroborate this evidence.  
7.4 Summary 
This project has shown that the putative periplasmic haem binding protein PhuT does in 
fact bind hemin, and has a predicted structure similar to that of other PBP’s. Secondary 
structure prediction suggested a majority alpha helical shape, however, spectral analysis 
showed more beta than alpha even though the CD spectrum had a shape characteristic 
of alpha helical protein. This was possibly due to the reference proteins within the 
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database on the Dichroweb analysis software. Periplasmic haem binding proteins have 
been observed to bind the Fe2+ and Fe3+ oxidation states of haem with different 
affinities, with many binding hemin preferentially. PhuT caused a shift in the hemin 
spectrum but not the haem spectrum. It is therefore possible that the M. haemolytica 
PhuT protein has a higher affinity for hemin than haem. Confirmation of the cellular 
location would provide the final information required to state that this protein is a 
periplasmic haem binding protein of M. haemolytica. The predicted haem PBP, PhuT has 
been shown to bind haem supporting the annotation on the NCBI database. 
APP Gly1 function is still unknown. No haem binding was observed in any studies 
performed, and no further ideas were gleaned from the results of this project. 
Preliminary investigations into APP Gly1- erythrocyte binding showed a slight shift in 
positive population in flow cytometry but this was not conclusive as a population shift 
was also observed with some controls (data not shown). Further preliminary adhesion 
studies using mouse anti-APP Gly1 antisera again did not appear to show any interaction 
with the porcine trachea, although the staining had a high level of background (data not 
shown). Unfortunately the low amount of antisera available limited the possibility of 
experimental repeats post-optimisation. The putative Gly1 homologue from A. 
pleuropneumoniae has, however, been discounted as a Gly1 family protein, and this 
investigation has cast doubt over whether it even exists within this bacterial genome, 
but A. suis or A. equuis. 
Overall this thesis has described previously unknown basic functions of five bacterial 
proteins and added to the structural knowledge of a putative family of haem binding 
proteins ‘Gly1’ found in Gram-negative bacteria. It has highlighted the potential of these 
proteins as vaccine candidates based on the discovery of their genes in bacterial isolates. 
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9. Appendix 
Appendix 1. PhuT secondary structure as predicted by SABLE server. 
 
Cell type Genotype 
K-12 M72 lac(am) trp(am) rpsL lambda cI857 deltaH1 
bio252 
BL21(DE3) F– ompT hsdSB(rB–, mB–) gal dcm (DE3) 
BL21(DE3)RIPL B F– ompT hsdS(rB– mB–) 
dcm+Tetrgalλ(DE3) endA Hte [argU 
proLCamr] [argU ileY leuW Strep/Specr] 
XLI Blue endA1 gyrA96(nalR) thi-1 recA1 relA1 lac 
glnV44 F'[ ::Tn10 proAB+ lacIq 
Δ(lacZ)M15] hsdR17(rK- mK+) 
Appendix 2. Plasmids used within this thesis.  
 
Appendix 3. Enterokinase cleavage of SARI C-His polyhistidine tag. 
 
 
